Conservation of mechanosignaling: responses of human adult mesenchymal stem cells and differentiated vascular cells to applied physical forces by Doyle, Adele Marion
CONSERVATION OF MECHANOSIGNALING:
RESPONSES OF HUMAN ADULT MESENCHYMAL STEM CELLS AND







of the Requirements for the Degree
Doctor of Philosophy in the
School of Biomedical Engineering
Georgia Institute of Technology
May 2010
CONSERVATION OF MECHANOSIGNALING:
RESPONSES OF HUMAN ADULT MESENCHYMAL STEM CELLS AND
DIFFERENTIATED VASCULAR CELLS TO APPLIED PHYSICAL FORCES
Approved by:
Professor Robert M. Nerem, Advisor
Mechanical Engineering
Georgia Institute of Technology
Professor Melissa L. Kemp
Biomedical Engineering
Georgia Institute of Technology
Professor Frank P. Barry
Regenerative Medicine Institute
(REMEDI)
National University of Galway, Ireland
Professor Andrew P. Kowalczyk
Cell Biology
Emory University
Professor Robert E. Guldberg
Mechanical Engineering
Georgia Institute of Technology
Date Approved: 22 March 2010
ACKNOWLEDGEMENTS
This work was made possible with the support, insight, and camraderie of many people.
I am very grateful to Dr. Robert Nerem, my advisor, for giving me the freedom to pursue
scientific questions I found most interesting. Dr. Nerem made possible my participation in
national and international conferences, an important community and source of critiques
throughout this work, and encouraged me to participate in broadening experiences in-
cluding an internship, research exchange, and summer course at the Marine Biological
Laboratory. These unique experiences have helped shape me as a scientist and person. I
am grateful and fortunate to be a Student Of Bob.
I have very much enjoyed interacting with my thesis committee during the evolution of
this work: Dr. Frank Barry, Dr. Robert Guldberg, Dr. Melissa Kemp, and Dr. Andrew
Kowalczyk. I am grateful for the creative insight each of them provided through their ques-
tions and comments on the work. In particular, I thank Drs. Barry and Guldberg for sharing
their perspective on mesenchymal stem cells and regenerative medicine, Dr. Kemp for her
expertise in cell signaling analysis, and Dr. Kowalczyk for grounding these results in terms
of broader cell biology. I am also most appreciative of my committee for their investment in
and mentorship of my scientific development.
Dr. Taby Ahsan, a former member of the Nerem Laboratory, provided mentorship and
careful, thorough training when I joined the laboratory. I am very grateful for the many hours
she invested. I am also grateful to Steve Woodard for his continually positive demeanor
and for keeping the Nerem Lab well-stocked and with serviced equipment.
I am grateful to the following principal investigators and their laboratories who shared
resources and expertise at various stages of my research: Dr. Frank Barry, Dr. Robert
Guldberg, Dr. Todd McDevitt, Dr. Andres Garcia, Dr. Larry McIntire, Dr. Hanjoong Jo, Dr.
Steve Stice, Dr. Alex Peister, and Dr. Kathy Griendling. Dr. Leonard Anderson, Michelle
iii
Leander, and Guoshen Wang at the Morehouse School of Medicine provided critical techni-
cal assistance related to the microarrays. Steve Pittard at Emory University provided rapid
technical assistance related to bioinformatics software. Jim McEntee machined bioreactor
components used for this work; I am grateful he shared some of his expertise with me. I
thank Johnafel Crowe, Tracey Couse, and Aqua Asberry for their assistance with IBB core
facilities. Darren Nowell provided helpful assistance regarding funding. Finally, I appreci-
ate the intellectual community, collaborative attitude, and administrative support provided
by faculty and staff afflilated with the Parker H. Petit Insitute for Bioengineering Bioscience
and the Georgia Institute of Technology/Emory University joint Wallace H. Coulter Depart-
ment of Biomedical Engineering.
For scientific critiques and camraderie in the Nerem Laboratory, I am grateful to current,
almuni, and visiting members: Dr. Taby Ahsan, Randy Ankeny, Dr. Josette Broiles, Dr.
Tiffany Brown, Dr. Jonathon Butcher, Dr. Vibha Choudhury, Lisa Cox, Dr. Garry Duffy,
Chris Durst, Dr. Ann Ensley, Dr. Zannatul Ferdous, Bob Gauvin, Dr. Sarah Griffiths, Casey
Holliday, Min-Song Hong, Kathy Huggins, Christian Mandrycky, Dr. Kara McCloskey, Dr.
Neethu Mohan, Dr. Prabha Nair, Barbara Nsiah, Dr. Lucy O’Keefe, Julia Raykin, Dr. Stacey
Schutte, Dr. Dror Seliktar, Dr. David Simpson, Dr. Jan Stegemann, Lynda Thomas, and
Steve Woodard.
I am grateful to my mentors outside the Georgia Institute of Technology/Emory Univer-
sity community. Dr. Athanasios Mantalaris and Dr. Judit Nagy at Imperial College London
hosted and provided intensive training in embryonic stem cell culture, encapsulation, and
proteomic assessment as part of an NSF International Research and Education in Engi-
neering experience. Dr. Michael Raxworthy made possible my internship at the Smith &
Nephew Research Center (York, UK). Finally, I am indebted to the Marine Biological Lab-
oratory Embryology course directors, Dr. Lee Niswander and Dr. Nipam Patel, the faculty
and course assistants, and my classmates involved in the 2009 course. Their enthusiam
for science and investment in teaching are remarkable. My doctoral pursuit was strongly
influenced by previous academic mentors: Dr. Allan M. Goldstein, Dr. Drucilla J. Roberts,
Dr. Allan N. Mayer, and Dr. Lizabeth A. Perkins (Massachusetts General Hospital); Dr.
iv
Larry A. Taber, Dr. Salvatore P. Sutera, Dr. Frank C-P. Yin, and Dr. Guy M. Genin (Wash-
ington University in St. Louis); Dr. Elliot L. Chaikof (Emory University); and Dr. Roger G.
Harrison (University of Oklahoma).
I am grateful to the National Insitutes of Health, National Science Foundation, American
Association of University Women, Georgia Insitute of Technology, and Coulter Department
of Biomedical Engineering for substantial financial support. I am also grateful to the Soci-
ety of Developmental Biology, Society of Biological Engineering, Tissue Engineering and
Regenerative Medicine International Society, and the Bud L. Suddath family for additional
financial support.
I thank the friends who kept me balanced and with a sense of humor during graduate
school: Leslie for her energy; Jen for her wit; Victoria, Rekha, and Abbey for their adven-
turous sides; Bob for his bluntness; Garry for his laughter; Sarah for her candor; and many
other fellow students and post-docs in the IBB and BME department laboratories.
The most important people who helped me reach this point are my family: AGD, DAD,
BCD, PRD, MCS, CCD, MCL, KPP, CHL, and OCR. I am indebted to them for their love
and support and grateful for the inspiration they provide.
v
TABLE OF CONTENTS
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
LIST OF SYMBOLS OR ABBREVIATIONS . . . . . . . . . . . . . . . . . . . . . . . xv
SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xvi
I INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Significance of Research . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Clinical Significance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Overview of Dissertation Approach . . . . . . . . . . . . . . . . . . . . . . 2
1.3.1 Specific Aim 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.3.2 Specific Aim 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.3.3 Specific Aim 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.4 Additional materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.5 Clarification of terms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.6 Significance of Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
II BACKGROUND AND SIGNIFICANCE . . . . . . . . . . . . . . . . . . . . . . . 7
2.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2 Review of Relevant Literature . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2.1 Mesenchymal stem cell isolation and characterization . . . . . . . 7
2.2.2 Contributions of mesenchymal stem cells in vascular therapies . . 8
2.2.3 Importance of mechanical cues in the vasculature . . . . . . . . . 8
2.2.4 Overview of mechanobiology . . . . . . . . . . . . . . . . . . . . . 9
2.2.5 Signaling response of vascular smooth muscle cells to cyclic strain 10
2.2.6 Signaling response of endothelial cells to steady laminar shear stress 12
2.2.7 Signaling response of mesenchymal stem cells to cyclic strain . . 13
2.2.8 Signaling response of MSCs to fluid shear stress . . . . . . . . . 13
vi
III CONSERVED AND CELL TYPE-DEPENDENT SIGNAL TRANSDUCTION IN MES-
ENCHYMAL STEM CELLS AND SMOOTH MUSCLE CELLS EXPOSED TO ME-
CHANICAL STRAIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.3.1 Signal transduction genes robustly expressed . . . . . . . . . . . 17
3.3.2 MSCs and SMCs differ in baseline expression of specific signal
transduction genes . . . . . . . . . . . . . . . . . . . . . . . . . . 19
3.3.3 Morphology of samples exposed to equibiaxial strain indistinguish-
able from static controls . . . . . . . . . . . . . . . . . . . . . . . . 19
3.3.4 Comparison of overall signal transduction gene expression in strain
model system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
3.3.5 Strain responses of SMCs and MSCs . . . . . . . . . . . . . . . . 20
3.3.6 Gene expression dependence on applied force and cell type . . . 21
3.3.7 PCR array sensitivity limits analysis of genes with low expression
levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.3.8 Temporal Kinetics of Gene Expression Changes . . . . . . . . . . 23
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.4.1 Strain Responses Conserved between MSCs and SMCs . . . . . 30
3.4.2 Strain Responses Specific to SMCs . . . . . . . . . . . . . . . . . 32
3.4.3 Strain Responses Specific to MSCs . . . . . . . . . . . . . . . . . 33
3.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.6 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.7 Supplemental Figures and Tables . . . . . . . . . . . . . . . . . . . . . . 37
IV TRANSCRIPTOME RESPONSES OF MESENCHYMAL STEM CELLS AND AOR-
TIC SMOOTH MUSCLE CELLS TO APPLIED EQUIBIAXIAL CYCLIC STRAIN 44
4.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
4.3.1 Morphology of cells in response to cyclic strain . . . . . . . . . . . 46
4.3.2 Global gene expression responses of MSCs and SMCs to cyclic
strain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
vii
4.3.3 Significance and fold-change comparisons of MSCs and SMCs
cyclic strain response . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.3.4 Paired t-test comparison of MSCs and SMCs strain-response . . 50
4.3.5 Identification of conserved strain-responsive genes . . . . . . . . 50
4.3.6 Chromosomal distribution of strain-responsive genes . . . . . . . 55
4.3.7 Signaling network analysis of conserved strain-responsive genes 55
4.3.8 Functional and regulatory analysis of strain-responsive genes . . 57
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.6 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.7 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
V MESENCHYMAL STEM CELLS RESPOND TO SHEAR STRESS WITH RE-
DUCED INFLAMMATORY SIGNALING . . . . . . . . . . . . . . . . . . . . . . 67
5.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
5.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
5.3.1 Cell shape and number in response to shear stress . . . . . . . . 71
5.3.2 Overall gene expression comparison . . . . . . . . . . . . . . . . 74
5.3.3 Shear response of endothelial differentiation genes . . . . . . . . 74
5.3.4 Shear response of immune and inflammatory genes . . . . . . . . 76
5.3.5 Effect of shear magnitude on gene expression response . . . . . 78
5.3.6 Correlation of protein expression with gene expression . . . . . . 80
5.3.7 Shear-response varies with underlying protein substrate . . . . . 82
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
5.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.6 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
VI TRANSCRIPTOME COMPARISON OF MESENCHYMAL STEM AND AORTIC
ENDOTHELIAL CELL RESPONSE TO VASCULAR-RELEVANT APPLIED FLUID
SHEAR STRESS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
6.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
6.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
viii
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
6.3.1 Morphology of ECs and MSCs in response to applied shear stress 94
6.3.2 Overview of microarray results . . . . . . . . . . . . . . . . . . . . 95
6.3.3 Shear-responsive genes identified in MSCs and ECs . . . . . . . 97
6.3.4 Global gene expression responses of MSCs and ECs to shear stress 99
6.3.5 Distribution of conserved shear-responsive genes across chromo-
somes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
6.3.6 Cellular and functional distribution of conserved shear-responsive
molecules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
6.3.7 Direct interactions within conserved shear-responsive gene set . . 102
6.3.8 Molecular function clusters affected by conserved shear stress-
responsive genes . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
6.3.9 Predicted transcription factor regulators of conserved shear-responsive
genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
6.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
6.6 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
6.7 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
VII DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
7.1 Limitations of Experimental Design . . . . . . . . . . . . . . . . . . . . . . 120
7.2 Responses to Cyclic Strain . . . . . . . . . . . . . . . . . . . . . . . . . . 122
7.3 Responses to Shear Stress . . . . . . . . . . . . . . . . . . . . . . . . . . 123
7.4 Comparison of Cyclic Strain and Shear Stress Mechanosensitive Gene
Expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
7.5 Mechanoresponse Varies with Underlying Protein Substrate . . . . . . . 127
7.6 Cellular Mechanisms to Sense Physical Forces . . . . . . . . . . . . . . . 128
7.7 Future directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
VIII CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
8.1 MSCs Cyclic Strain Response Compared to SMCs . . . . . . . . . . . . . 133
8.2 MSCs Shear Stress Response Compared to ECs . . . . . . . . . . . . . 133
8.3 Vascular-relevant Mechanobiology . . . . . . . . . . . . . . . . . . . . . . 134
8.4 Closing Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
ix
APPENDIX A CHARACTERIZATION OF MESENCHYMAL STEM CELLS . . . . 137
APPENDIX B DETAILED PROTOCOLS . . . . . . . . . . . . . . . . . . . . . . . 147
APPENDIX C SUPPORTING DOCUMENTATION: MESENCHYMAL STEM CELLS
REARRANGE INTO MULTICELLULAR CLUSTERS IN RESPONSE TO EQUIB-
IAXIAL CYCLIC STRAIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
APPENDIX D MICROARRAY SUPPLEMENTAL TABLES . . . . . . . . . . . . . 169
APPENDIX E MECHANORESPONSE MODELING . . . . . . . . . . . . . . . . . 225
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 228
x
LIST OF TABLES
1 Distribution of up- and down-regulated genes. . . . . . . . . . . . . . . . . . 23
2 Gene expression responses to applied cyclic strain. . . . . . . . . . . . . . 40
3 Gene Table for Signal Transduction PathwayFinder PCR Array (SA Biosciences). 41
4 Cell type-dependent signal transduction gene expression. . . . . . . . . . . 42
5 Summary table of genes significantly altered by cyclic strain . . . . . . . . . 43
6 Highly significant strain-responsive genes in MSCs. . . . . . . . . . . . . . 52
7 Highly significant strain-responsive genes in SMCs. . . . . . . . . . . . . . 53
8 DAVID functional clustering of conserved, strain-responsive genes. . . . . . 58
9 Transcription regulatory networks predicted to mediate MSCs and SMCs
response to cyclic strain. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
10 Immune and inflammatory response genes in endothelial cells . . . . . . . 69
11 Gene Ontology (GO) terms relatively upregulated in conserved shear-responsive
genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
12 Functional clusters significantly (p < 0.05) affected by conserved shear-
responsive genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
13 Transcription factor regulation of conserved shear-responsive genes. . . . . 118
14 Genes with conserved strain-responses in MSCs and SMCs . . . . . . . . 169
15 Conserved shear-responsive genes identified using two factor ANOVA and
paired t-tests of ECs and MSCs. . . . . . . . . . . . . . . . . . . . . . . . . 194
xi
LIST OF FIGURES
1 Overview of cell and force type comparisons. . . . . . . . . . . . . . . . . . 4
2 Characteristic Protein Surface Marker Expression in MSCs . . . . . . . . . 8
3 Publications related to MSCs. . . . . . . . . . . . . . . . . . . . . . . . . . . 9
4 Physical forces in the vasculature. . . . . . . . . . . . . . . . . . . . . . . . 10
5 Experimental groups compared for expression of signal transduction genes,
assessed using PCR arrays. . . . . . . . . . . . . . . . . . . . . . . . . . . 18
6 Signal transduction gene expression levels in MSCs and SMCs under main-
tenance culture conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
7 Heatmap of genes with significantly different expression in MSCs and SMCs
under maintenance conditions. . . . . . . . . . . . . . . . . . . . . . . . . . 19
8 Morphology and signal transduction gene expression levels of MSCs and
SMCs exposed to equibiaxial strain (10%, 1 Hz) or static culture for 24 hours. 22
9 Gene expression changes in MSCs (blue) and SMCs (orange) in response
to applied cyclic strain (10%, 1 Hz for 24 hr) assessed using a signal trans-
duction PCR array. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
10 Two-factor ANOVA of signal transduction gene responses to strain . . . . . 28
11 Expression kinetics of genes with known or predicted strain responsiveness
conserved between MSCs and SMCs. . . . . . . . . . . . . . . . . . . . . . 29
12 Detection of genes in MSCs and SMCs under maintenance culture conditions. 38
13 Relative gene expression levels for genes identified as cyclic strain respon-
sive using one or more methods. . . . . . . . . . . . . . . . . . . . . . . . . 39
14 Schematic of cyclic strain microarray experimental design. . . . . . . . . . . 47
15 Cell morphology response to equibiaxial cyclic strain. . . . . . . . . . . . . 47
16 Summary of gene expression differences between sample groups. . . . . . 48
17 Volcano plots comparing significance and fold-change results in SMCs and
MSCs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
18 Strain-responsive genes in MSCs and SMCs identified via paired t-tests. . . 50
19 Comparing strain-responsive gene sets identified via two-factor ANOVA or
paired t-test. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
20 Distribution of conserved, strain-responsive genes according to chromoso-
mal location. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
21 Cellular location and molecular function distribution in strain-responsive sig-
naling network. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
xii
22 Phase morphology of ECs and MSCs in response to static or applied shear
stress culture. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
23 Quantification of cell number and viability in MSCs. . . . . . . . . . . . . . . 73
24 Kinetics of endothelial differentiation gene expression in response to applied
shear stress. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
25 Kinetics of immune and inflammatory gene expression in response to ap-
plied shear stress. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
26 Shear-responsive gene expression is dependent on the magnitude of ap-
plied shear stress. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
27 Protein expression in ECs and MSCs exposed to shear stress. . . . . . . . 81
28 Effect of underlying protein substrate on MSCs response to applied shear
stress. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
29 Schematic of known interactions between genes on immune and inflamma-
tory marker panel. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
30 Schematic of shear stress microarray experimental design. . . . . . . . . . 94
31 Comparison of cell morphology in response to shear stress. . . . . . . . . . 95
32 Overview of microarray analysis of ECs and MSCs samples exposed to ap-
plied shear stress. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
33 Volcano plots comparing significance and fold-change distributions of gene
expression changes due to applied shear stress. . . . . . . . . . . . . . . . 97
34 Nested loops of MSCs and ECs shear-responsive genes identified via paired
t-test. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
35 Venn diagram representation of shear-responsive genes in MSCs and ECs. 100
36 Distribution of conserved shear-responsive genes across chromosomes. . . 101
37 Cellular locations and molecular functions associated with conserved shear
stress-responsive signaling network. . . . . . . . . . . . . . . . . . . . . . . 103
38 Direct signaling interactions between conserved shear-responsive genes. . 104
39 Flow cytometry characterization of Lot . . . . . . . . . . . . . . . . . . . . . 138
40 Osteogenic differentiation of Lot . . . . . . . . . . . . . . . . . . . . . . . . . 139
41 Adipogenic differentiation of Lot . . . . . . . . . . . . . . . . . . . . . . . . . 140
42 Flow cytometry characterization of Lot . . . . . . . . . . . . . . . . . . . . . 142
43 Osteogenic differentiation of Lot . . . . . . . . . . . . . . . . . . . . . . . . . 143
44 Adipogenic differentiation of Lot . . . . . . . . . . . . . . . . . . . . . . . . . 144
45 Genes with conserved responses to strain and shear stress. . . . . . . . . 226
xiii
46 List of genes with conserved force-responses to cyclic strain and shear stress.227
xiv
LIST OF SYMBOLS OR ABBREVIATIONS
Cox2 prostoglandin synthase 2, a.k.a. Cox-2, gene.
CVD cardiovascular disease.
ECs human aortic endothelial cells.
eNos endothelial nitric oxide synthase, a.k.a. Nos3, gene.
EPC endothelial progenitor cell.
ESC embryonic stem cell.
GvHD graft versus host disease.
Hmox1 heme oxygenase 1 gene.
Il8 interleukin 8 gene.
Klf2 Kruppel-like factor 2 gene.
Mcp1 monocyte chemotactic protein 1 gene.
MI myocardial infarction.
MSCs human adult bone marrow-derived mesenchymal stem cells.
Pecam1 platelet endothelial cell adhesion molecule 1, a.k.a. CD31, gene.
SMCs human aortic smooth muscle cells.
Vcam1 vascular cell adhesion molecule 1 gene.
VE-Cad vascular endothelial cell adhesion molecule, a.k.a. CD144 or Cadherin 5,
gene.
vWF von Willebrand factor gene.
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SUMMARY
Mesenchymal stem cells (MSCs) may benefit vascular cell-based therapies as
smooth muscle or endothelial cell substitutes or through paracrine actions to repair, re-
place, or regenerate vascular tissue. Previous studies have demonstrated that MSCs can
adopt traits of smooth muscle cells (SMCs) or endothelial cells (ECs), as well as secrete
specific factors that tune signaling and material properties in the local environment. Few
studies have investigated the cell signaling response of MSCs to mechanical forces present
in the vasculature: specifically, shear stress due to blood flow and cyclic strain due to pul-
satile blood flow. Thus, the central objective of this dissertation was to determine the
signaling responses of MSCs to vascular-relevant applied physical forces, in comparison
with that of differentiated vascular cells.
Vascular-relevant mechanosignaling of MSCs was assessed through two comparisons:
(1) MSC and SMC responses to applied cyclic strain and (2) MSC and EC responses
to applied fluid shear stress. MSCs and SMCs were seeded on fibronectin-coated sil-
icone and subjected in vitro to cyclic strain (10%, 1 Hz) or parallel static culture using
a custom-built equibiaxial cyclic strain device. Gene expression analysis of 84 signal
transduction molecules demonstrated both cell types respond with significant (p < 0.05,
n=3) fold-changes (|FC| ≥ 1.5) within 24 hours of applied equibiaxial strain. Most strain-
responsive genes identified were significantly strain-responsive in only one cell type. A
signaling trio of Interleukin 8, Vascular cell adhesion molecule 1, and Heme oxygenase 1
was significantly altered in both MSCs and SMCs, suggesting cyclic strain regulates im-
mune and inflammatory functions in both cell types. The response to shear stress of MSCs
and ECs was compared using cells seeded on type I collagen or fibronectin and exposed
to steady laminar shear stress (5 or 15 dyn/cm2) using a parallel plate shear chamber
system. Gene expression was compared in MSCs and ECs for a panel of immune and
inflammation-related markers. Expression of Cox-2 and Hmox-1 increased significantly
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(p < 0.05, n3; |FC| ≥ 1.5) in both cell types. Reduced shear stress-responses of Mcp-1,
Pecam-1, and VE-Cad in MSCs relative to ECs suggests that MSCs promote less inflam-
mation and immune activation in response to shear stress than ECs. Mechanosensitivity
profiles for MSCs and differentiated vascular cells were broadened using whole genome
microarrays. These high-throughput studies confirmed that (1) signaling profiles between
sample groups vary significantly more (p < 0.05, n=3) with cell type than applied force
condition and (2) a subset of conserved mechanosensitive genes alter expression levels
significantly and in the same direction fold-change in multiple cell types. Bioinformatics
analysis of these conserved mechanoresponsive genes highlighted oxidative stress, cell
cycle, and DNA replication as functions regulated by vascular-relevant mechanical cues.
These studies demonstrate that MSCs partially reproduce differentiated vascular cell
mechanosignaling, while simultaneously altering expression of genes not typically force-
responsive in vascular cells. This work defines a role for conserved mechanosignals,
based on genes whose expression in response to applied force alters significantly (p <
0.05, n ≥ 3) and by at least 1.5-fold change in multiple cell types and/or force types.
Comparisons completed for this dissertation motivate future studies to track the functional
impact of specific similar or unique MSC mechanoresponses. This work contributes to





Cardiovascular disease continues to be the primary cause of death in the U.S. each year
[319]. Treatment of cardiovascular disease (CVD) is limited by our ability to replace, re-
generate, or repair the native, physiological function [79]. Stem cell-based therapies offer
one way to improve on this, using biological mechanisms to treat cardiovascular disease
[226, 14, 217]. Several groups have investigated various types of stem cells for treatment
of CVD, often focusing on either differentiation to generate a new source of vascular cells
or repair of specific functions (e.g., ejection fraction improvements after myocardial infarc-
tion, MI) [87, 48]. Little is known about the vascular-relevant mechanosensitivity of stem
cells, although mechanical cues are inherent in the vasculature and affect signaling in en-
dothelial and smooth muscle cells [158, 74, 89]. The central objective of this work is to
investigate the effects of physiologically-relevant mechanical cues on mesenchymal stem
cell signaling, one of the most promising stem cell sources for cardiovascular therapies.
1.1 Significance of Research
Mechanical forces are an inherent component of the microenvironment to which cells are
exposed, both in vivo and in vitro. This dissertation contributes to rational design of tissue
engineered and regenerative medicine therapies by providing (a) knowledge of the cell sig-
naling response of MSCs to cardiovascular-relevant applied physical forces and (b) com-
parison of MSCs response with that of cells normally found in the vasculature. Very limited
data exists describing the force-sensitivity of stem cells, specifically MSCs. Execution of
the specific aims in this dissertation provides data relevant to basic stem cell, particularly
MSCs, biology. Though motivated in the context of vascular therapies, this work can also
benefit other applications in which cyclic strain and/or shear stress are relevant. In terms
of fundamental mechanobiology, these aims provide a systematic analysis of mechanical
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responses in three cell types. The high-throughput approach may provide a framework
for future mechanoresponse studies. Furthermore, these in vitro cell culture systems may
serve as models of biological response in which to study development, disease, and poten-
tial therapeutics. Finally, this data set describing the signaling pathways active at different
stages of differentiation may be relevant to the field of developmental biology, given the
importance placed on understanding and controlling cellular differentiation.
1.2 Clinical Significance
Data from the Centers for Disease Control and Prevention ranks cardiovascular disease
as the number one cause of death in the United States [319]. Heart, cerebrovascular,
and hypertension-related diseases accounted for 32% of all deaths in 2007, according to
the most recent data available from the CDC [319]. More than 25 million people (1̃2% of
the adult population) in the US are non-institutionalized victims of heart disease [227] and
27% of persons aged 20 years and older have hypertension [33], a disease specifically
related to the vasculature. In 2007, care of cardiovascular diseases in the U.S. is projected
to require more than $400 billion in direct healthcare and related morbidity/mortality costs
[198]. Advances in treatment options for cardiovascular diseases are needed to reduce
both the number of patients affected and the associated economic burden. Cell-based
therapies are one proposed method by which to use biological mechanisms of action to
promote health [122]. Mesenchymal stem cells, a bone marrow-derived adult progenitor
cell source, are currently involved in more than 85 clinical trials world-wide listed in the NIH
clinical trials database [197] and are reported in several published trial results [91, 150,
275, 11, 38, 39, 127, 128, 164].
1.3 Overview of Dissertation Approach
Mesenchymal stem cells (MSCs) may benefit vascular therapies through paracrine action
or potentially differentiation along vascular lineages. In spite of clues that MSCs may ame-
liorate vascular problems, we lack broad and predictive understanding about MSCs signal-
ing in the vascular environment. To address this knowledge gap and expand knowledge
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of vascular cell mechanoresponse, parallel comparisons for MSCs and differentiated vas-
cular cells have been completed. Our central hypothesis is that cell signaling changes in
response to applied physical force are conserved between MSCs and differentiated cells.
The MSCs mechanoresponse was compared to endothelial cells exposed to steady lam-
inar fluid shear stress and to vascular smooth muscle cells exposed to equibiaxial cyclic
strain. Signaling was assessed using either a panel of related markers under a range of
force conditions or using microarrays for high-throughput signaling analysis under a single
shear stress or strain condition. Three specific aims, represented in Figure 1 and described
below, were completed to address the central hypothesis.
1.3.1 Specific Aim 1.
Determine the mechanoresponse, in particular Interleukin 8 signaling, of MSCs and
aortic smooth muscle cells (SMCs) as a function of equibiaxial cyclic strain. The
working hypothesis is that Interleukin 8 will be activated in response to cyclic strain in both
MSCs and SMCs. MSCs and SMCs were exposed to equibiaxial cyclic strain (10%, 1 Hz)
for 24 hours and assessed using PCR arrays for expression of signal transduction genes.
Novel strain responsive genes, unique to a single cell type or present in multiple cell types,
were identified using significance and fold change criteria. A strain-responsive signaling
motif, including Interleukin 8, was identified from PCR array analysis. Kinetics (0-24 hr) of
strain-response for genes in this signaling node were quantified in MSCs and SMCs using
standard qPCR. Results are described in Chapter 3.
1.3.2 Specific Aim 2.
Determine the inflammatory and immune mechanoresponses, specifically Pecam1
signaling, of MSCs and aortic endothelial cells (ECs) as a function of steady laminar
shear stress magnitude and duration. The working hypothesis is that Pecam1 gene and
protein expression will increase in response to shear stress in both MSCs and ECs. MSCs
and ECs were subjected to varying durations (0-48 hr) of steady laminar fluid shear stress
at a low (5 dyn/cm2) or high (15 dyn/cm2) magnitude shear stress, approximating small
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Figure 1: Overview of cell and force type comparisons included in dissertation. The
response to equibiaxial cyclic strain of MSCs and SMCs is compared in Aim 1 (left). In
Aim 2, MSCs and ECs are compared using their response to steady laminar shear stress
(right). Aim 3 employs high-throughput assessments for both cell type comparisons to
better characterize the signaling responses to cyclic strain or shear stress.
and large vessel shear stress levels, respectively. Shear-responsive gene expression was
quantified for a panel of eight immune and inflammatory markers, including those also
used to infer endothelial differentiation. Correlation of gene and protein expression for
Pecam1, VE-Cad, and vWF was determined using immunocytochemistry and confocal
imaging. Cell number quantification and effect of underlying protein substrate were used
to further understand how MSCss respond to applied shear stress. Results are described
in Chapter 5.
1.3.3 Specific Aim 3.
Determine the gene expression signaling profile, using cDNA microarrays, for MSCs
exposed to cyclic strain or shear stress and vascular differentiated cells exposed to
the same force. The working hypothesis is that the signaling profile of gene and protein
expression is conserved between MSCs and terminally differentiated cells in response to
site-appropriate forces characteristic of the originating vascular tissue. A high-throughput
strain and high-throughput shear analysis were completed, comparing MSCs and SMCs
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in the former and MSCs and ECs in the latter after exposure to the physical forces de-
scribed above. Microarray analysis was first completed using traditional methods, identi-
fying mechanoresponsive genes with significance and fold change criteria and predicting
functional relevance with bioinformatics software. These results are described separately
for the strain comparison (Chapter 4) and shear comparison (Chapter 6). Preliminary anal-
ysis of whole genome mechanoresponse modeling, comparing across both cell type and
force condition, is included in Appendix E.
1.4 Additional materials
Context for the primary research described above is provided in additional chapters. A
review of relevant work completed by others is included in Chapter 2. Chapter 7 discusses
the overall implications of work completed to address these specific aims. Appendices
include detailed protocols and peripherally-related studies completed to understand MSCs
biology.
1.5 Clarification of terms
Throughout this thesis, two terms are used repeatedly to describe mechanosignaling re-
sponses: ‘significant’ and ‘conserved.’
• For this document, the term ‘significant’ indicates a statistical difference between two
populations. Two-factor ANOVA and paired t-tests are the most frequently used sta-
tistical tests to assess differences. Unless otherwise specified, differences are con-
sidered significant when the probability of occurrence by chance is less than 5% (e.g.,
p < 0.05). Biological significance of these changes is suggested, but not proven, by
this mathematical definition.
• The term ‘conserved’ describes quantities ‘maintained constant during a process of
chemical, physical, or evolutionary change’ [184]. In biology-related fields, conserved
signaling molecules often refer to presence of a gene or protein in different species,
based on homology between gene or protein sequences or, more recently, network
motifs [50]. This dissertation proposes mechanoresponsiveness as an additional
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property by which to define ‘conserved’ elements. Conserved mechanoresponsive
molecules referenced in this document alter by at least 1.5-fold magnitude, the de-
tection threshold of gene assessment methods used, and are statistically significant
(p < 0.05, n=3) according to at least three measures: paired t-tests in both cell types
(MSCs and SMCs or MSCs and ECs) and corrected force-dependent p-value from
two-factor ANOVA. Molecules can be conserved in terms of strain response between
MSCs and SMCs (Chapters 3 and 4) or shear stress response between MSCs and
ECs. A few molecules were identified with conserved force-responsiveness in all
conditions (similar changes across three cell types and two force types), as listed in
Appendix E.
1.6 Significance of Results
Results from this dissertation contribute to the fields of cardiovascular biology, stem cells,
tissue engineering and regenerative medicine, and mechanobiology. New instances of
gene mechanosensitivity were identified in multiple cell types and due to both cyclic strain
and shear stress. This data provides one of the first descriptions of MSCs signaling in
response to vascular-relevant mechanical cues, distinct from differentiation-focused stud-
ies or those using orthopedic levels of physical forces. MSCs responded to applied forces
through a combination of changes also present in differentiated vascular cells and those
observed only in MSCs. Differences in MSCs and vascular cell signaling necessitate fur-
ther scrutiny before these cells can be confidently used in a vascular cell-based therapy.
The systematic comparisons and high-throughput data analysis used here to understand
mechanoresponse may also be applied to other cell types. In addition, the theme of
mechanoresponse as a combination of conserved and unique features provides a frame-






This work builds on previous studies establishing the importance of mechanosignaling for
vascular physiology, as well as evidence indicating MSCs may improve vascular function.
The following literature review focuses on the biology of MSCs, mechanical cues in the
vasculature, and mechanoresponses of smooth muscle cells and endothelial cells. Current
knowledge regarding mechanosensitivity of MSCs is also presented.
2.2 Review of Relevant Literature
2.2.1 Mesenchymal stem cell isolation and characterization
Human mesenchymal stem cells (MSCs) are derived from the bone marrow and isolated
using a density gradient separation and subsequent plating of the mononuclear cell frac-
tion. MSCs are 0.001-0.01% of the resulting adherent cells [225]. MSCs have historically
been defined according to: (a) a protein expression profile (Figure 2); (b) the potential to dif-
ferentiate along osteogenic, chondrogenic, and adipogenic lineages; and (c) an adherent,
spindle-shaped morphology [225, 65]. Since neither the protein markers nor differentiation
capacity are unique to MSCs, one outstanding challenge in the field is the lack of a con-
clusive assay to define MSCs. Furthermore, variations in tissue source, isolation method,
and characterization of cells have resulted in ambiguities throughout the literature regard-
ing the equivalence of cells used by different groups [302]. For experiments completed for
this dissertation, the term MSCs refers to cells commercially available through Lonza that
have been harvested and cultured from normal human bone marrow and characterized
for surface marker expression (CD105+, CD166+, CD29+, CD44+, CD14-, CD34-, and
CD34-) and potential to differentiate along adipogenic, chondrogenic, and osteogenic lin-
eages [165]. Verification of surface protein marker expression and differentiation potential
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Figure 2: Characteristic Protein Surface Marker Expression in Mesenchymal Stem
Cells. Human adult bone marrow-derived MSCs are characterized by orthopedic-related
differentiation potential, adherent and spindle-shaped morphology, and positive or negative
expression of a panel of surface proteins (listed above). Protein list modified from [226].
was repeated for donors used in this dissertation with MSCs expanded to experimental
use passage (Appendix A).
2.2.2 Contributions of mesenchymal stem cells in vascular therapies
MSCs are an attractive option for cardiovascular cell-based therapies due to their pro-
liferative, multilineage, and paracrine potential [122, 179, 224, 30]. Mesenchymal stem
cells have been proposed as a multipotent, adult stem cell source for use in cardiovascu-
lar applications [226, 80, 87]. Rapid growth in the number of recently published articles
related to mesenchymal stem cells highlights the growing interest of the scientific com-
munity in MSCs-based therapies, and specifically for vascular-related applications (Fig-
ure 3). Several studies suggest beneficial effects of MSCs may be due to differentia-
tion into smooth muscle-like [147, 204, 62, 168, 167, 86, 6, 9, 316] or endothelial-like
[45, 118, 37, 329, 315, 214] cells. However, recent work suggests the source of beneficial
effects of MSCs on host tissue can occur through paracrine effects [54, 133, 207, 230].
The specific contribution of MSCs to vascular repair or regeneration may be a combination
of both these mechanisms.
2.2.3 Importance of mechanical cues in the vasculature
Mechanical forces in the vasculature (Figure 4) have been well studied in large blood ves-
sels such as the aorta and pulmonary artery [10, 154]. Heart contractions and the radial
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Figure 3: Publications related to MSCs. Annual manuscript publications related to MSCs
in general or to MSCs and the vasculature. Data based on ISI Web of Knowledge database
searches for either “mesenchymal stem” (outlined bars) or “mesenchymal stem” and vas-
cula* (solid bars) [236]. In 2009, 562 of a total of 3205 “mesenchymal stem” publications
related to the vasculature.
compliance of vessels result in a pulsatile blood pressure profile and cyclic distension.
The tunica media, the thickest layer of the vessel wall and populated primarily with SMCs,
is expected to sustain a significant portion of the cyclic strain in both the radial and cir-
cumferential directions. Strain mediates changes in SMCs that may affect cytoskeleton
contraction and, subsequently, vessel compliance and downstream blood pressure. Blood
flow through the vessel lumen induces shear stress on the inner surface, lined with an en-
dothelial cell monolayer. Steady laminar shear stress on endothelial cells is important to
maintain a quiescent, non-inflammatory, and non-immunogenic state, pivotal in preventing
blood clotting and subsequent closure of the vessel.
2.2.4 Overview of mechanobiology
Mechanobiology is the study of cells biological response to mechanical loads and the sig-
naling pathways by which these loads are transduced into a cascade of cellular and molec-
ular events [305]. Known mechanisms, measurement methods, and models of cellular
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Figure 4: Physical forces in the vasculature. Adapted from [10]. Cyclic strain acts on
all layers of the vessel wall, including ECs and SMCs, while fluid shear stress acts on the
ECs lining the vessel lumen.
reaction to applied physical forces have been recently reviewed [99, 117]. During develop-
ment, mechanical cues are essential in formation of several regions including limbs [202],
lungs [112], and the aortic arch [322]. Throughout adult life, mechanical cues are critical
for normal function in many tissues, including the ear [77], eye [277], bone [244], cartilage
[32], and heart [151]. Mechanosensing can occur via adhesive connections and associ-
ated cytoskeletal networks or via the cell membrane and membrane-associated proteins
[17, 108, 297, 331]. These physical cues are expected to trigger conformational changes
of signaling molecules that activate cell signaling pathways [296]. Cells unable to trans-
late environmental mechanical cues into biochemical action via gene and protein signaling
pathways can trigger disease [111, 211]. Cell signaling responses triggered by applied
physical forces depend not only on the affected cell and tissue type [27, 95], but also on
specific force parameters such as magnitude and duration [288]. Several groups have in-
vestigated the role of specific signaling components in response to applied physical force.
The following sections describe these results in terms of the cell types and forces relevant
to this dissertation.
2.2.5 Signaling response of vascular smooth muscle cells to cyclic strain
Adult smooth muscle cells respond to cyclic strain with an increase in proliferation, in-
creased collagen production, changes in cytoskeletal composition and arrangement, and
altered gene and protein expression. Mechanical tension is also present at sites of smooth
muscle myogenesis [115] and has been shown in vitro to upregulate expression of genes
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related to differentiation of SMCs [170, 328], suggesting mechanical tension contributes to
development of SMCs. Mechanical strain mechanosensors, downstream genes and pro-
teins targets, and subsequent functional effects in SMCs were reviewed by Haga et al [88].
In brief, the few studies investigating the effects of strain on human SMCs have focused
primarily on changes in gene expression [73, 249, 195], with one study assessing changes
in proteoglycan synthesis and organization [153]. Strain-induced changes, particularly in
terms of membrane or cytoskeletal proteins, have been extensively studied in rat smooth
muscle cells [26, 235, 161, 265, 190]. Strain was found to alter focal adhesion-related
components, inducing vinculin expression and transient paxillin expression within minutes
[52]. Exposure to strain for hours can alter cytoskeletal protein expression by upregulating
the SM1 isoform of smooth muscle myosin heavy chain [235]. Furthermore, two days of
strain appears to shift the functional status of SMCs from contractile to synthetic, reducing
expression of alpha-smooth muscle actin and calponin contractile proteins and increasing
expression of vimentin, an intermediate filament protein [26].
Interleukin 8 (Il8), also known as CXCL8, is a secreted chemokine involved in inflam-
mation, angiogenesis [16], and neutrophil chemoattraction. IL8 protein binds to receptors
IL8R-alpha (CXCR1) and IL8R-beta (CXCR2). Il8 signaling affects inflammation-related
vascular disorders including atherogenesis and hypertension [22, 131]. Multiple studies
have shown that cyclic strain increases Il8 gene and protein expression in airway epithe-
lial and smooth muscle cells [295, 216, 145], endothelial cells [209], endometrial stromal
cells [90], and uterine smooth muscle cells [166]. In contrast, cyclic strain of skeletal
myotubes results in decreased IL8 protein secretion in skeletal myotubes [287]. Il8 expres-
sion is also induced by shear stress, as detected in human umbilical cord ECs [42]. No
studies to date have evaluated mechanosignaling of Il8 in vascular smooth muscle cells.
Results generated for this dissertation thus fill a gap in the literature, demonstrating novel
mechanosensitivity of this functionally important molecule in another vascular cell type.
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2.2.6 Signaling response of endothelial cells to steady laminar shear stress
The response of ECs to applied shear stress depends on both the vessel bed used for
harvest of ECs [27, 43, 63, 276] and the type of shear applied, such as oscillatory, pul-
satile, or steady laminar [41, 101]. Steady laminar shear stress promotes atheroprotective,
anti-inflammatory conditions associated with functional endothelium [309]. Conversely,
atherosclerosis occurs most commonly in regions of oscillatory, turbulent, and/or low shear
stress [280, 234]. This dissertation focuses on shear effects observed on human aor-
tic ECs under steady laminar shear stress, similar to the physiologic shear stress profile
present in large vessels [313]. Laminar shear stress on ECs affects cell functions includ-
ing: cell survival, proliferation, lipid metabolism, cytoskeletal organization, ECs turnover
and macromolecular permeability [44], migration [268], leukocyte adhesion [187, 286, 330],
and numerous changes in gene and protein activation [44, 23, 36, 314]. Immune response
and inflammation are two key functions related to cardiovascular health and influenced by
shear of the endothelial layer [97]. Genes in these functions with an established laminar
shear-response in aortic ECs include: cyclooxygenase 2 (Cox2) [101, 97], endothelial ni-
tric oxide synthase (eNos) [177, 291], heme oxygenase 1 (Hmox1) [101, 308], Kruppel-like
factor 2 (Klf2) [109, 61], monocyte chemotactic protein 1 (Mcp1) [41, 259, 260], platelet-
endothelial cell adhesion molecule (Pecam1) [212, 290], vascular endothelial cadherin
(VE-Cad) [141, 201].
Applied shear stress has been shown to promote differentiation along an endothelial lin-
eage in multiple stem cell types, including endothelial progenitor cells (EPC) [], embryonic
stem cells (ESC) [], and MSCs []. Gene and protein indicators used to track endothelial-
like differentiation include Pecam1, VE-Cad, and vWF [239]. Both Pecam1 and VE-Cad
are shear-responsive in ECs and increased in stem cells exposed to shear stress []. Col-
lectively, Pecam1 signaling is both a marker of differentiation and shear stress response
characteristic of ECs. Activation of Pecam1 signaling
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2.2.7 Signaling response of mesenchymal stem cells to cyclic strain
Several bioreactor systems have been designed for application of strain to MSCs: uni- and
equi-axial strains on MSCs monolayers [178, 264] and uniaxial and more complex strains
on 3-D cell-seeded scaffolds [4]. Applied strain systems have been employed to differenti-
ate MSCs along osteogenic [258, 113, 139, 56, 76], chondrogenic [76, 105, 106, 160, 28],
and tendon and ligament [223, 299, 256, 124] lineages. Several groups report the ERK1/2
and p38 MAP kinase pathways are cyclic strain-responsive in MSCs [261, 237], with one
group also reporting strain-induction of BMP2 [273]. For heart valve applications, strain
of MSCs in monolayer results in collagen synthesis similar to that observed in aortic valve
interstitial cells when strained under the same conditions [144]. The Li laboratory (UC-
Berkeley) has investigated MSCs for vascular therapies and demonstrated a differential
response to uniaxial versus equibiaxial cyclic strain. They and others have shown that
uniaxial strain upregulates expression of SMCs-related differentiation genes and proteins
[218, 148, 146, 162, 137].
2.2.8 Signaling response of MSCs to fluid shear stress
MSCs have been exposed to a range of shear stresses in vitro [327, 245, 100, 55, 232].
Several studies focus on fluid shear stress as a means to differentiate MSCs along os-
teogenic [245, 232, 143] or chondrogenic [299, 250] lineages. ERK1/2 [132], MAP kinase
and calcium [238], as well as NF-kappa-B [130] and nuclear factor of activated T cells
(NFAT) [7], have been implicated in the response of MSCs to applied fluid shear. Shear
stress magnitudes relevant to the skeletal tissues, with which MSCs are frequently associ-
ated, are typically several orders of magnitude lower than that relevant for large diameter
blood vessels. Furthermore, applied force stimulation for the purpose of MSCs differen-
tiation typically occurs over days to weeks, a timescale that does not capture the initial
mechanosignaling events that are the focus of this dissertation. Fluid shear of MSCs also
upregulates gene expression of the inflammatory marker cyclooxygenase 2 (Cox2) [7], as
is also observed in ECs.
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For cardiovascular regenerative medicine applications, physiologic responses to me-
chanical cues may be a determining factor in the success of cell-based therapies. This
dissertation compares mechano-related signaling of MSCs and normal endothelial and
smooth muscle cells to cardiovascular-relevant physiologic forces. Results from this work
help uncover which signaling pathways will respond similarly in MSCs versus those that
will signal in atypical ways. Once these molecules are identified, future studies are needed
to determine the benefit or harm of differential signaling.
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CHAPTER III
CONSERVED AND CELL TYPE-DEPENDENT SIGNAL TRANSDUCTION IN
MESENCHYMAL STEM CELLS AND SMOOTH MUSCLE CELLS EXPOSED
TO MECHANICAL STRAIN
3.1 Abstract
Mechanical cues cause changes in cell signaling. In the context of stem cell therapies,
these changes may affect therapy efficacy. Mesenchymal stem cells (MSCs) are proposed
for use in vascular therapies, yet little is known about their signaling in response to cyclic
strain, a typical vascular mechanical cue. We compared MSCs and aortic smooth muscle
cell (SMCs) for signal transduction gene expression under standard growth conditions and
in response to applied strain (10%, 1 Hz). MSCs and SMCs cultured in respective growth
media express significantly (p ≤ 0.05, n=3) different levels of 42 of 84 signal transduction
genes assessed, suggesting MSCs will respond differently than SMCs if introduced as a
vascular therapy. When exposed to applied cyclic strain, SMCs responded within 24 hours
with increased number and magnitude change gene expression relative to MSCs. Il8,
Vcam1, and Hmox1 were strain-responsive in both cell types, with similar magnitude fold-
changes between cell types in spite of 100-fold differences in relative expression levels. Il8,
Vcam1, and Hmox1 are all involved in inflammatory-related signaling. Our results suggest
that cells respond to applied mechanical force using a combination of conserved and cell-
type specific mechanisms.
3.2 Background
Mechanosignaling of stem cells compared with differentiated cells is poorly understood.
Mechanical cues trigger changes in cell signaling observable at the nucleotide, transcrip-
tion, translation, post-translation and second messenger levels [111, 221, 305]. Previous
studies of the cellular effects of mechanical cues focus primarily on mechanoresponses
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of differentiated cell types or tissues [292, 111]. Current efforts to develop vascular cell-
based therapies require broadening this focus to include the mechanoresponses of stem
and progenitor cells. This manuscript focuses on how mesenchymal stem cells, a putative
cell source, respond to vascular-relevant levels of applied cyclic strain.
Vascular smooth muscle cells experience and respond dynamically to cyclic strain. In
the vascular system, smooth muscle cells (SMCs) experience cyclic strain due to pulsatile
heart contractions. Cyclic strain affects vascular smooth muscle cell functions including
alignment, migration, proliferation, and differentiation [157, 251, 233]. Signaling pathways
mediating the SMCs strain-response are activated within minutes (e.g., MAPK family and
PKC) [157, 233], hours (e.g., Notch3 and Hedgehog) [191], and days (e.g., smooth muscle
contractile and osteoblast characteristic genes) [19, 200] of applied cyclic strain. Patho-
logical conditions such as hypertension or atherosclerosis can alter vessel mechanical
properties and associated mechanosignaling [152]. Several groups, including ours, have
attempted to engineer vascular smooth muscle-based 3-D constructs for in vitro study of
vascular biology and to create a vascular substitute [269, 156, 199]. Due to the short-
age of available SMCs and their limited regenerative capacity, clinically-relevant vascular
therapies will likely require an alternate cell source.
Potent trophic effects make mesenchymal stem cells (MSCs) an attractive choice for
a vascular therapy [230, 225]. MSCs are derived from adult bone marrow and char-
acterized by isolation method and a panel of cell surface protein markers [226]. These
multipotent stem cells self-renew and have the potential to differentiate along osteogenic,
chondrogenic, and adipogenic lineages. MSC-like cells, including SMCs and pericytes,
surround endothelial cells throughout the vasculature [182, 51]. In some cases, MSCs
adopt SMC-like traits including expression of genes and proteins involved in smooth mus-
cle contraction [134, 149]. MSCs secrete angiogenic factors, remodel the extracellular
matrix in a wound environment, and modulate the immune and inflammatory responses
[247, 194, 317, 133]. Current clinical trials are testing safety and efficacy of MSCs for
treating ischemic stroke, acute myocardial infarction, congestive heart failure, and car-
diac surgery [197, 80, 122]. Studies of MSCs mechanoresponse to date have focused
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on differentiation of MSCs along SMC-like or orthopedic lineages under site-appropriate
mechanical force regimes [218, 104, 148, 243, 273]. Activation of more general signaling
pathways in MSCs exposed to applied mechanical forces, in particular vascular-relevant
conditions, is unknown.
In this chapter, signal transduction gene expression is compared between human adult
bone marrow-derived MSCs and human aortic SMCs (Figure 5). Initial signaling conditions
were compared by gene expression in MSCs and SMCs cultured in standard growth media.
To compare mechanoresponses, signal transduction gene expression were compared in
MSCs and SMCs exposed to a range of matched equibiaxial cyclic strain conditions. We
find the signal transduction response to strain includes conserved and cell-type specific
elements.
3.3 Results
3.3.1 Signal transduction genes robustly expressed
MSCs and SMCs cultured under maintenance conditions have similar distributions of genes
detected during 40 cycles of qRT-PCR, as highlighted by the cumulative distribution lines in
Figure 6. Housekeeping genes Actb, Gapdh, and Rpl13a are among the earliest detected
in both cell types, with all 5 housekeeping genes detected by threshold cycle 25 (Sup-
plemental Figure 12). Most signal transduction genes assessed are detected between
threshold cycles 20.00 and 30.00. By threshold cycle 25.00, 42% and 44% genes are de-
tected in MSCs and SMCs, respectively; by cycle 30, 71% and 76% genes are detected in
MSCs and SMCs. When cultured under cell type-specific maintenance conditions, SMCs
have a moderate (1.25-fold), but significant (p ≤ 0.05, n=3), increase in the average overall
expression level of signal transduction genes relative to MSCs (SMCs-Ct=26.66±0.15 vs.
MSCs-Ct=26.98±0.06). Genes with highest relative expression in both cell types affect the
cell cycle (Cdkn1a), extracellular matrix (Fn1), signaling regulation through growth factors
(Igfbp3) and transcription (Hsbp1).
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Figure 5: Experimental groups compared for expression of signal transduction
genes, assessed using PCR arrays. (Comparison I.) Gene expression levels initially
present in MSCs and SMCs were compared under expansion conditions in standard main-
tenance culture medium (MSCsGM or SmGM2, respectively). (Comparison II.) Strain re-
sponses for both cell types were subsequently compared using the differential responses
of strain versus static samples for MSCs (IIa.) and SMCs (IIb.)
Figure 6: Signal transduction gene expression levels in MSCs and SMCs under
maintenance culture conditions. (A) Histogram (bars) and cumulative distribution (over-
laid lines) of average threshold cycle raw values for all wells assessed on a signal trans-
duction PCR array, showing similar profiles for MSCs (blue) and SMCs (orange). Triplicate
arrays per group. (B) Table of signal transduction genes detected in both cell types for a
given threshold cycle range.
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Figure 7: Heatmap of relative expression values (2-4Ct) for genes with significantly
(p ≤ 0.05, n=3) different expression in MSCs and SMCs cultured under maintenance
conditions. Two-dimensional clustering groups samples (arrays) with similar overall ex-
pression horizontally and individual genes with similar expression levels vertically.
3.3.2 MSCs and SMCs differ in baseline expression of specific signal transduction
genes
Four of five housekeeping genes are expressed significantly (p ≤ 0.05, n=3) differently
in SMCs versus MSCs: B2m (2.47-fold up in SMCs), Actb (1.3-fold up), Gapdh (1.5-fold
down), and Hprt1 (2.1-fold down). Rpl13a expression does not significantly (p=0.932, n=3)
differ between MSCs and SMCs. In terms of signal transduction genes, 42 of 84 genes as-
sessed differ significantly between MSCs and SMCs, determined using an unpaired t-test.
Similar numbers of genes are expressed at relatively higher levels (24 genes more highly
expressed in SMCs; 22 genes in MSCs). Genes with comparatively highest expression
in SMCs include Wnt2 (133-fold), Il8 (126-fold), and Rbp1 (104-fold) and in MSCs include
Vcam1 (49-fold), Wisp1 (23-fold), and En1 (11-fold).
3.3.3 Morphology of samples exposed to equibiaxial strain indistinguishable from
static controls
MSCs (Figure 8A-B) and SMCs (Figure 8D-E) exposed to applied strain for 24 hours are
not visibly different from parallel static controls in terms of cell size, shape, or multicellular
arrangement, as assessed using phase microscopy. Phase images of samples subjected
to applied strain or parallel static culture for 6 or 24 hours show an increase in cell density
in all groups (MSCs-Static, MSCs-Strain, SMCs-Static, and SMCs-Strain; data not shown).
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3.3.4 Comparison of overall signal transduction gene expression in strain model
system
Average threshold cycle (Ct), an indicator of overall gene expression level, is significantly
(p < 0.0001, n=6) dependent on cell type, based on two-way ANOVA. MSCs have ap-
proximately 2-fold lower overall signal transduction gene expression than SMCs (SMCs-
Ct=27.14±0.39 vs. MSCs-Ct= 28.24±0.22) when cultured on fibronectin-coated silicone.
Paired t-test comparison of average threshold cycles within a single cell type indicated
gene expression levels are significantly different under strain and static conditions for
MSCs (p ≤ 0.01, n=3; 1.3-fold increase in strain samples) (Figure 8C), but not SMCs
(p=0.636, n=3) (Figure 8D). Variation in overall average threshold cycle within a group
(n=3 arrays) was consistently 2-fold greater for SMCs than MSCs for all culture condition
comparisons (maintenance, static culture on fibronectin-coated silicone, and applied strain
on fibronectin-coated silicone), although this difference was not significant (p=0.11, n=3).
3.3.5 Strain responses of SMCs and MSCs
We defined ‘strain-responsive’ genes as those with significant (p ≤ 0.05, n=3) differences
in expression levels between strain vs. static samples of at least 1.5-fold up- or down-
regulation. More strain-responsive signal transduction genes were identified in SMCs than
MSCs (9 versus 5, from a group of 84 genes assessed) (Figure 9A). Two genes, Interleukin
8 (Il8) and Vascular Cell Adhesion Molecule 1 (Vcam1), were strain responsive in both cell
types. Il8 increases in response to strain (MSCs: 2.24±0.35; SMCs: 2.59±0.31). In the
strain model system, average Il8 expression levels are 160-fold greater in SMCs compared
to MSCs (Figure 9B). VCAM1 decreases in response to strain (MSCs: -1.61±0.04; SMCs:
-4.35±0.07). Average Vcam1 expression is 127-fold greater in MSCs than SMCs (Fig-
ure 9C). Bone morphogenetic protein 4 (Bmp4: -1.54±0.06 fold change ), Homeobox A1
(Hoxa1: -1.56±0.09), and P-selectin ligand (Selplg: +1.58±0.20) are strain-responsive in
MSCs, but not SMCs. CCAAT/enhancer binding protein beta (Cebpb: +1.97±0.53), Fatty
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Acid Synthase (Fasn: +1.52±0.22), Interleukin 1 alpha (Il1α: +1.47±0.11), Interferon reg-
ulatory factor 1 (Irf1: 1.47±0.16), Matrix metallopeptidase 7 (Mmp7: -1.85±0.03), Cellu-
lar retinol binding protein 1 (Rrp1: -1.67±0.03), and CD71/Transferrin Receptor C (Tfrc:
+1.58±0.15) are strain-responsive in SMCs, but not MSCs.
A less stringent definition of ‘strain-responsive’, generated by removing the minimum
fold change criteria and reducing the significance criteria (p ≤ 0.10, n=3), identifies approx-
imately 5 times as many additional strain-responsive genes in SMCs as MSCs (SMCs: 5
and 9 additional genes for respective criteria changes vs. MSCs: 0 and 3 genes) (Fig-
ure 9A). These less stringent ‘strain-responsive’ criteria identify three additional genes as
having conserved strain responsiveness across cell type: Baculoviral IAP repeat-containing
2 (Birc2), Bmp4 (identified using high stringent criteria only in MSCs), and Il1α (identi-
fied using high stringent criteria only in SMCs). For both high stringency (p≤0.05 and
|FC| ≥ 1.5) and low stringency (p≤0.10 only) strain-responsive criteria, MSCs have a
reduced number and magnitude fold-change of strain-responsive genes than SMCs (Ta-
ble 1). In addition, comparison of strain-responses with initial expression levels under
maintenance culture shows that strain-responsive gene expression is independent of ini-
tial values (Supplemental Figure 13).
3.3.6 Gene expression dependence on applied force and cell type
Two-factor ANOVA was used to determine the dependence of gene expression on force
condition, cell type, or an interaction between factors. Results of ANOVA are summarized
in Figure 10, with complete results for each gene listed in Table 1. Approximately seven
times as many genes have expression significantly (p ≤ 0.05, n=3) dependent on cell
type as force condition (48 vs. 7 genes) (Figure 10A). Statistical analyses by t-test and
ANOVA were combined to generate lists of genes with expression affected by cell type
(Supplemental Table 4) or mechanical strain (Supplemental Table 5).
Two-factor ANOVA corroborated differences in cell type expression profiles identified
in the maintenance culture comparison. 4 of 4 housekeeping genes and 27 of 42 signal
transduction genes differ between cell types significantly (p ≤ 0.05, n=3) when cultured
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Figure 8: Morphology and signal transduction gene expression levels of MSCs and
SMCs exposed to equibiaxial strain (10%, 1 Hz) or static culture for 24 hours. Neither
MSCs (A-B) nor SMCs (D-E) show observable differences in cellular patterning after ap-
plied strain (B, E) compared with parallel static controls (A, D), as assessed using phase
microscopy. Overall expression levels of signal transduction genes are similar under strain
(solid bars) and static (outline bars) culture conditions for both MSCs (C) and SMCs (F).
Scale bars = 100 µm.
on either TCPS or the strain model system (Table 4). Five genes showed significant cell
type- or interaction-dependent expression only when cultured in the strain model system,
in contrast to 15 genes with differences in cell type unique to the maintenance culture
environment (Table 4).
Most genes identified via ANOVA with significant (p ≤ 0.05, n=3) force-dependent ex-
pression (Figure 10B) had been identified as strain-responsive using criteria outlined above
(Vcam1, Il8, Rbp1, Tfrc, Bmp4, and Fn1) (Figure 9A) and also showed significant cell type-
dependent gene expression. Of these genes, Vcam1 and Tfrc expression was significantly
(p=0.021 and p=0.037, respectively; n=3) dependent on an interaction between cell type
and force condition. SMCs samples had greater magnitude fold change response to strain
of Vcam1 and Tfrc than MSCs samples. Mdm2 p53 binding protein homolog (Mdm2) ex-
pression was dependent significantly on force condition (p=0.041, n=3), but not cell type
(p=0.296, n=3) nor interaction (p=0.828, n=3). Mdm2 was identified as force-responsive via
two-factor ANOVA, but not t-test comparisons, due to the increase in effective sample size
from pooling samples from both cell types (ANOVA static vs. strain: n=6 versus t-tests:
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n=3). Although Mdm2 expression was not significant in paired t-tests (MSCs: p=0.112;
SMCs: p=0.296), expression did increase in all samples in response to strain (MSCs:
1.22±0.15; SMCs: 1.28±0.20) (Table 2).
Table 1: Table showing distribution of up- and down-regulated genes.
3.3.7 PCR array sensitivity limits analysis of genes with low expression levels
Analysis of some signal transduction genes was limited by incomplete data sets. Expres-
sion of 9 of 84 signal transduction genes (but no housekeeping or control wells) assessed
using this array could not be detected on at least half the arrays. Genes with a ‘not de-
tected’ value on at least 9 of 18 PCR arrays include, in order of highest to lowest undetected
rate: Il4 (16/18 arrays), Il2 (15/18), Sele (14/18), Cxcl9 (13/18), Tert (12/18), Faslg (12/18),
Foxa2 (9/18), and Klk2 (9/18). These undetected readings correlate with genes whose
expression ranks in the lowest 10% on a given array for both MSCs (r=0.754) and SMCs
(r=0.768), suggesting the ‘not detected’ readings reflect low or absent gene expression
rather than technical errors in data acquisition. Most ‘not detected’ errors were distributed
evenly across MSCs and SMCs samples and static, strain and maintenance culture groups.
However, FOXA2 ‘not detected’ expression errors occurred consistently and exclusively in
MSCs samples.
3.3.8 Temporal Kinetics of Gene Expression Changes
To quantify the Il8 and Vcam1 strain-response during the first 24 hours of applied strain,
mRNA expression level fold changes (strain/static) were determined via standard qPCR
using samples exposed to applied strain or parallel static culture for 0, 2, 6, 12, or 24 hours
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Figure 9: Gene expression changes in MSCs (blue) and SMCs (orange) in response
to applied cyclic strain (10%, 1 Hz for 24 hr) assessed using a signal transduction
PCR array. (A) Venn diagram comparing genes identified in either MSCs or SMCs whose
expression differs moderately significantly (p≤0.10, thin outer boundary) or highly signifi-
cantly (p≤0.05, thick inner boundary) in response to strain. Shaded regions indicate fold
up- or down-regulation ≥1.5 for highly significantly strain-responsive genes. Interleukin
8 (Il8) and Vascular Cell Adhesion Molecule-1 (Vcam1) expression is highly significantly
(p ≤ 0.05) altered (|FC| ≥ 1.5) in both cell types. (B) Relative gene expression of Il8 in
MSCs and SMCs under static (outlined bar) or strain (solid bar) culture conditions. (C)
Relative gene expression of Vcam1.
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(n=3-4/group) (Figure 11). Kinetic analysis of Il8 and Vcam1 confirmed their up- and down-
regulation, respectively, after 24 hours applied cyclic strain. In SMCs, Il8 is significantly
(p≤0.05, n≥3) upregulated after 12 hours (1.79±0.27-fold) and 24 hours (2.91±1.92) ap-
plied strain. In MSCs, Il8 upregulation is significant only after 24 hours applied strain
(1.88±0.52-fold).
The bioinformatics software Ingenuity Pathways Analysis (IPA) was used to deter-
mine connections between strain-responsive signaling molecules. The primary signaling
network identified from this analysis is associated with ‘cardiovascular system develop-
ment and function,’ suggesting the general signal transduction genes identified as strain-
responsive using PCR arrays are also important for the cardiovascular system. Il8 has
been shown to upregulate Vcam1 in other studies. Additional potentially strain-responsive
molecules were identified via IPA. Interleukin 8 indirectly regulates Vascular cell adhesion
molecule 1. Other molecules also regulating Vcam1 include Vegf, Il1α, and Heme oxy-
genase 1 (Hmox1). Vegfa and Il1a reportedly regulate Vcam1 and Il8. Hmox1 appears
to be at a similar level of regulation as Il8: downstream of Vegfa and Il1α and upstream
of Vcam1). Il1α strain-responsive expression could not be confirmed in subsequent fol-
low up experiments, even using the same primer sequence and RNA samples. Kinetic
analysis of Vegfa confirmed the results of the PCR array data: in neither SMCs nor MSCs
was Vegfa expression significantly (p ≤ 0.05) altered by at least 1.5-fold during the first
24 hours applied strain. In contrast, Hmox1 expression significantly increased in both cell
types. Hmox1 expression in SMCs increased significantly (p≤0.001) after 6 (4.7-fold), 12
(6.4-fold), and 24 (5.1-fold) hours of applied strain. In MSCs, the magnitude of Hmox1 ex-
pression change lagged behind the response in SMCs, with significant (p≤0.005) changes
after 6 (1.9-fold), 12 (2.5-fold), and 24 (2.5-fold) hours strain. Expression remained con-
stant or decreased between 12 and 24 hours applied strain, unlike the continued changes
in Il8 and Vcam1 observed during the first 24 hours applied strain. Collectively, this data in-
dicate a Vcam1-mediated strain response may be triggered by strain-responsive molecules
Il8 and Hmox1, but not by further upstream regulators Vegfa and Il1α.
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3.4 Discussion
To determine whether MSCs can substitute for SMCs, signal transduction gene expression
in both cell types was compared under maintenance and applied cyclic strain conditions.
Signal transduction genes were robustly expressed in both cell types under maintenance
and applied force conditions. Approximately 10% of genes showed strain-responsive ex-
pression levels in either one or both cell types. MSCs exhibit a muted response to cyclic
strain in terms of number, magnitude, and rate of change of gene expression. In both SMCs
and MSCs, expression of Il8 and Hmox1 increased, while Vcam1 expression decreased.
We show that cellular response to applied force includes shared and cell type-specific com-
ponents, and we add to the list of molecules with known force-responsiveness. We propose
the existence of a conserved, functionally-important mechanosignaling node, based on the
similarity of strain-responses across cell type and known regulatory relationships between
Il8, Hmox1, and Vcam1.
This comparison of mechanosignaling is limited by the focus on the gene expression,
without parallel information on protein and regulatory state. We focused on signal trans-
duction molecules, yet other strain-responsive genes would likely be identified using tran-
scriptome comparison. The observed response to mechanical cues may depend on other
environmental factors inherent in the system, including cell culture media and underlying
protein substrate [104, 103]. Altering the magnitude, frequency, or duration of applied
strain may also influence subsequent signaling changes [84, 291]. Finally, mechanosig-
naling comparison using this method is limited by messenger RNA stability, enriching for
transcripts able to withstand the sample processing [47].
MSCs and SMCs differed markedly in their initial expression profiles, as suggested by
signaling comparisons in MSC-like cell lines [35]. Significant differences in expression lev-
els of 4 of 5 housekeeping genes indicates maintenance functions may differ between the
cell types. In SMCs, genes with relatively highest expression levels (Wnt2, Rbp1, and Il8)
are also associated with vascular functions. Wnt2 knock-out mice show placental vascu-
lature defects [188]. Wnt ligands and their Frz receptors are involved in angiogenesis and
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smooth muscle cell proliferation [135, 293]. Cellular retinol binding protein 1 (Rbp1) is a
phenotypic marker of smooth muscle cells isolated from older donors or regions of intimal
thickening [210]. Interleukin 8 (Il8, a.k.a. CXCL8) mediates inflammatory responses, acting
as a chemoattractant for neutrophils and a potent angiogenic factor [241]. Genes whose
expression is comparatively highest in MSCs include Vcam1, Wisp1, and En1. These
genes have not been reported to have specific biological functions in MSCs. However,
greater expression of these genes in MSCs compared to SMCs suggests that undifferenti-
ated MSCs may act more like vascular cells from injured regions. This is because Vcam1
binds leukocytes and is expressed more under inflammatory and atherosclerotic conditions
[203] and Wisp1 is reportedly upregulated in venous SMCs after injury [231]. Engrailed-1
has no reported vascular-specific function. These differences in initial gene expression
may be due to cell type (e.g., chromatin modifications), maintenance culture media (e.g.,
biochemical cues), or another factor. It is not possible to distinguish between these causes
based solely on this data.
After 24 hours applied strain at levels similar to that of large vessels (10%, 1 Hz), neither
SMCs nor MSCs showed cellular rearrangements. This morphology is due in part to the
underlying fibronectin coating, based on previous studies [67]. Cyclic strain did not result in
significant changes in average signal transduction gene expression in SMCs, and slightly
increased average expression levels in MSCs (1.3-fold; p ≤ 0.01, n=3). The change in
MSCs, but not SMCs, may be because SMCs were previously conditioned to cyclic strain
in vivo. In spite of similar morphology and overall signal transduction gene expression,
genes were identified in both cell types with expression significantly (p ≤ 0.05, n=3) altered
in strain versus static samples. More genes were identified as strain-responsive in SMCs
than MSCs. Differences in initial expression levels did not account for differences in sub-
sequent strain-responsiveness. This cell type-specific mechanosensitivity may result from
differences in upstream signaling components, in spatial patterning of signaling molecules,
an interaction effect of biochemical (media) and mechanical cues, or another factor.
Two-factor ANOVA comparing all static and strain samples confirmed that expression
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Figure 10: Two-factor ANOVA of signal transduction gene responses to applied
cyclic strain. Two-factor ANOVA comparing dependence of gene expression on cell type
(MSCs or SMCs) and force condition (10% strain at 1 Hz or static culture). (A) Venn di-
agram indicating number of genes significantly dependent on cell type, force condition,
and/or an interaction effect. (B) Table listing ANOVA p-values for all genes identified with
significant (p < 0.05, n=3) force-dependent gene expression.
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Figure 11: Expression kinetics of genes with known or predicted strain respon-
siveness conserved between MSCs (outlined bars) and SMCs (solid bars). Average
paired fold changes (strain/static) for Il8 (A), Vcam1 (B), Vegfa (C), and Hmox1 (D) are
shown based on strain and parallel static control samples harvested after 0, 2, 6, 12, or
24 hours. Error bars represent standard error of the mean. Strain vs. static samples that
differ significantly (p≤0.05, n≥3) from one another based on a paired t-test are indicated
by asterisks (*); fold changes after applied strain that differ significantly (p≤0.05, n≥3) from
initial noise levels (0 hour data) based on an unpaired t-test are indicated by daggers (†).
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of many signal transduction genes varies significantly with cell type (Figure 10). In compar-
ison to maintenance culture conditions, though, culture in the applied strain model system
decreased the number of genes that differ significantly between cell types. This suggests
culture on fibronectin-coated silicone promotes more similar signaling between SMCs and
MSCs than tissue culture-treated polystyrene. Culture in the strain model system also
decreased overall expression levels in both cell types relative to maintenance conditions
(MSCs-Ct: 27.0 vs. 28.2; SMCs-Ct: 26.7 vs. 27.1) (Figure 8). Thus biomaterials used for
cell-based therapies offer one way to tune the cell signaling profile.
This data demonstrates both MSCs and SMCs can respond to cyclic strain within 6
hours with changes in message regulation. Signal transduction genes strain-sensitive in
SMCs include: Cebpb, Fasn, Il1α, Irf1, Mmp7, Rbp1, TfrC, Il8, and Vcam1. In MSCs,
strain-responsive signal transduction genes include: Bmp4, Hoxa1, Selplg, Il8, and Vcam1.
These changes in gene expression levels are likely to be downstream targets of signaling
cascades [296]. Future studies may identify which early sensors mediate the expression
changes observed after hours of applied strain.
3.4.1 Strain Responses Conserved between MSCs and SMCs
Of the 84 genes assessed on the PCR arrays, only Il8 and Vcam1 were significantly strain-
responsive in both MSCs and SMCs. Gene expression altered in the same direction (Il8:
up; Vcam1: down) for both cell types in response to strain. The magnitude fold-change
was also conserved between the two cell types, in spite of 100-fold difference in relative
expression levels. Recent work has shown that cells regulate signal/noise ratios, rather
than absolute levels of gene expression [82, 83]. The similarity of fold change, but not
absolute expression levels, suggests Il8 and Vcam1 mechanoresponse may be controlled
by a similar regulatory mechanism.
Interleukin 8 is strain-responsive in airway epithelial cells and recently in MSCs, pro-
viding evidence that mechanosensitivity of this molecule is conserved across a wide range
of cell types [145, 274]. Il8 has not been previously demonstrated strain-responsive in the
vascular system. The similarity of MSCs and SMCs Il8 strain-responses suggests MSCs
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may be able to mimic the angiogenic and immune-related functions this molecule has in
SMCs.
Vcam1 is an IgG family member whose expression is typically associated with acti-
vated endothelia [21]. Vcam1 has been shown to decrease in response to cyclic strain in
endothelial cells and, recently, valvular interstitial cells [13, 263]. Vcam1 is upregulated
in SMCs under inflammatory conditions [92], but no reports of strain-sensitivity in SMCs
have been published. The decrease in Vcam1 observed in MSCs and SMCs, consistent
with other cell types, suggests that mechanical strain at physiologic levels promotes a qui-
escent phenotype. Culture in the strain model system decreased Vcam1 expression for
both cell types and doubled the difference in Vcam1 expression levels between cell types
(Vcam1strain system:127-fold vs. Vcam1maintenance:49-fold), underscoring the importance of
mechanical and material cues in determining cell signaling state.
Heme oxygenase 1 was predicted and verified as a conserved strain-responsive gene.
Ontology analysis with IPA linked Hmox1 and Il8 to Vcam1 as upstream regulators. Il8 and
Hmox1 reportedly increase and decrease, respectively, Vcam1 [92, 252]. The decrease in
Vcam1 observed in the current study may result from the net effect of a greater increase in
Hmox1 expression than Il8. The mechanism of regulation between these molecules is not
known. However, similar direction and relative magnitude fold changes between cell types
for all three genes suggest a common regulatory motif may exist. This may be because the
function regulated by Il8/Hmox1/Vcam1 is evolutionarily important for multiple cell types.
Future studies are needed to determine whether these molecules interact directly, whether
an independent target regulates all three molecules, and whether signaling regulation oc-
curs at the gene/protein levels. Furthermore, ontology software was not sufficient to predict
the functional outcome of this trio of signaling changes. Functional studies could test for
increased neutrophil recruitment and angiogenic potential and decreased oxidative stress
and leukocyte adhesion.
31
3.4.2 Strain Responses Specific to SMCs
The transcription factor Cebpb contributes to immune and inflammatory responses, adipo-
genesis, and Collagen Type I expression [248, 18, 222]. Cebp-β has not been previously
reported to be mechanosensitive. However, family member and binding partner Cebp-α
decreases in umbilical cord perivascular cells in response to lower frequency equibiaxial
cyclic strain (10%, 0.5 Hz for 24 hours) and Cebp family members are involved in adipo-
genesis, a process negatively regulated by cyclic strain [289]. The observed upregulation
(2-fold) in SMCs is consistent with increased extracellular matrix synthesis in response to
strain or to a change in the immune/inflammatory response state of the cells. This latter
function is supported by SMCs strain-responses in other components of the Cebpb sig-
naling network: IL8 is upregulated by Cebpb [120] and Irf1 forms a complex with Cebpb
that activates the Il18 promoter [110]. The lower magnitude/significance strain-response
of Cebpb in MSCs (p=0.11; FC=1.46±0.34) may be due to the activity of adipogenesis
signaling pathways in this cell type.
Fasn is involved in fatty acid synthesis and oxidation reduction [183]. Fasn has not
been reported to be mechanosensitive, nor is it associated with functions in the vascu-
lature, SMCs, or MSCs. Fasn is upregulated in many human tumors [183]. Its role in
lipogenesis, an important function regardless of organ type, suggests its signaling is reg-
ulated in all cells. These data show Fasn is strain-responsive in SMCs (FC=1.52±0.22;
p=0.041), but not MSCs. Long-chain fatty acids affect atherogenesis [59]. Follow-up stud-
ies in SMCs could test whether increased Fasn expression correlates with other markers
of atherosclerosis.
IL1α was identified as strain-sensitive by the PCR arrays, yet follow up qPCR stud-
ies using the same primer and RNA samples could not confirm this result. This may be
because the IL1α transcript is less stable or because the array results are a false positive.
The transcription factor Irf1 regulates interferon alpha and beta, as well as their down-
stream targets [176]. It regulates apoptosis, tumor suppression, and iNos signaling. Irf1, in
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addition to regulating Il8 expression, also regulates Vcam1 expression [206]. Mechanoreg-
ulation of Irf1 expression has not been reported. Irf1 is significantly upregulated in SMCs
exposed to cyclic strain, but does not change in MSCs. MSCs and SMCs express virtually
the same amount of Irf1 under maintenance culture, suggesting gene expression may not
be inherently force-responsive, but can be a downstream indicator of another force-sensing
mechanism.
Mmp7 is an extracellular matrix protease targeting proteoglycans, fibronectin, elastin,
and casein. Mmp7 has no reported strain-sensitivity, although one study reports an in-
crease in MMP7 protein levels after culture in a rapid flow bioreactor [257]. Mmp7 ex-
pression has not been reported in MSCs, but is expressed in some instances in SMCs
[68, 123]. Mmp7 expression decreases significantly in SMCs, but does not significantly
change in MSCs. The greater variation in Mmp7 expression in strain versus static or main-
tenance cultures suggests physical force may affect the stringency of signaling regulation,
as well as overall levels.
Rbp1 is a carrier protein involved in retinol transport and a marker of SMCs wound
healing [318]. Rbp1 is associated with neither mechanosensitivity nor expression in MSCs.
Rbp1 decreases in both cell types in response to strain, but is only significant in SMCs
(pSMCs=0.003 vs. pMSCs=0.246).
TfrC, also known as CD71, is a protein surface marker used to characterize MSCs
[226]. TfrC does not alter expression in MSCs exposed to cyclic strain, but is significantly
upregulated in SMCs. No characteristic function has been described for Tfrc in SMCs,
MSCs, or the vasculature.
3.4.3 Strain Responses Specific to MSCs
Bmp4 is involved in MSCs differentiation towards osteocytes, adipocytes, and smooth
muscle-like cells [325]. In addition, Bmp4 is upregulated in cases of oscillatory flow and
atherogenesis [266, 119]. Bmp4 decreases in both cell types, but only significantly in
MSCs. Down-regulation of Bmp4 in response to a physiological mechanical cue is consis-
tent with relatively lower Bmp4 expression under physiological flow conditions compared
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to low, oscillatory or calcified regions.
Homeobox A1, Hoxa1, is a transcription factor involved in embryonic development
including gene regulation, morphogenesis, and differentiation. Non-lethal mutations in
Hoxa1 result in vascular malformations [283]. Hoxa1 is not associated with particular func-
tions in adult organism MSCs or SMCs. Hoxa1 is expressed in MSCs at higher levels and
is downregulated in response to strain, compared to lower and constant Hoxa1 expression
levels in SMCs. The initial higher levels and subsequent decrease in Hoxa1 expression in
MSCs may be related to the initial stem cell state of the cells, followed by partial differenti-
ation due to mechanical cues.
The last gene identified as strain-responsive by paired t-test analysis is P-selectin lig-
and, Selplg. Selplg is expressed at high levels and increases in response to strain, com-
pared with lower and constant expression levels in SMCs. Selplg binds activated platelets
and endothelia and are involved in inflammation and atherosclerosis [298]. Selplg is not
associated with particular functions in MSCs, nor has it been previously reported as strain-
responsive. Higher expression in MSCs suggests these cells may bind more tightly than
SMCs in inflamed or injured areas (P-selectin+). Since Selplg is expressed on immune
related cells, myeloid cells and stimulated T lymphocytes, MSCs binding to P-selectin re-
ceptors may be one means by which MSCs modulate the local immune response.
3.5 Conclusions
Few studies have been completed to determine signaling changes in SMCs due to ap-
plied cyclic strain. Thus, this study contributes to our knowledge of SMCs biology. This
work highlights conserved and cell type-specific genes involved in the strain response of
MSCs and SMCs. Overall, MSCs show reduced number, magnitude and speed of gene
expression change, relative to SMCs. This may be because they are not fully differen-
tiated, or because strain-sensitivity is a particular characteristic of SMCs. Before using
MSCs as a SMCs substitute, we need to determine which features of SMCs signaling are
most important for MSCs to successfully replicate. This data suggests MSCs may enable
similar immune and inflammatory-related signaling, but will not match many other aspects
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of SMCs strain-response. This data also suggests MSCs may adhere more to sites of
vascular injury than SMCs, due to increased P-selectin adhesion.
Based on comparisons in this study, we propose that mechanosensing occurs via a
combination of evolutionarily-conserved signaling changes and cell type-specific changes.
We use semi-high throughput PCR arrays to identify novel strain-responsive genes and
bioinformatics analysis to successfully predict mechanoresponsive molecules. Through
specific gene examples, we demonstrate that: (a) strain responses can be conserved via
absolute or relative (fold change) level of gene expression, (b) strain-responses are deter-
mined via combinations of multiple factors, not merely the level of initial gene expression,
and (c) functionally important mechanoresponses may also be regulated through sample
variance, as in the case of Mmp7. Identifying conserved aspects and critical parameters
governing cellular mechanoresponse will improve our ability to understand the causes of
disease and to design cell-based therapies that account for mechanical manipulations.
3.6 Materials and Methods
Supplies Cells and culture media were purchased from Lonza. PCR arrays and associated
materials were purchased from SA Biosciences. Standard qPCR reagents were purchased
from Qiagen (RNA isolation), Invitrogen (cDNA synthesis), and ABI (qPCR mastermix).
Cell culture of MSCs & SMCs Human adult bone marrow-derived mesenchymal stem
cells and aortic smooth muscle cells were cultured according to manufacturer’s recommen-
dations (Lonza). MSCs were expanded to Passage 6 and characterized for expression of
protein surface markers and differentiation potential along osteogenic, chondrogenic, and
adipogenic lineages prior to experimental use. SMCs expanded to Passage 3 were used
for experiments.
Applied strain Equibiaxial cyclic strain was applied using a custom-built device [267].
Briefly, cells were seeded on etched, protein-coated silicone membranes at 10,000 cells/cm2,
calculated using a Coulter Counter Multisizer 3. For each membrane holder chamber
(MHC), cells were allowed to attach in 2 ml media for four hours at 37·C, prior to addition
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of media up to 25 ml final volume and static preconditioning culture on the silicone sub-
strate for 48 hours total. Samples were subsequently exposed to defined applied strain
(10%, 1 Hz) or parallel static culture for ≤24 hours. To assess cell morphology, phase
images of samples were taken using an Axiovert microscope (Zeiss) immediately prior to
and following exposure to mechanical force.
PCR Array assessment RNA was isolated according to manufacturer’s instructions
(Qiagen) and quantified using a NanoDrop spectrophotometer, followed by cDNA synthe-
sis and PCR array assessment according to SA Biosciences guidelines. PCR arrays were
analyzed using a MyiQ thermal cycler (Bio-Rad). All arrays (n=18) passed the human
genomic DNA control (Supplemental Fig 12) and PCR efficiency control included on the
arrays. Relative expression values for each gene of interest (GOI) were calculated using
the ∆∆Ct method (Ct(GOIstrain) − Ct(HKPGstrain))/(Ct(GOIstatic) − Ct(HKPGstatic)).
Ct(HKPG) was determined using five housekeeping genes included on the PCR arrays
(Supplemental Table 3). Normalization to housekeeping genes, fold change, and statistical
calculations were completed using custom scripts in Matlab (Mathworks, Inc.). Signaling
analysis was completed in part using the manually-curated bioinformatics software, Inge-
nuity Pathways Analysis (Ingenuity). To identify connections and predict additional strain-
responsive molecules, an input gene list including identified strain-responsive (|FC|≥1.5,
p ≤ 0.05) genes, genes culled from the literature as strain-responsive in SMCs under
similar conditions, and genes important for immune and inflammatory responses in the
vasculature was analyzed in IPA.
Standard qPCR assessment Individual genes were assessed using standard qPCR.
RNA was isolated from kinetic experiments and quantified as above, followed by cDNA
synthesis using a FirstStrand III SuperScript Kit (Invitrogen) and PCR reaction with Power
SYBR Green mastermix (ABI). qPCR samples were run on a StepOne Plus machine (ABI)
and baseline-subtracted Ct analyzed in Excel (Microsoft). All data were converted to molar
concentrations using a standard curve and normalized to Gapdh expression. Two fold-
changes were calculated: a strain response (the ratio of strain/static relative expression)
and a cell type response (ratio of MSCs/SMCs expression under respective maintenance
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conditions). A 1.5-fold change threshold was used to identify strain-responsive genes.
Statistical analysis Maintenance comparisons were completed using unpaired t-tests.
Static and strain samples were compared using paired t-tests and two-factor ANOVA with
post-hoc Tukey tests. Unless otherwise stated, significance is defined as p ≤ 0.05. PCR
arrays were completed in triplicate for each group, with each array representing data from
four pooled independent samples from a single independent experiment. Temporal kinetics
assessments were completed for n=3-4, with each replicate representing a single sample
from an independent experiment. A randomized experimental design was used to minimize
bias due to experimental variability.
3.7 Supplemental Figures and Tables
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Figure 12: Supplemental Figure. Detection of genes in MSCs and SMCs under main-
tenance culture conditions. Black text = signal transduction genes. Red text = house-
keeping genes or human genomic DNA control.
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Figure 13: Supplemental Figure 2. Relative gene expression levels for genes iden-
tified as cyclic strain responsive using one or more methods. Relative gene expres-
sion (2-4Ct) values for three experimental replicates are shown for MSCs (left) and SMCs
(right) under maintenance culture (green circles), static control conditions (red squares)
and after 24 hours applied cyclic strain (10%, 1 Hz) (blue triangles). Genes shown are
those identified as strain-responsive by either paired t-test or ANOVA, specifically: (A)
Bmp4, (B) Cebpb, (C) Fasn, (D) Fn1, (E) Hoxa1, (F) Il1a, (G) Il8, (H) Irf1, (I) Mdm2, (J)
Mmp7, (K) Rbp1, (L) Selplg, (M) Tfrc, and (N) Vcam1. Three PCR arrays per sample
group.
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Table 2: Table of gene expression responses to applied cyclic strain. Results for
each cell type are presented in terms of a fold change (ratio of strain/static relative gene
expression) and standard deviation and significance based on a paired t-test. Overall
dependence of gene expression on force condition, cell type, or an interaction effect of
force condition and cell type is shown as significance values from a two-factor ANOVA.
P-values identified as significant (p ≤ 0.05, n=3) are shown in blue, bold text.
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Table 3: Table of genes included on Signal Transduction PathwayFinderTM PCR Ar-
ray (SA Biosciences). Gene identification information for 84 signal transduction genes
and 5 housekeeping genes included on human Pathway FinderTM Signal Transduction
PCR array (modified from SA Biosciences Gene Table). Control wells included on array
but not listed in this table include: a single well to assess human genomic DNA con-
tamination (HGDC), triplicate wells assessing a positive PCR control to verify the qPCR
amplification (PPC), and triplicate wells assessing a reverse transcription control verifying
cDNA synthesis (RTC).
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Table 4: Table of cell type-dependent signal transduction gene expression. Signif-
icance (p ≤ 0.05, n=3) based on unpaired t-test for maintenance culture conditions or
two-factor ANOVA for strain model system (strain and parallel static controls for both cell
types). 47 of 84 signal transduction genes have significant (p ≤ 0.05, n=3) differences in
expression between MSCs and SMCs under at least one culture condition. Expression
of 4 of 5 housekeeping genes differs between cell types in both maintenance and strain
model system culture. 1Significant interaction effect between cell type and force condition.
2No comparison with strain model system possible due to insufficient data set for ANOVA.
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Table 5: Table summarizing genes with significant (p < 0.05) expression differences
due to applied strain. Genes were classified as significant based on one or more of
the following statistical tests: paired t-test of MSCs, paired t-test of SMCs, or two-factor
ANOVA. Genes shown include those both up- or down-regulated in response to strain.
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CHAPTER IV
TRANSCRIPTOME RESPONSES OF MESENCHYMAL STEM CELLS AND
AORTIC SMOOTH MUSCLE CELLS TO APPLIED EQUIBIAXIAL CYCLIC
STRAIN
4.1 Abstract
Both mesenchymal stem cells (MSCs) and smooth muscle cells (SMCs) respond to equib-
iaxial cyclic strain with gene expression signaling changes within 24 hours. Few studies
have analyzed the transcriptome response of SMCs to cyclic strain, though, and assess-
ments of MSCs response to cyclic strain have focused on differentiation towards SMCs.
To more broadly determine the similarities and differences of gene-based cyclic strain re-
sponses in MSCs and SMCs, we analyzed cells seeded on fibronectin-coated silicone and
exposed to either equibiaxial cyclic strain (10%, 1 Hz) or parallel static culture for 24 hours
using whole human genome microarrays (Agilent). MSCs and SMCs overall expression
profiles differ primarily in terms of cell type, with less marked profile shifts due to force con-
dition, based on principal component analysis and two-factor ANOVA. Two-tailed paired
t-tests and two-factor ANOVA were used to identify genes statistically significantly altered
in response to applied force. Strain-responsive genes (paired t-test: p < 0.05, n=3 and
|FC| > 1.5) were present in both cell types, albeit more numerous and lower average
fold change in MSCs compared to SMCs. Gene expression sensitive to mechanical strain
primarily affected molecules in the cytoplasm or nucleus, and altered oxidative stress, pro-
tein binding, and ferritin signaling. MSCs and SMCs differ markedly in their initial and
strain-responsive transcriptomes, yet share a subset of strain-responses across cell types.




DNA microarrays can be used to simultaneously track expression level changes in thou-
sands of genes [246]. Gene expression is an energy-intensive, multi-step, and highly reg-
ulated process [303]. Changes in related gene expression levels that are statistically sig-
nificant and of magnitude above a detection threshold correlate with functional changes in
cell behavior due to a treatment [196]. Combining expression data for multiple genes with
the database of information about molecular signaling and function triangulates on phys-
iologic processes most frequently triggered by the altered genes. We employed this tool
to study cellular response to applied cyclic strain, comparing aortic smooth muscle and
mesenchymal stem cell transcriptomes exposed to equibiaxial cyclic strain (10%, 1 Hz) or
parallel static culture. We hypothesize that comparisons across disparate cell types and
use of high-throughput data will highlight broad features of cellular mechanoresponse.
High-throughput approaches have been applied to smooth muscle cells to screen chem-
ical libraries for affects on angiogenesis or SMCs contraction [72, 320]; characterize cell-
biomaterial interactions [3]; track oxidative stress, collagen assembly, or changes in mem-
brane potential [242, 121, 311]; and sequence novel receptors [102]. One high-throughput
technology, cDNA microarrays, has been used to study many aspects of smooth mus-
cle cell biology. Two microarray studies focused on SMCs signaling responses to applied
cyclic strain using microarrays [73, 140]. Feng et al applied equibiaxial cyclic strain (4%, 1
Hz for 12 or 24 hours) to human aortic SMCs cultured on fibronectin-coated surfaces and
identified a small subset of genes altered in response to strain. More recently, Kona et al
analyzed the synergistic effects of cyclic strain (10%, 1 Hz for 3 days) and growth factor
stimulation. Kona et al report that cyclic strain increased inflammatory gene expression
and decreased proliferation and apoptosis-related genes.
Although a newer field, MSCs have also been studied using high-throughput tech-
niques. Perhaps due to the popularity of stem cell-based therapies and relative ease of
culture of MSCs, these cells are often used in proof-of-principle experiments for devel-
opment of new technologies. These high-throughput techniques include tissue printing
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approaches [219], culture environment tests of surface or media modifications [138, 40],
and high-throughput differentiation [240]. More than 150 reports have analyzed gene ex-
pression using high-throughput microarrays to assess MSCs. These microarray compar-
isons focus on transcriptional changes of MSCs-like cells derived from different sources
[285, 301]; of undifferentiated MSCs with MSCs differentiated towards osteogenic, chon-
drogenic, adipogenic, and neuronal lineages ; and different culture conditions [254]. Only
three studies have investigated the effects of applied force on mesenchymal stem cells
[81, 148, 218]. These studies indicate MSCs response to force varies with the type of
mechanical cue: gene expression changes in MSCs vary depending on whether the cells
are subjected to uniaxial or biaxial strain [218], or whether cells are aligned parallel or per-
pendicular to applied uniaxial strain [148]. Another study tested MSCs response to applied
shear stress, but is difficult to interpret since neither biological nor experimental microarray
replicates were completed [81]. More work is needed to better understand how mechanical
conditions impact MSCs signaling.
The cyclic strain due to blood flow that aortic smooth muscle cells experience in vivo
can be simulated in vitro using bioreactors. Aortic smooth muscle cells were exposed
to equibiaxial cyclic strain (10%, 1 Hz) for 24 hours on fibronectin-coated silicone using a
custom-built bioreactor [267]. Human adult bone marrow-derived mesenchymal stem cells,
a cell type proposed for vascular therapies [226] and thought to provide stromal support
to endothelial cells in vivo [51], were exposed to matched mechanical conditions. Whole
human genome microarrays were completed using cDNA samples generated from each
treatment group (4 biological replicates/microarray sample; 3 independent experiments/cell
type). Strain-responsive transcriptomes in SMCs and MSCs were compared to determine
common and cell type-specific mechanosignaling.
4.3 Results
4.3.1 Morphology of cells in response to cyclic strain
MSCs and SMCs seeded on fibronectin-coated silicone were exposed to equibiaxial cyclic
strain (10%, 1 Hz) (Figure 14). Neither cell type showed morphological rearrangements
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Figure 14: Schematic of cyclic strain microarray experimental design. MSCs and
SMCs transcriptomes were compared using whole genome microarray comparison. Paired
t-tests for three independent experiments were completed for each cell type (vertical ar-
rows), followed by comparison of strain responses across cell type (horizontal arrow).
Figure 15: Cell morphology response to equibiaxial cyclic strain. Representative
images of MSCs (bottom row) and SMCs (top row) exposed to static culture (left column)
or applied strain (10%, 1 Hz) (right column) for 24 hours on fibronectin-coated silicone.
Scale bars = 100µm.
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Figure 16: Summary of gene expression differences between sample groups. (A)
Principal component analysis, showing cell types group together (MSCs: red, SMCs: blue).
Arrows link static to paired strain samples. Principal component 1 (x-axis) separates the
cell types. Principal component 3 (z-axis) correlates with SMCs strain vs. static differ-
ences. (B) Venn diagram of two-factor ANOVA with Benjamini-Hochberg Multiple Testing
Correction results, showing more genes have expression significantly (p < 0.05, n=3) de-
pendent on cell-type than force condition.
as assessed by phase images (Figure 15). Density of both cell types increased relative to
pre-strain images, suggesting cells proliferate during the duration of applied strain.
4.3.2 Global gene expression responses of MSCs and SMCs to cyclic strain
Pooled MSCs and SMCs samples exposed to either cyclic strain or parallel static culture
were assessed using whole human genome microarrays. Principal component analysis
indicated that the 12 samples (4 groups; 3 pooled samples/group) segregate primarily
according to cell type, via principal component 1, and according to force condition, via
principle component 3 (Figure 16A). These large differences in cell type gene expression
are corroborated by two-factor ANOVA (Figure 16B). More than 17,000 genes (approxi-
mately 50% of the total assessed) have expression significantly (corrected p-value < 0.05,
n=3) dependent on cell type. Only 822 genes (approximately 2% of total assessed) have
expression significantly dependent on force condition. A minority of these genes (132/822)
showed dependence on force condition, but not cell type. No genes were identified with
significant interaction effects due to a combination of force and cell type conditions.
48
Figure 17: Volcano plots comparing significance and fold-change results in SMCs
and MSCs. Genes identified in SMCs (A) and MSCs (B) whose expression alters signif-
icantly (colored squares: p < 0.05, n=3) by at least 1.5-fold difference (green squares).
36 and 39 genes are identified in MSCs and SMCs, respectively, as highly significantly
(p < 0.001) strain-responsive (insets). Higher stringency p-value cut-offs were used, since
application of MTC resulted in no significantly altered genes.
4.3.3 Significance and fold-change comparisons of MSCs and SMCs cyclic strain
response
Strain-responsive genes were also identified using paired t-tests for strain versus static
samples. Volcano plots, shown in Figure 17, graphically present the distribution of genes
based on fold-change (deviation along the x-axis, left or right of the mid-line) and signifi-
cance (increasing along the y-axis from the baseline). Genes significantly (p < 0.05) upreg-
ulated (|FC| > 1.5) are shown in green in the upper right quadrant, with those significantly
(p < 0.05) down-regulated (|FC| < 1.5) in green in the upper left quadrant. Spots shown
in red indicate genes significantly altered, but below the fold-change sensitivity threshold.
Inset figures highlight the distribution of genes under more stringent significance cut-offs
(p < 0.001). SMCs gene expression was shifted towards lower significance values, com-
pared to MSCs (Figure 17A vs. B) . SMCs fold changes varied ±8-fold relative to paired
static controls, with significant genes altering by -4 to +8-fold (Figure 17A). Overall gene
expression in MSCs vary ±16-fold, with significant genes occupying a narrower magnitude
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Figure 18: Strain-responsive genes in MSCs and SMCs identified via paired t-tests.
Nested circles representing the number of genes with p < 0.05 in a paired t-test (no mul-
tiple testing correction applied), as shown in the outermost outlined rings; the number of
genes with p < 0.001, as shown in the lightly shaded rings; and the number of genes with
p < 0.001 that also change expression levels by at least 1.5-fold, as shown in the darkest
shaded center rings. MSCs results are shown in blue (left) or orange (right).
range, approximately ±4-fold (Figure 17B). Significance levels for both cell types ranged
four orders of magnitude, from 0.05 to 0.0001.
4.3.4 Paired t-test comparison of MSCs and SMCs strain-response
Figure 18 categorizes the number of genes meeting a range of significance and fold
change criteria based on paired t-tests. More genes in MSCs than SMCs are strain-
responsive for both low stringency (p < 0.05: 5756 vs 3299 genes) and high stringency
(p < 0.001: 176 vs. 109 genes) p-value thresholds . When multiple testing corrections and
fold change cut-offs (|FC| > 1.5) are applied, similar numbers of genes are identified in
MSCs and SMCs as highly strain-responsive (36 vs 39).
4.3.5 Identification of conserved strain-responsive genes
Genes were defined to be cyclic strain-responsive when expression levels varying by at
least 1.5-fold were significantly (p < 0.05) different between strain and static samples,
determined using at least one of three tests: two-factor ANOVA, paired t-test of SMCs,
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Figure 19: Comparing strain-responsive gene sets identified via two-factor ANOVA
or paired t-test. (A) Venn diagram overlays showing significantly different genes (two-
factor ANOVA: corrected p-value < 0.05; paired t-tests: p-value < 0.05; n=3). (B) Venn
diagram showing high stringency criteria to identify strain-responsive genes. Gene lists
were narrowed by correcting p-values for multiple testing using the Benjamini-Hochberg
method and increasing p-value (p < 0.001, n=3) and paired fold change cut-off (|FC| < 1.5)
thresholds.
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Table 6: Highly significant strain-responsive genes in MSCs. List of genes identified
using a paired t-test with p < 0.001 and at least 1.5-fold change in expression level.
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Table 7: Highly significant strain-responsive genes in SMCs. List of genes identified
using a paired t-test with p < 0.001 and at least 1.5-fold change in expression level.
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Figure 20: Distribution of conserved, strain-responsive genes according to chro-
mosomal location. 442 genes were identified with significantly (p < 0.05, n=3) altered
expression levels in response to cyclic strain both two-factor ANOVA and paired t-tests of
SMCs and MSCs samples. The histogram above plots the distribution of chromosomal
locations for these 442 genes. The reference line indicates the average number of strain-
response genes per chromosome (µ=17.6±11.0). Chromosomes 23 and 24 refer to the X
and Y chromosomes, respectively.
or paired t-test of MSCs (Figure 19). Genes that met statistical significance and fold
change cut-offs for multiple tests (SMCs; MSCs; ANOVA) were defined as ’conserved’
strain-responsive genes. Two-factor ANOVA identified 822 genes with significant (p < 0.05)
dependence on force condition. Paired t-tests identified approximately 6,000 genes signif-
icantly (p < 0.05) altered in MSCs and 3,300 genes in SMCs (Figure 19A). When multiple
testing corrections were applied and the significance criteria was increased to p < 0.001,
many fewer genes were identified as strain-responsive: 36 and 39 in MSCs and SMCs, re-
spectively (Figure 19B). Detailed lists of these highly strain-responsive genes are included
in Table 6 for MSCs and Table 7 for SMCs. Only one gene, pleckstrein homology domain
containing family K member 1 (PLEKHK1), met stringent force-responsive criteria for both
cell types. Using the lower p-value threshold (p < 0.05), 442 genes are identified as con-
served strain-responsive genes by all three statistical tests (Figure 19A). A complete list of
these conserved strain-responsive genes is included in the appendix (Table 14).
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4.3.6 Chromosomal distribution of strain-responsive genes
To determine whether strain-responsive genes correlated with specific chromosomes, the
chromosomal distribution of conserved, significantly strain-responsive genes was deter-
mined (Figure 20). This distribution was characterized by a mean (µ=17.6) and standard
deviation (σ=11.0) of the number of strain-responsive genes per chromosome. Assuming
a normal distribution of strain-responsive genes throughout the genome, the 68% and 95%
confidence intervals for number of strain-responsive genes per chromosome are [6.6-28.6]
and [0-39.6] respectively. Chromosomes falling outside the 95% confidence level include
Chromosome 1 (41 of 442 strain responsive genes). Chromosomes with increased num-
bers of strain-responsive genes above the 68% confidence interval include 2 (35 genes), 3
(36 genes), and 10 (29 genes). Chromosomes with fewer strain-responsive genes include
13 (5 genes), 18 (4 genes), 21 (1 gene), and Y (0 genes).
4.3.7 Signaling network analysis of conserved strain-responsive genes
The set of 442 conserved strain-responsive genes was analyzed using Ingenuity Pathways
Analysis software to identify relationships between these molecules. A signaling network
of 730 molecules was generated from the manually-curated database of known gene, pro-
tein, and small molecule interactions. These 730 molecules were analyzed for primary
subcellular location (Figure 21A) and molecular function (Figure 21B). Genes significantly
altered due to strain are found primarily in the cytoplasm (28%), the nucleus (18%) and
plasma membrane (14%), and finally the extracellular space (7%). Due to limitations in
high-throughput data analysis using IPA, 33% of the molecules in this signaling network
were not associated with a particular cellular location.
Molecules in this strain-responsive network were most commonly enzymes (19%); tran-
scription regulators or group molecules (9%); transporters (6%); or kinases, phosphatases,
and complex molecules (4%). Only 1% of molecules in this network were growth fac-
tors, transmembrane receptors, or endogenous mammalian chemicals. Less than 1% of
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Figure 21: Cellular location and molecular function distribution in strain-responsive
signaling network. IPA software analysis of 442 conserved, strain-responsive genes
identified a signaling network of 730 genes. (A) Subcellular distribution of molecules
from conserved strain-responsive signaling network. (B) Molecular function distribution
of molecules in conserved strain-responsive network.
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molecules were translation regulators, ligand-dependent nuclear receptors, or ion chan-
nels. Similarly to the cellular location analysis, many of these molecules were not associ-
ated with a specific molecular type (35%).
4.3.8 Functional and regulatory analysis of strain-responsive genes
DAVID software was used to determine biological functions that correlate to the 442 con-
served strain-responsive genes. Clustering analysis with DAVID resulted in 109 functional
clusters. Significant (p < 0.05) clusters are described in Table 8. Oxidoreductase activity,
protein homodimerization, ion homeostasis, and ferritin signaling functions dominated the
list of significant clusters. To determine transcriptional regulators involved in the signaling
network, conserved strain-responsive genes were analyzed using CARRIE. 24 transcrip-
tion factors in MSCs and 53 transcription factors in SMCs are predicted to be regulators of
strain-response in each cell type (Table 9). Differences in this list of predicted active tran-
scription regulators may be due to fold change difference data for each cell type included in
the analysis. 15 transcription factors are predicited to be significantly (p < 0.001) involved
in mediating cyclic strain response in both cell types.
4.4 Discussion
MSCs and SMCs were exposed to a single force condition, equibiaxial cyclic strain (10%,
1 Hz) for 24 hours on fibronectin-coated silicone, and compared for changes in gene ex-
pression. Gene expression varied significantly more with cell type than force condition,
as determined using two-factor ANOVA and principal component analysis. Genes in both
cell types responded with significant (p < 0.05, n = 3), > 1.5-fold magnitude differences,
with reduced overall magnitude fold-changes in MSCs. A novel set of ‘conserved’ strain-
responsive genes was defined based on statistical analyses. This set of molecules was
found primarily in the cytoplasm and included enzymes and regulators of transcription.
Cell functions enriched in this set relate to general cell biology functions including oxidative
stress regulation, protein binding, and ion and ferritin homeostasis. Predicted transcrip-
tional regulation of this set of conserved strain-responsive genes included several factors
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Table 8: DAVID functional clustering of conserved, strain-responsive genes. DAVID
analysis of 442 strain-responsive genes identified with both two-factor ANOVA and paired
t-tests identified 12 significant (p < 0.05) clusters.
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Table 9: Transcription regulatory networks predicted to mediate MSCs and SMCs
response to cyclic strain. CARRIE analysis was used to analyze transcription networks
regulating the set of 442 conserved, strain-responsive genes. Transcription factors were
identified as significant (p < 0.001) in either cell type based on paired fold change levels in
each cell type.
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in both SMCs and MSCs and others specific to one cell type, mimicking the conserved and
cell type-specific components of the gene response.
Due to the expense of microarray analysis, only one cyclic strain condition was as-
sessed per cell type. Future work is needed to describe protein-level changes. Thus, the
set of identified strain-responsive molecules is biased towards those whose response oc-
curs at the mRNA level. Future studies may identify other molecules as strain-sensitive
that are altered post-transcriptionally. To generate sufficient genes in the intersection de-
fined as ‘conserved’ strain-responsive, multiple testing corrections were not applied to all
paired t-test analyses. Efforts to sort data based on multiple different criteria (with or with-
out MTC, with or without fold change cut-offs, statistical significance in multiple tests, etc.)
were used as a means to triangulate on the conserved force-responsive molecules.
Neither MSCs nor SMCs showed obvious cellular rearrangements following cyclic strain
on fibronectin-coated silicone. The morphological similarities between samples exposed to
cyclic strain or parallel static culture belie the marked differences in gene expression occur-
ring in both cell types. Transcriptome responses in each cell type were initially assessed
with global measures, PCA and two-factor ANOVA. The separation of sample groups (cell
type; force condition) along defined principal component axes indicates cellular behavior
can be described based on mathematical descriptions. Three principal components were
required in order to separate static versus strain samples, suggesting that other factors,
including cell type and possibly biochemical media type, dominate signaling differences
of principal component 1 and 2. Follow up work could test whether the axes defined in
GeneSpring’s PCA correlate with altered expression of a particular subset of genes.
Two types of statistical tests were used to identify individual strain-responsive molecules
in either or both cell types: two-factor ANOVA and paired t-tests. The paired t-tests were
necessary due to inherent experimental variability. Paired data was not accounted for in
the ANOVA, leading to two differences from paired t-tests: (1) some genes were signifi-
cantly only in paired t-tests because pairing could detect a trend obscured by noisy data
and (2) some genes were significantly force-dependent only in the ANOVA because subtle
cyclic strain vs. static differences required more replicates (e..g, n=6 vs. n=3) to detect.
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ANOVA highlighted the strong cell type-dependence of gene expression, with approx-
imately 50% of genes dependent significantly on cell type versus 2% dependent on force
condition. Genes significantly altered in SMCs (p < 0.05 or p < 0.0001) had larger aver-
age magnitude fold changes than genes significantly altered in MSCs. It is not possible
to determine based on this data whether the highly significant (p < 0.001) gene changes
observed in MSCs at low fold change magnitudes (|FC| < 1.5) are functionally important.
One possibility is that lower abundance transcripts in stem cells may be able to trigger
functionally important events related to differentiation, reasonable given the effects of low
abundance pluripotency factors such as Oct4 [312]. Analysis of nested sets of significant
and fold-change cut-off genes indicate similar numbers of genes are identified as most
strain-responsive (corrected p-value< 0.001 and |FC| > 1.5) in both cell types. With these
most stringent criteria for strain-sensitivity, only one molecule appears in both MSCs and
SMCs sets. The fact that many more genes are identified with slightly relaxed criteria
(p < 0.05 in all three statistical tests) suggests that specific molecules may be regulated at
different precision levels between cell types.
Pleckstrein homology domain containing family K member 1 (PLEKHK1) is the only
gene that met stringent force-responsive criteria (corrected p-value < 0.001) for both cell
types. PLEKHK1, also known as rhotekin 2 (RTKN2), is an intracellular plasma membrane-
associated molecule conserved across multiple species and involved in hematopoiesis, cell
proliferation, and signal transduction [49]. Very little is known about PLEKHK1 and there
are no reports of force-sensitivity of this molecule. However, association of PLEKHK1 with
the force-associated RhoA pathway suggests it may be strain-sensitive [5]. The conserved
Rho binding domain of PLEKHK1 binds the activated, GTP-bound form of the small GT-
Pase RhoA. RhoA binds ROCK, inhibiting myosin phosphorylation, affecting force sensing
and force generation.
Data published by other groups has shown regions of genomic DNA can be sensitive
to applied mechanical forces [25]. The heterogeneous distribution pattern observed in this
case suggests that a subset of chromosomes (e.g., Chromosome 1) may be predisposed
to alter gene regulation in response to cyclic strain. Other chromosomes may be more
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resistant to mechanically-induced transcription changes.
No clear bias between cytoplasmic, nuclear, or plasma membrane-associated compo-
nents was observed in the IPA-generated conserved strain-responsive signaling network.
The low fraction of extracellular space molecules identified may result from a bias due
to gene expression or because mechanosensitive regulation of extracellular-associated
molecules occurs at the protein level. The prevalence of enzymatic functions in this sig-
naling network suggests conserved strain-responses alter the potential signaling reactions
that can occur within cells exposed to cyclic strain. Transcription regulator involvement in
the conserved strain response suggests a feed-forward regulatory loop may exist, translat-
ing gene expression changes into subsequent changes in transcription regulation.
The functions identified using DAVID analysis are associated with physiologic function
of multiple cell types, rather than specialized functions of differentiated cell types. This is
consistent with the theory that mechanosensing is an inherent function of which all cells are
capable, as well as one that affects fundamental cell maintenance processes [111, 296].
Analysis with CARRIE to predict transcription factors that regulate the observed response
to cyclic strain highlights 15 factors likely to be involved in controlling cell signaling in both
cell types. This set of common transcription factors includes examples of known mechani-
cal strain-sensitive transcription factors like serum response factor (SRF) [306].
4.5 Conclusions
This work identifies a set of genes that may mediate cellular response to applied cyclic
strain in multiple cell types. This work includes those known to be strain-responsive (e.g.,
SRF), as well as novel genes (e.g., PLEKHK1). The wide distribution of strain-sensitive
molecules in the cell, representation among essential molecule types like enzymes, and
association with necessary cell functions like oxidoreductase activity collectively highlight
the importance of mechanical cues in controlling cell signaling. Future studies may investi-
gate whether these strain-responses are also conserved across other cell types. Account-
ing for differences in MSCs vs. SMCs strain-response may enable more controlled use of
MSCs in a vascular cell-based therapy.
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4.6 Materials and Methods
Supplies Cells and culture media were purchased from Lonza. PCR arrays and associated
materials were purchased from SA Biosciences. Standard qPCR reagents were purchased
from Qiagen (RNA isolation), Invitrogen (cDNA synthesis), and ABI (qPCR mastermix).
Cell culture of MSCs & SMCs Human adult bone marrow-derived mesenchymal stem
cells and aortic smooth muscle cells were cultured according to manufacturer’s recommen-
dations (Lonza). MSCs were expanded to Passage 6 and characterized for expression of
protein surface markers and differentiation potential along osteogenic, chondrogenic, and
adipogenic lineages prior to experimental use. SMCs expanded to Passage 3 were used
for experiments.
Applied strain Equibiaxial cyclic strain was applied using a custom-built device [267].
Briefly, cells were seeded on etched, human plasma fibronectin-coated silicone at 10,000
cells/cm2, calculated using a Coulter Counter Multisizer 3 (Beckman Coulter). For each
membrane holder chamber (MHC), cells were allowed to attach in 2 ml media for four
hours at 37·C, prior to addition of media up to 25 ml final volume and static preconditioning
culture on the silicone substrate for 48 hours total. Samples were subsequently exposed
to defined applied strain (10%, 1 Hz) or parallel static culture for ≤24 hours. To assess cell
morphology, phase images of samples were taken using an Axiovert microscope (Zeiss)
immediately prior to and following exposure to mechanical force.
Microarray sample preparation To minimize noise due to biological and experimental
variability, cell lysates were pooled from four independent samples per static or applied
strain replicate. Experiments were completed in triplicate. RNA was isolated according
to manufacturer’s protocols using an RNeasy Isolation Kit (Qiagen). All samples passed
two levels of quality control: first, the concentration, A 260
280
, and A 260
230
were measured using
a Nanodrop (Thermo Scientific) and second, the RNA integrity number (RIN) was deter-
mined using a Bioanalyzer (Agilent). cDNA synthesized from high quality RNA samples
was labeled for one-color detection and run on a whole human genome 60-mer microarray
(Agilent), four arrays per slide. Microarray images were captured using Feature Extraction
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software and passed manufacturer-recommended quality control metrics for image unifor-
mity.
Microarray data analysis Feature Extraction data was imported into Gene Spring 10.0
for normalization and statistical assessment. 12 of 12 arrays passed quality control met-
rics within GeneSpring, enabling three replicates per group to be analyzed. Genes were
filtered to ensure present or marginal expression levels in at least one sample. ANOVA with
Benjamini-Hochberg multiple testing correction of all sample groups was used to determine
whether gene expression depended significantly on cell type or force condition. T-tests with
paired static and strain samples per experiment were used to identify genes significantly
altered in either SMCs or MSCs. When multiple testing corrections applied to paired t-tests
resulted in few to no genes identified, increased significance cut-offs (p=0.001 vs. p=0.05)
were used instead. Conserved strain-responsive genes were defined as those meeting
three criteria: two-way ANOVA significant dependence on applied force (p < 0.05), SMCs
paired t-test significant difference between static and applied strain groups (p < 0.05), and
MSCs paired t-test significant differences (p < 0.05).
Functional, regulatory, and subcellular location analysis of strain-responsive genes was
completed using Ingenuity Pathways Analysis (Ingenuity), the Database for Annotation,
Visualization and Integrated Discovery (DAVID) 2008 [107, 64], and the Computational
Ascertainment of Regulatory Relationships (Inferred from Expression) (CARRIE) software
[93, 94]. For IPA analysis, GenBank Accession Numbers for the set of conserved force-
responsive molecules were uploaded as a data set and analyzed for core analysis using
direct and indirect relationships, endogenous chemicals, and up to 25 networks per anal-
ysis, each with up to 35 molecules. Descriptions for each molecule associated with the
resulting 25 networks of direct and indirect interactions were exported from IPA into MS
Excel and sorted according to molecular function or subcellular location. GenBank acces-
sion numbers for conserved force-responsive probes were uploaded to the DAVID inter-
face as the gene list and compared to the Homo sapiens background gene list. Functional
annotation clustering was performed via DAVID version 6.7b and results exported to MS
Excel for table formatting. Both IPA and DAVID analysis relied only on GenBank Accession
64
numbers. For prediction of transcriptional regulators, both GenBank Accession numbers,
as well as fold change and p-values, were uploaded for each cell type. Pre-processed
array data in this format were uploaded and analyzed using the TRANSFAC Human ma-
trix list and HG-U133 promoter list. Transcription factors were defined as significant if the
frequency of significant sites in random promoters was < leq0.001 and the p-value for
binding site overabundance in one promoter was ≥0.01. Finally, chromosomal location
analysis was completed by sorting data output from GeneSpring for the conserved set of
force-responsive probes.
Standard qPCR assessment Individual genes were assessed using standard qPCR.
RNA was isolated from kinetic experiments and quantified as above. cDNA was synthe-
sized using a FirstStrand III SuperScript Kit (Invitrogen) and prepared for qPCR with cus-
tom designed primers (Primer Express 3 software; Invitrogen custom primer synthesis;
ABI SYBR mastermix). qPCR samples were run on a StepOne Plus machine (ABI) and
baseline-subtracted Ct analyzed in Excel (Microsoft). All data were converted to molar
concentrations using a standard curve and normalized to Gapdh expression. Two fold-
changes were calculated: a strain response (the ratio of strain/static relative expression)
and a cell type response (ratio of MSCs/SMCs expression under respective maintenance
conditions). A 1.5-fold change threshold was used to identify strain-responsive genes. Fold
change in gene expression calculated using microarrays versus qPCR were compared.
Statistical analysis Microarray data were analyzed with two-factor ANOVA or paired
t-test. Functional significance was determined using statistical methods inherent in IPA,
DAVID, or CARRIE, respectively. qPCR data was analyzed in MS Excel with two-tailed
paired t-tests. Experimental design was employed to minimize the effect of biological vari-
ability (i.e., 4 pooled samples per microarray) and randomize the effect of experimental
variability (n≥3 independent experiments/comparison). Significance cut-offs, defined ex-
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MESENCHYMAL STEM CELLS RESPOND TO SHEAR STRESS WITH
REDUCED INFLAMMATORY SIGNALING
5.1 Abstract
MSCs may contribute to an endothelial therapy via differentiation or their ability to modu-
late cell behavior via paracrine signaling. Inflammation and immune-related signaling are
early onset, functionally-important indicators of the vascular response to shear stress, yet
the ability of MSCs to signal in a site-appropriate manner has not been quantified. The
objective of this study was to determine the signaling response of MSCs to physiologically-
relevant vascular shear stress, in comparison with that of ECs. MSCs and ECs were ex-
posed to two different shear stress magnitudes (5 or 15 dyn/cm2 or parallel static control)
and durations (0, 2, 6, 12, or 24 hours) using a parallel plate shear system. RNA iso-
lated from all samples was assessed using quantitative RT-PCR for expression of genes
characteristic of ECs differentiation or ECs inflammatory response to shear stress. MSCs
response to shear stress was similar to ECs for Cox-2, Hmox-1, and vWF. MSCs expres-
sion was undetectable or unresponsive to shear stress for eNos, Klf2, and VE-Cad, in
contrast with shear-sensitivity in ECs. MSCs and ECs response to shear stress altered in
opposite directions for Pecam-1 and Mcp-1. These results indicate that shear stress trig-
gers an immune and inflammatory response in both ECs and MSCs. In addition, this data
demonstrates that shear stress alone is not sufficient to differentiate MSCs towards ECs
within 48 hours. This work highlights genes with mechanosensitivity conserved across
cell type, meriting future investigation into the functional importance of this conserved im-
mune/inflammatory response and into the mechanism(s) controlling the shear-response in
both cell types. This work shows MSCs may reduce inflammatory and immune signaling




Cell-based therapies may improve on current clinical options by employing biological mech-
anisms not yet possible to engineer synthetically. Mesenchymal stem cells, one potential
cell source, are an adult multipotent mesenchymal cell type classically defined as bone
marrow-derived and capable of differentiating towards orthopedic and adipogenic lineages.
Recent studies have derived MSCs-like cells from a wide variety of tissues and demon-
strated their differentiation potential towards a broader range of cell types. Studies of
MSCs for vascular applications have shown MSCs can adopt traits of differentiated vas-
cular cells; reduce inflammatory damage and immune response and promote growth via
paracrine factors; and are phenotypically similar to pericytes, an in vivo cell type support-
ing the vasculature. The potential of MSCs to mimic vascular cell response to physical
forces remains poorly characterized though. The objective of this study was to determine
the response of mesenchymal stem cells to fluid shear stress, a mechanical cue known to
regulate immune and inflammatory signaling in endothelial cells.
Immunity and inflammation are involved in angiogenesis, atherosclerosis, tumor pro-
gression, and diabetes, among other functional markers of health and disease [31]. Inflam-
mation is the process by which the body responds to injury (physical, chemical, microbial,
etc.) and attempts to remove the irritant and enable tissue repair [193]. Inflammatory cues
trigger an immune response, a process through which foreign and disease components
are identified and killed [169]. Depending on the initial trigger, the inflammation and im-
mune response may resolve normally or may persist as a chronic condition. Endothelial
cells play a critical role regulating the chemoattractive and adhesive environment of the
vessel lumen, and thereby the inflammatory and immune activity at the vessel wall [175].
Cytokines, chemokines, adhesive molecules, and oxidative stress regulators signal as part
of ECs regulation of immune and inflammatory responses [175, 169, 215]. Several of these
molecules are known to be responsive to blood flow, as summarized in Table 10. While
these signaling molecules each contribute to inflammation and immune activation, they
can also interact with one another (Figure 29).
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Table 10: Genes involved in endothelial cell regulation of immune and inflammatory
responses. Gene names, and their synonyms, are listed in terms of functional category
relevant to these studies, subcellular location, molecular function type, biological function,
and known gene expression response to applied shear stress in endothelial cells.
Several options have been proposed for incorporating MSCs in a vascular therapy. For
prefabricated vascular grafts, MSCs may be seeded on the inside of a synthetic or natural
polymer tube, mimicking endothelialization [294]. For cardiac applications, in which local
vascularization may be desired, MSCs may also be presented in a homogenous gel to be
used as a patch on the injured area [262]. Direct delivery of MSCs is possible through
intravascular (systemic) or intramuscular or endocardial (local) injection [229]. Cells used
may vary in preparation, ranging from fresh bone marrow preparations to preconditioned,
differentiated MSCs-derived cells. The therapy may employ MSCs as a solo cell therapeu-
tic or in combination with other therapeutic components [229]. In all cases, MSCs intended
to line the lumen of a vessel will be subjected to shear stress.
Both mesenchymal stem cells and endothelial cells arise from the mesoderm. Mes-
enchymal stem cells in vivo are associated with the perivascular niche [51, 29] Undifferen-
tiated MSCs express markers functionally important in ECs, such as VEGF [332]. Animal
and human clinical trials of MSCs-based cardiovascular therapies indicate these cells may
adopt traits of vascular cells upon implantation [80]. Genetic engineering techniques for
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Tie2, Flk1, Ang, Vegf, and eNos have been used to track and/or promote endothelial-like
differentiation. Both biochemical and mechanical cues have been used to enhance the
endothelial phenotype of MSCs in vitro [118, 66]. Soluble (VEGF, IGF, EGF, bFGF, hydro-
cortisone, ascorbic acid, heparin) and insoluble (extracellular matrix) biochemical cues can
increase expression of endothelial gene and protein markers and improve functional as-
sessments such as formation of tubes on Matrigel [332, 168, 167]. Shear stress has been
shown to upregulate and sustain expression of endothelial-related markers in the presence
of biochemical stimuli, but may not be sufficient to trigger endothelial differentiation alone
[15, 8]. Gene and protein expression levels are frequently employed metrics to assess
differentiation. For the majority of these both in vivo and in vitro studies, expression levels
of PECAM-1, an early marker, and VE-Cad and vWF, later markers, were used to infer
endothelial differentiation.
MSCs may contribute to vascular health through paracrine actions, rather than direct
differentiation [12]. MSCs secreted factors can promote cell proliferation and inhibit cell
death. MSCs-secreted growth factors also promote angiogenesis. Secretion of proteases
by MSCs enables chemical composition and mechanical property remodeling of the tis-
sue. Presence of MSCs in a vascular injury can affect cell migration and recruit reparative
and replacement cell types to the area. MSCs unique cytokine and HLA expression pro-
files enable them to modulate and suppress inflammation and immune reactions in the
surrounding tissue.
The responses of MSCs to applied shear stress have been investigated primarily for
osteogenic and vasculogenic mechanical regimens. Shear stress at osteogenic-relevant
levels has been shown to promote osteogenic differentiation [327, 132, 271, 255]. Compu-
tational models to predict the effects of compression and fluid flow have also been devel-
oped to predict MSCs response to flow [327, 129]. Several groups have investigated shear
stress as a method to enhance endothelial differentiation of MSCs and related cell types
(e.g., amniotic fluid- or adipose-derived stem cells) [8, 15]. These data conflict regarding
the effect of shear stress as a sufficient cue to differentiate MSCs towards endothelial cells
within 48 hours. In vivo, MSCs are likely exposed to low levels of shear stress in the bone
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marrow environment. MSCs-like cells have also been isolated from other locations with
shear stress (amniotic fluid; human umbilical cord) [282]. Few studies have been done to
analyze shear stress-sensitive cell signaling, independent of differentiation markers.
Evidence to date suggests MSCs are promising options for vascular therapies and
potentially endothelial cell substitutes. Shear stress alters MSCs signaling and behavior
as a function of shear stress parameters (magnitude, duration, duty cycle, and ramp) and
interaction with biochemical cues. Control of immune and inflammatory signaling is an
important component of physiological response of ECs to shear stress. However, parallel
assessments have not been reported describing whether MSCs can mimic this response.
In this study, ECs and MSCs are exposed to varied magnitude and duration steady laminar
shear stress and assessed for changes in a panel of 8 immune and inflammation markers.
Shear stress promotes an anti-inflammatory, immunosuppressive state in MSCs, without
evidence of endothelial differentiation.
5.3 Results
5.3.1 Cell shape and number in response to shear stress
Cells were subjected to steady laminar shear stress (5 or 15 dyn/cm2) or parallel static
culture in their respective culture media. Samples were visualized with phase microscopy
and RNA harvested for gene expression assessment after 0, 6, 12, 24, or 48 hours. ECs
exposed to 15 dyn/cm2 shear stress elongate and align parallel to the direction of shear
within 48 hours. Small areas of local cell alignment are visible within 12 hours of applied
shear, as shown in Figure 22A. ECs exposed to 5 dyn/cm2 shear stress do not markedly
elongate or align parallel to the direction of applied shear. Qualitatively, cells appear to align
perpendicular to the direction of applied shear stress. Cell number increased markedly in
static samples, but not shear samples, during the 48 hour culture period. Cell density after
48 hours applied shear stress of either 5 or 15 dyn/cm2 resulted in lower cell density than
parallel static samples.
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Figure 22: Phase morphology of ECs and MSCs in response to static or applied
shear stress culture. ECs (A) and MSCs (B) after static culture (A & B, top row), 5
dyn/cm2 shear stress (A & B, middle row), or 15 dyn/cm2 (A & B, bottom row) applied
shear stress. Scale bars = 100µm.
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Figure 23: Quantification of cell number and viability in MSCs, using ViCell. Cell
number decreases significantly in response to applied shear stress, with no significant
differences between shear magnitudes of 5 and 15 dyn/cm2. Viability does not change
significantly (p=0.234, n=3) between groups.)
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MSCs cultured on Type I Collagen-coated glass slides are spindle-shaped cells occu-
pying more surface area than ECs. Applied shear stress up to 48 hours does not pro-
mote a cobblestone morphology in MSCs. Similar to ECs, MSCs cell density increases
markedly in static samples, but not shear samples, during 48 hours. Cell number signif-
icantly (p ≤ 0.001, n=3) decreased in response to shear stress, although viability did not
(p=0.234, n=3), as shown in Figure 23. Inhomogeneous cell density of MSCs appears
within 12 hours of applied shear (5 or 15 dyn/cm2), relative to the same samples immedi-
ately prior to shear and to time-matched static control samples. These gaps and clusters
persist in shear samples throughout 48 hours of applied shear stress. Gaps are larger and
more rounded in samples exposed to 15 dyn/cm2 compared to 5 dyn/cm2. Alignment of
MSCs parallel to the direction of applied shear stress is present only in local areas and
after at least 24 hours applied shear stress.
5.3.2 Overall gene expression comparison
Expression of eight genes characteristic of endothelial cells and immune/inflammatory re-
sponse were quantified using real time-PCR. MSCs had ≤ 103 lower expression for vWF,
eNos, Pecam-1, and VE-Cad, with the latter three indistinguishable from no template qPCR
controls. Cox2, Hmox1, Klf2, and Mcp1 were expressed at similar magnitudes in MSCs
and ECs. On average, shear stress resulted in significant differences in gene expression in
ECs earlier than MSCs. ECs also had larger average fold change gene expression levels
due to applied shear stress.
5.3.3 Shear response of endothelial differentiation genes
qPCR results from immune and inflammatory genes also characteristic of endothelial dif-
ferentiation are shown in Figure 24. In ECs, Pecam-1 expression steadily and significantly
(p ≤ 0.05, n=3-4) increases from 6 to 48 hours of applied shear stress (5 or 15 dyn/cm2).
VE-Cad expression increased significantly after 24 hours (5 dyn/cm2) and 48 hours (5
and 15 dyn/cm2). vWF expression increased slightly throughout the duration of applied
shear, but was significant only after 6 hours of shear stress at 15 dyn/cm2. Fold change
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Figure 24: Kinetics of endothelial differentiation gene expression in response to
applied shear stress. ECs (left, blue) and MSCs (right, red) were exposed to varied
steady laminar shear stress magnitude (0, 5, or 15 dyn/cm2) of varied duration (0, 6, 12, 24,
or 48 hours). Asteriks indicate significant (p ≤ 0.05,n=3-4) differences in gene expression
relative to static controls.
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at 6 hours was shear magnitude-dependent (p=0.011, n=3-4; FC5dyn/sq−cm1.38 ± 0.19,
FC15dyn/sq−cm = 1.72 ± 0.21) (Figure 26). MSCs expression followed a markedly different
pattern. Pecam-1 and VE-Cad were expressed at very low levels in MSCs. Pecam-1 tran-
siently and significantly increased following 12 hours applied shear stress (5 dyn/cm2), but
decreased significantly in both shear groups following 48 hours of applied shear. vWF was
expressed in unstimulated MSCs (0 hr) and increased significantly after 6 (15 dyn/cm2),
24 (5 dyn/cm2), and 48 (15 dyn/cm2) hours applied shear stress. Expression of endothelial
differentiation genes was not shear magnitude-dependent in MSCs (Figure 26).
5.3.4 Shear response of immune and inflammatory genes
In addition to Pecam-1, VE-Cad, and vWF, ECs and MSCs were assessed for expression
of five other common markers of physiologic ECs shear response, all related to immune
and inflammatory function (Figure 25). Gene expression changes detected in ECs ex-
posed to steady laminar shear stress were consistent with previous reports: Cox-2, eNos,
Hmox1, and Klf2 increase. Mcp1 increased significantly only transiently (p=0.027, n=3-4;
FC15dyn/sq−cm = 3.62± 0.74).
MSCs shear response pattern differed markedly from that of ECs for eNos, Klf2, and
Mcp1. MSCs expression of eNos could not be distinguished from qPCR no template con-
trols; application of shear stress did not significantly alter eNos expression. The transcrip-
tion factor Klf2 was significantly altered in MSCs after 15 dyn/cm2 shear stress, but at levels
below the 1.5-fold detection limit for qPCR (p=0.024, FC0hr = −1.26 ± 0.08 and p=0.050,
FC24hr = 1.22±0.09). Mcp-1 expression was significantly decreased after 12 (15 dyn/cm2),
24 (5 and 15 dyn/cm2), or 48 (5 and 15 dyn/cm2) hours applied shear stress, in contrast
to the increase in Mcp1 observed in ECs after 12 hours applied shear. Significant Mcp-
1 downregulation in MSCs remained relatively constant following applied shear stress of
either 5 dyn/cm2 (FCavg = 2.66± 0.10) or 15 dyn/cm2 (FCavg = 3.73± 0.73)
Shear stress responses of ECs and MSCs were similar for Cox-2 and Hmox-1. MSCs
expression of Cox-2 also increased in response to shear, but decayed more quickly than
in ECs (12 hr vs. 48 hr). Cox-2 shear response in MSCs occurred within minutes at
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Figure 25: Kinetics of immune and inflammatory gene expression in response to
applied shear stress. ECs (left, blue) and MSCs (right, red) were exposed to varied
steady laminar shear stress magnitude (0, 5, or 15 dyn/cm2) of varied duration (0, 6, 12,
24, or 48 hours). Asteriks indicate significant (p ≤ 0.05,n=3-4) differences in gene expres-
sion relative to static controls. § indicates significant (p ≤ 0.05,n=3-4) differences in gene
expression levels between 5 and 15 dyn/cm2 groups.
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high shear magnitude (p=0.027, n=3-4; FC15dyn/sq−cm = 3.62 ± 0.74) and peaked after
6 hours (5̃-fold increase in both 5 and 15 dyn/cm2 vs. static). Hmox1 shear-response
was conserved between MSCs and ECs, increasing in both cell types. Expression of
Hmox-1 peaked in both cells types after 12 hours applied shear, although this maximum
represented a sharp peak in MSCs (12 hr) compared to a gradual decrease in Hmox-1
upregulation (6 - 48 hr) in ECs. Maximum Hmox-1 fold change was greater in ECs than
MSCs (FCECs−max = 10.1± 3.6 vs. FCMSCs−max = 8.1± 3.6).
5.3.5 Effect of shear magnitude on gene expression response
Cells were exposed to a low (5 dyn/cm2) and high (15 dyn/cm2) shear stress to approximate
the differences in physiologic shear stress cues between small vessels and large vessels,
respectively. More genes show shear-magnitude dependence in ECs than MSCs. Paired
t-tests identified significant (p≤0.05, n=3-4) differences between shear magnitude groups
for Cox2, eNos, Klf2, and vWF in ECs and for Cox-2 and Mcp1 in MSCs (Figure 24-25,
§, and Figure 26, *). Figure 26 compares fold change differences over time and across
cell type for genes whose expression varies significantly with shear magnitude (5 vs. 15
dyn/cm2) in one or more conditions.
Higher magnitude shear stress in ECs resulted in a faster decrease in Cox2 upregula-
tion after 24 and 48 hours applied shear. eNos expression in ECs was significantly different
after 6 and 12 hours applied shear of either in 5 vs. 15 dyn/cm2 groups, but the increase in
gene expression at higher shear stress was moderate (6 hours: FC5dyn/sq−cm = 1.3 ± 0.1
vs. FC15dyn/sq−cm = 2.6 ± 0.2; 12 hours: FC5dyn/sq−cm = 1.3 ± 0.04 vs. FC15dyn/sq−cm =
2.0 ± 0.1). ECs expression of Klf2 was significantly different between low and high shear
magnitudes after minutes (0 hour) and 6, 12, or 48 hours applied shear. In all cases, higher
shear stress magnitude correlated with increased Klf2 expression. Like eNos shear magni-
tude differences, ECs expression of vWF significantly differed between groups after 6 hours
applied shear stress, but the magnitude difference was slight (FC5dyn/sq−cm = 1.4± 0.2 vs.
FC15dyn/sq−cm = 1.7± 0.2).
In MSCs, Cox2 was significantly upregulated within minutes (0 hour) only at high shear
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Figure 26: Shear-responsive gene expression is dependent on the magnitude of
applied shear stress. Asterisks (*) indicate significant (p < 0.05, n ≥ 3) differences in
gene expression after 5 or 15 dyn/cm2 magnitude applied shear stress, based on a paired
t-test. Fold change values for 5 dyn/cm2 (striped columns) and 15 dyn/cm2 (solid bars) are
shown for ECs (blue) and MSCs (red) for each timepoint. More instances of magnitude-
dependent gene expression occur in ECs than MSCs.
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magnitude (15 dyn/cm2). Differences in shear magnitude effects were also significant at 24
hours, but did not pass the 1.5-fold change threshold. MSCs downregulation of Mcp1 was
greater in 15 dyn/cm2 samples after 12, 24, and 48 hours, although this difference was only
significant after 48 hours (FC5dyn/sq−cm = −2.73± 0.04 vs. FC15dyn/sq−cm = −3.82± 0.03).
5.3.6 Correlation of protein expression with gene expression
Expression levels and spatial localization were assessed for PECAM-1, VE-CAD, and vWF
protein to determine whether shear-responsive gene expression correlated with protein
changes (Figure 27). For all three proteins, expression levels were lower in MSCs than
ECs. In ECs, PECAM-1 increased significantly after 24 (FC=1.85; p ≤ 0.05, n ≥ 3) and
48 (FC=2.07; p ≤ 0.1, n ≥ 3) hours, similar to changes observed in gene expression.
PECAM-1 expression in MSCs did not change significantly (p24h=0.132, p48h=0.348, n ≥ 3)
in response to shear stress. Confocal images show PECAM-1 is concentrated at cell-cell
junctions in ECs, in contrast to diffuse staining in MSCs.
VE-CAD levels increased significantly (p ≤ 0.1, n ≥ 3) in ECs following 24 hours applied
shear, but was no longer statistically significantly increased after 48 hours shear stress
(p=0.511, n ≥ 3). VE-CAD levels in MSCs also increased, albeit not significantly, after 24
hours (FC=1.64; p=0.375, n ≥ 3) or 48 hours (FC=2.22; p=0.665), n ≥ 3) applied shear
stress. Spatial localization of VE-CAD was similar to PECAM-1 for both ECs and MSCs,
showing cell-cell junction and diffuse staining, respectively.
vWF protein levels did not change significantly in either cell type after 24 or 48 hours
applied shear stress. vWF protein was localized around nuclei in ECs, whereas vWF
expression appeared diffuse throughout the cytoplasm in MSCs. Unlike PECAM-1 and
VE-CAD, localization of vWF in ECs and MSCs was not uniform across a field of cells. In
ECs, some cells showed intense perinuclear vWF staining [60], while other cells expressed
comparatively undetectable levels of vWF. In MSCs, vWF protein localization was diffuse
across all cells, but contained cell-scale elongated regions of intense staining.
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Figure 27: Protein expression in ECs and MSCs exposed to shear stress. Protein
expression determined using immunocytochemistry for PECAM-1 (top two rows), VE-Cad
(middle two rows), and vWF (bottom two rows). ECs (left two columns) and MSCs (middle
two columns) images are shown, with intensity levels normalized to each image, in order
to emphasize differences in protein localization between samples. To quantify changes in
protein expression per cell, average pixel intensity per nuclei was quantified using unpro-
cessed images (graphs).
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Figure 28: Effect of underlying protein substrate on MSCs response to applied shear
stress. Comparison of shear on fibronectin-coated (left column) or type IV collagen (right
column) morphology after 48 hours exposure to static (top row) or applied shear stress (15
dynes/cm2; bottom row). Inset images show morphology immediately prior to application
of shear stress. Altered protein substrate results in reduced rearrangement of MSCs in
response to shear stress.
5.3.7 Shear-response varies with underlying protein substrate
Cell-matrix adhesions can affect how an applied force is mechanically translated to and
chemically interpreted by cells [67, 104]. To determine whether the remodeling observed
in MSCs exposed to shear stress on Type I Collagen-coated silicone was a function of cell-
matrix interactions, MSCs were seeded on fibronectin- or Type IV collagen-coated silicone
and exposed to 15 dyn/cm2 shear stress for 24 hours. Cellular rearrangements were not as
visible in shear samples of either Fibronectin or Type IV Collagen after 24 hours (Figure 28)
as in MSCs exposed to shear stress on Type I Collagen (Figure 22).
5.4 Discussion
When exposed to shear stress on Type I Collagen-coated glass, MSCs do not form a con-
fluent, aligned monolayer of cells as seen with ECs. Exposure of MSCs to shear stress
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Figure 29: Schematic of known interactions between genes on immune and inflam-
matory marker panel. Connections between molecules are annoted with the relationship
type and number of known relationships. Relationship types include: activation (A), ex-
pression (E), phosphorylation (P), protein-protein interactions (PP), or translocation (TR).
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reduces cell number and results in appearance of a network of gaps and overlapping clus-
ters and small areas of local alignment to the direction of shear stress. For the panel of 8
immune and inflammatory genes assessed, MSCs have lower expression levels compared
to ECs (7 of 8 genes), reduced shear-responsiveness (49 vs. 22 instances), and slower
response kinetics (3 vs. 6 genes significantly altered within 6 hours). MSCs alter signaling
in response to applied shear stress, but do not correlate with endothelial differentiation.
Application of shear stress significantly increases vWF expression in MSCs. This is not
accompanied by upregulation of other endothelial differentiation-related genes, PECAM1
and VE-Cad, though, nor is vWF expression significantly shear-responsive in ECs. Differ-
ent in protein quantities and spatial patterning indicate MSCs and ECs differ at both the
gene and protein level.
A limited panel of gene and protein markers was used to infer the effect of shear stress
on immune and inflammatory responses. A more complete assessment of immune and
inflammatory response would include additional signaling molecules and functional as-
sessments such as leukocyte adhesion. Low cell yield per sample (2̃50,000 cells/cm2),
due to bioreactor constraints and limited antibody availability, hindered protein quantifica-
tion and spatial localization of all gene markers analyzed. Multiple time points (0-48 hours)
and shear magnitudes (5 or 15 dyn/cm2) provide data on a range of mechanical conditions.
However, broader conclusions about shear threshold-sensing or signaling changes due to
long-term mechanical conditioning could be made with a wider range of shear magnitudes
and longer duration studies.
MSCs do not align in confluent layers parallel to the direction of applied shear, as ECs
can within 48 hours. Further studies are needed to determine whether the lack of cell align-
ment parallel to the direction of applied shear stress is detrimental for a vascular therapy.
Decreased cell number in MSCs samples exposed to shear stress may be caused by a
decrease in proliferation or an increase in cell death [213, 15]. No significant decrease in
cell viability suggests the decrease in cell number represents a physiologic, not pathologic,
response. Furthermore, ECs are known to decrease proliferation in response to shear
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stress [163], suggesting that mitosis regulation by mechanical shear stress may be a con-
served morphological event. The cellular rearrangements observed in MSCs seeded on
type I collagen in response to shear stress appear to be mediated by cell-matrix interac-
tions, since shear-dependent MSCs rearrangements decrease when cells are seeded on
type IV collagen- or fibronectin- coated surfaces. This response could be due to changes
in signaling or mechanical stiffness inherent to the adsorbed protein molecule. Alterna-
tively, differences in MSCs alignment and cellular rearrangement in response to shear
stress could result from greater similarity of MSCs with other adherent cell types (e.g.,
fibroblasts), rather than ECs.
Other groups have reported that MSCs adopt endothelial traits in response to shear
stress [205, 66, 304]. In these studies, gene expression levels of vWF, a late marker of en-
dothelial differentiation, increased in MSCs in response to shear stress. However, neither
protein levels of vWF nor increases in expression of earlier markers of ECs differentiation,
Pecam-1 and VE-Cad, were observed. This data suggest 48 hours of applied shear stress
at either 5 or 15 dyn/cm2 is not sufficient to trigger endothelial-like differentiation in MSCs.
Differences from O’Cearbhaill et al and Dong et al results may be due to marked differ-
ences in applied mechanical cues, 2-D vs. 3-D culture environments, or MSCs species
[66, 205]. Bai et al tested the effect of shear magnitude with or without VEGF stimula-
tion on expression of the VEGF receptor, Flk1, another marker of ECs [8]. Flk1 increased
transiently in MSCs in response to shear stress (10-20 dyn/cm2), decreasing by 48 hours.
This is consistent with a response in MSCs of endothelial-relevant markers to shear stress,
without clear differentiation along an endothelial lineage. Protein quantification of Pecam1,
VE-Cad, and vWF was consistent with ECs gene changes. No significant differences in
MSCs expression of Pecam1 or vWF protein though indicates slower kinetics or post-
transcriptional regulatory mechanisms at work.
Exposure of ECs to applied shear stress promoted an anti-inflammatory environment
with increased expression of cell-cell adhesion molecules, Pecam1 and VECad. Expres-
sion of clotting-related molecule vWF increased, albeit not significantly, in ECs. The sig-
nificant decrease in Mcp1 and Pecam1 observed in MSCs suggests these cells may have
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reduced monocyte and leukocyte adhesion compared to ECs. Significantly increased ex-
pression of vWF in response to shear stress may promote clotting [159], a factor that may
impact success of an MSCs-based therapy in which cells experience shear stress. MSCs
exposed to shear stress matched the upregulation of Cox-2 and Hmox-1 observed in ECs.
eNos expression was undetectable in MSCs, but studies by others have shown transduced
MSCs can signal through eNos [126]. Klf2 expression was highly upregulated in ECs in
response to shear (5̃-fold increase after 6, 12, 24, and 48 hours in both 5 and 15 dyn/cm2).
The lack of Klf2 expression in MSCs suggests MSCs will not upregulate the downstream
targets of Klf2, highlighting another difference in MSCs and ECs signaling.
MSCs and ECs differed in protein levels and localization of endothelial-relevant mark-
ers, Pecam1, VE-Cad, and vWF. For all three markers, MSCs expressed lower levels and
showed more diffuse staining than ECs. Differences in significantly shear-responsive gene
expression versus protein expression levels (PECAM1: MSCs-48hr; VE-Cad: ECs-48hr;
vWF: MSCs-24hr and MSCs-48hr) demonstrate that gene and protein levels are indepen-
dently regulated. The impact of shear-responsive changes at the gene expression level
may be modified by subsequent post-transcriptional changes. Differences in protein lo-
calization highlight the importance of post-translational mechanisms also in regulating cell
signaling responses to applied shear stress. For example, non-uniform distribution of vWF
protein suggests vWF localization is actively regulated in ECs (presence/absence; perin-
uclear vs. cytoplasmic distribution) [114] and MSCs (regions of concentrated expression,
possibly adjacent to cell membranes). Specialized functions of ECs may rely on protein
modification mechanisms to achieve physiologic signaling.
ECs signaling was more sensitive to shear stress magnitude than MSCs, suggesting
more refined mechanosensing capacity in ECs. This may be due to extended precondi-
tioning of the cells during development and adult function, similar to methods reported to
benefit in vitro cultures [189]. For the two shear magnitudes tested (5-15 dyn/cm2), MSCs
appear to respond in a binary manner. Only Cox2 immediate signaling (0 hr timepoint) and
Mcp1 signaling at 48 hours showed significant differences in expression between 5 and 15
dyn/cm2. Testing a larger range of shear magnitudes would determine whether additional
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critical signaling thresholds exist (e.g., minimum or maximum induced signaling).
5.5 Conclusions
In summary, this data show MSCs and ECs differ in terms of basal gene and protein
expression levels, protein localization, response to applied shear, and kinetics of shear-
response. Differences in shear-responsive signaling are summarized in Figure 29, with
similar responses between MSCs and ECs for Cox2, Hmox1, and vWF and dissimilar re-
sponses for eNos, Klf2, Mcp1, Pecam1, and VE-Cad. These signaling differences suggest
MSCs may promote a low-inflammatory, low immunogenic environment when exposed to
shear stress as part of a cell therapy. MSCs remodeling in response to shear stress and
failure to upregulate characteristic endothelial markers suggest additional cues may be
required if MSCs are to be used as endothelial layer substitutes. This study also demon-
strates the dependence of MSCs mechanoresponse on the cell-matrix attachment mech-
anism, with different responses observed for type I collagen compared to type IV collagen
or fibronectin.
5.6 Materials and Methods
Supplies Cells and bullet kit media for early passage cells were purchased from Lonza.
Lab-made culture media components included MSCs-qualified serum (Atlanta Biologi-
cals); penicillin/streptomycin, EGF, and IGF-1 (Gibco); hydrocortizone, VEGF, and ascor-
bic acid (Sigma); recombinant human bFGF (PeproTech), fetal bovine serum (MediaTech).
Shear stress was applied on glass slides coated with either rat tail Type I Collagen (BD
Biosciences), mouse Type IV Collagen (BD Biosciences), or human plasma Fibronectin
(Gibco). Parallel plate shear loops were fabricated as previously described [155]. Gene
expression was assessed using reagents for RNA isolation (Qiagen), cDNA synthesis (In-
vitrogen), standard qPCR (ABI), and custom-synthesized primers (Invitrogen). Immunos-
tain reagents were purchase for donkey serum (Sigma); primary antibodies PECAM-1 (Mil-
lipore), VE-CAD (Santa Cruz Biotechnology), and vWF (Dako); and secondary antibodies
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Cy3-conjugated donkey anti-mouse IgG (Jackson Immunoresearch), and AlexaFluor 488-
conjugated donkey anti-goat and anti-rabbit IgG (Invitrogen).
Cell culture of MSCs & ECs Human adult bone marrow-derived mesenchymal stem
cells (MSCs) and aortic endothelial cells (ECs) were cultured according to manufacturer’s
recommendations (Lonza). MSCs were expanded in MSCs bullet kit media and frozen at
Passage 5. MSCs were thawed at P.5 and used in shear stress experiments at P.6 using
lab-made media: high-glucose DMEM with 10% MSCs-qualified serum , 2mM L-glutamine,
1% penicillin/streptomycin. MSCs at experimental use passage were characterized for ex-
pression of protein surface markers and differentiation potential along osteogenic, chondro-
genic, and adipogenic lineages. ECs were expanded to P.3 in bullet kit media and frozen.
ECs were thawed in lab-made media (MCDB-131 with 5% FBS, 1% penicillin/streptomycin,
1% L-glutamine, 0.001 mg/ml hydrocortizone, 0.002 µg/ml FGF, 0.010 µg/ml EGF, 0.002
µg/ml IGF, 0.001 µg/ml VEGF, and 50 µg/ml ascorbic acid). To conserve growth factor use,
ECs were subjected to shear stress in MCDB-131 with 5% FBS, 1% penicillin/streptomycin,
1% L-glutamine, 0.0005 µg/ml EGF, and 0.002 µg/ml FGF.
Applied shear stress Steady laminar fluid shear stress was applied using a parallel
plate shear system, as previously described [155]. Briefly, media circulated continuously
through a reservoir, peristaltic pump (McMaster-Carr), pulse dampener, and slide chamber
with defined flow containing a cell-seeded, protein-coated glass slide. Prior to and follow-
ing applied shear, cells were visualized with phase images using an Axiovert microscope
(Zeiss) and SPOT software (Diagnostic Images).
Cell Number and Viability MSCs were exposed to 15 dyn/cm2 shear stress or parallel
static culture for 48 hours. Cell number and viability was quantified for trypsinized cells
using a Vi-CELL Series Cell Viability Analyzer (Beckman Coulter).
Gene Expression RNA was isolated, cDNA synthesized from 0.5 µg RNA, and gene
expression levels quantified using qPCR as previously described [67]. Primers were de-
signed using Primer Express 3 software (ABI). Four replicates were generated per cell type
(ECs or MSCs) per time point (0, 6, 12, 24, or 48 hr) and per force condition (0 - Static,
5 dyn/cm2, or 15 dyn/cm2), for a total of 120 samples. A randomized design was used to
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minimize effects due to experimental variation. Target gene levels (fM) were normalized to
the housekeeping gene Gapdh (fM). Although Gapdh expression in ECs decreased signif-
icantly (p < 0.05, n=3-4) in response to 48 hours shear stress at either 5 or 15 dynes/cm2,
this was below the detection limit cut-off of 1.5-fold. Due to technical errors (shear sam-
ple leakage or RNA too dilute for cDNA synthesis), statistical analysis of gene expression
could not be completed for MSCs subjected to 5 dyn/cm2 for either 6 or 24 hours (shear
groups: n=2). Connections between signaling molecules were determined with Ingenuity
Pathways Analysis software (IPA).
Protein distribution and quantification Protein expression was assessed using an-
tibody staining and confocal imaging. MSCs and ECs were seeded on Type I Collagen-
coated glass slides and exposed to 15 dyn/cm2 shear stress or parallel static culture for
24 or 48 hours. Samples were fixed in 4% formaldehyde and stored in PBS at 4◦C prior to
staining. Samples were permeabilized with 0.05% Triton-X for intracellular markers (VE-
Cad and vWF), blocked in 5% donkey serum/0.1% BSA in PBS, stained overnight at 4◦C in
primary antibody (1/100 dilution) and secondary antibody (1/100) for 1 hour at room tem-
perature, and counterstained with Hoechst 33258 to label nuclei. Samples were imaged
on a Zeiss LSM 510 META confocal microscope. A ratio of average image pixel intensity
per number of nuclei was calculated for each image using measurements made in Im-
age J (NIH). Unpaired t-tests for each cell type were completed to determine significant
differences between applied shear and static culture conditions. Following quantification
of protein levels on raw image files, all images were processed for auto-contrast in Pho-
toshop (Adobe) and compared across groups to highlight patterning differences between
cell type and force conditions. To enable comparison between treatment groups, ECs and
MSCs samples were antibody stained together and imaged using the same confocal laser
settings.
Protein substrate studies To determine the effect of underlying protein substrate on
resulting shear response, glass slides were coated using 5µg/cm2 solutions of Type I Col-
lagen, Type IV Collagen, or Fibronectin.
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Statistical analysis Unless otherwise stated, significance is defined as p≤0.05. Mul-
tifactorial ANOVA was used to determine differences in gene expression due to cell type,
force condition, or treatment duration. Paired and unpaired t-tests were used to compare




TRANSCRIPTOME COMPARISON OF MESENCHYMAL STEM AND AORTIC
ENDOTHELIAL CELL RESPONSE TO VASCULAR-RELEVANT APPLIED
FLUID SHEAR STRESS
6.1 Abstract
Development of cell-based therapies to treat endothelial dysfunction will decrease the high
personal and financial cost of vascular disease. To evaluate the potential of mesenchymal
stem cells as endothelial cell substitutes, transcriptome responses to vascular-relevant lev-
els of fluid shear stress were compared between human adult bone marrow-derived mes-
enchymal stem cells (MSCs) and human aortic endothelial cells (ECs). Cells seeded on
fibronectin-coated glass slides were exposed to steady laminar shear stress (15 dyn/cm2)
for 24 hours. RNA was isolated and pooled (n=4 samples/group) from shear and paral-
lel static cultures for each experiment; pooled RNA (n=3 experiments per cell type) was
assessed using whole human genome microarrays. Results were validated with litera-
ture comparisons and qPCR. Microarray samples group according to cell type and force
condition, via principal component analysis. Shear-responsive transcriptomes, defined as
the set of genes with significantly (paired t-test p < 0.05) altered expression of at least
1.5-fold, identified 5590 and 1772 genes for ECs and MSCs, respectively. Conserved
shear-responsive genes met paired t-test and fold change criteria in both cell types, as
well as significant (p < 0.05) force-dependent gene expression as determined using two-
factor ANOVA. Analysis of the set of 574 probes meeting this ‘conserved’ shear-response
definition identified shared traits of shear-responsive genes, including: correlation of shear-
responsive genes with chromosomes 4, 11, and 17; uneven cellular location and molecu-
lar function distribution; potential regulatory signaling nodes including transcription factors
and highly linked molecules; and evidence that cell cycle functions are regulated by shear
stress, independent of cell type. This data demonstrate MSCs mimic relatively few of the
91
gene expression responses to shear stress present in ECs. Combined with morphological
differences in cell response to shear stress, this data suggests MSCs cannot be assumed
to mimic ECs mechanosignaling responses.
6.2 Background
Endothelial cells (ECs) respond with unique signaling changes to different types of shear
stress, including oscillatory versus steady, laminar versus turbulent, and varied duration
applied shear stress [78, 208, 61]. These signaling changes have been studied through nu-
merous studies using both high-throughput and single factor approaches. Shear-responsive
signaling changes in ECs help regulate a broad range of functions including proliferation,
migration, inflammatory and immune activation, and angiogenesis [58, 309, 78]. The abil-
ity to signal appropriately in response to shear stress has been used as a metric to eval-
uate cell-based therapies designed to repair, replace, or regenerate vascular endothelium
[185, 326]. Whole genome microarray characterization of the ECs and mesenchymal stem
cell (MSCs) responses to shear stress enables rapid identification of RNA-based similari-
ties and differences in mechanosignaling.
Shear stress is involved in prevention and progression of vascular diseases, notably
atherosclerosis [58, 57]. Microarray data has contributed in multiple ways to knowledge
of ECs shear-response. Endothelial cells derived from different regions of the vascula-
ture respond to shear stress differently [36, 181, 27, 208]. Dai et al used finite element
analysis to determine shear flow profiles in human carotid arteries in areas of high and
low probability atherogenesis [53]. Subsequent microarray analysis of HUVECs exposed
to these profiles identified genes sensitive to either atheroprone or atheroprotective shear
regimens. High-throughput signaling analysis of endothelial cells exposed to steady lami-
nar shear stress at physiologic levels (10-25 dyn/2) identify anti-apoptotic, anti-proliferative,
anti-oxidant, and pro-differentiative effects [309]. Microarray analysis has also been used
to track differences in endothelial shear-response due to co-culture [98].
While numerous high-throughput studies describe the response of ECs to shear stress,
few have investigated how potential ECs cell substitutes respond to shear stress. Stem
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cells proposed as ECs substitutes include embryonic stem cells (ESCs), mesenchymal
stem cells and MSCs-like cells such as adipose-derived stem cells (ADSCs) and am-
niotic fluid-derived cells (AFSCs), and endothelial progenitor cells (EPCs). Embryonic
stem cells respond to vascular-relevant levels of shear stress with upregulation of early
endothelial-differentiation markers (Ahsan and Nerem, unpublished). Embryonic stem cells
differentiated towards ECs respond to applied shear stress similarly to ECs [185]. AFSCs
pre-differentiated towards ECs also respond similarly to endothelial cells [326]. ADSCs
exposed to shear stress upregulate endothelial-relevant markers nitric oxide and VEGF,
but not markers characteristic of ECs differentiation [15]. EPCs are closest to ECs in
terms of differentiation lineages. In response to shear stress, EPCs differentiate towards
and respond similarly to ECs [321, 323, 278, 279]. These studies of stem cell shear-
responsiveness typically focus on a few assessments, rather than broader response profil-
ing using high-throughput techniques.
MSCs are a promising therapeutic stem cell source to their relative ease of access,
potential for autologous therapy, immunomodulatory and paracrine signaling effects, and
fewer ethical concerns related to cell origin. Studies of MSCs response to shear stress
have focused on immediate cell signaling [142], orthopedic cell responses [81], and vascu-
lar responses [15, 66]. Microarray analyses have been used to monitor MSCs mechanore-
sponses to cyclic strain [146, 218] and for preliminary analysis of shear stress-responsive
signaling at low magnitudes (1 dyn/cm2) [81]. More than 150 studies have employed mi-
croarrays to study MSCs signaling changes as a function of: tissue source ; donor age/cell
passage differentiation along classic lineages - osteogenic, chondrogenic, and adipogenic
and in vitro culture environments .
Parallel cell type comparisons have been used to study mechanosensing in different
types of vascular cells (endothelial vs. smooth muscle [228]; vascular vs. valvular ECs [27];
EPC vs. ECs [24]), fibroblasts (tendon, cornea, skin [171]), and bone cells (osteoblasts vs.
osteoclasts [125]). One studied compared the response to applied force between more dis-
tantly related cell types (ECs vs chondrocyte response to shear stress [96]). We combined
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Figure 30: Schematic of shear stress microarray experimental design. MSCs and
ECs transcriptomes were compared using whole genome microarray comparison. Paired t-
tests for three independent experiments were completed for each cell type (vertical arrows),
followed by comparison of shear responses across cell type (horizontal arrow).
these two approaches, highthroughput expression detection via microarrays and compar-
ative cell type analysis, to study the response to vascular-relevant levels of steady laminar
shear stress of human aortic endothelial cells and human adult bone marrow-derived mes-
enchymal stem cells. This signaling analysis highlights vascular-relevant functions that
MSCs may be suited or ill-matched to mimic.
6.3 Results
6.3.1 Morphology of ECs and MSCs in response to applied shear stress
ECs and MSCs were exposed to 15 dyn/cm2 steady laminar shear stress on fibronectin-
coated glass slides for 24 hours in their respective culture media. Three independent
experiments per cell type were completed, with four independent samples per group per
experiment (Figure 30). Representative phase images of MSCs and ECs are shown in
Figure 31. Within 24 hours, local regions of ECs monolayers align parallel to the direction
of applied shear stress (Figure 31B vs. A). ECs appear less dense in samples exposed
to shear stress than those exposed to static culture, consistent with other reports that
shear stress decreases ECs proliferation. In contrast, MSCs were larger in adherent size
than ECs; spindle-shaped after both static or applied shear stress, in contrast to ECs
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Figure 31: Comparison of cell morphology in response to shear stress. Phase im-
ages of ECs (A, B) and MSCs (C, D) after either static (A, C) or 15 dyn/cm2 steady laminar
shear stress (B, D) culture for 24 hours on fibronectin-coated silicone. Shear stress was
applied in the horizontal direction, relative to these images.
cobblestone morphology; and did not align to the direction of applied shear stress. Small
gaps between cells were visible in MSCs samples exposed to shear stress, compared to
parallel static, confluent cultures.
6.3.2 Overview of microarray results
Principal component analysis and two-factor ANOVA provide global overviews of microar-
ray data, differentiating sample and gene expression patterns. The twelve pooled microar-
ray samples can be clearly separated by cell type (MSCs: blue; ECs: red) along principal
component 1, and by force condition (arrows) along principal component 2 (Figure 32C) or
3 (Figure 32A). Both 3-D and 2-D representations of PCA are shown for easier visualiza-
tion of paired sample distribution and force condition and cell type separation, respectively.
The marked differences in gene expression profiles between cell type are corroborated by
two-factor ANOVA, in which 18,735 genes (5̃0% of the total assessed) have expression sig-
nificantly dependent on cell type versus 7078 (1̃6%) or 3161 (7̃%) genes vary significantly
with force condition or an interaction effect, respectively (Figure 32B) .
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Figure 32: Overview of microarray analysis of ECs and MSCs samples exposed to
applied shear stress (15 dyn/cm2). Cells were seeded on fibronectin-coated glass and
exposed to shear stress using a parallel plate shear system for 24 hours. (A) 3-D principal
component analysis separates ECs and MSCs samples according to principal compo-
nent 1 (y-axis). Shear and static samples separate along principal component 3 (x-axis).
(B) Venn diagram showing two-factor ANOVA results. Within the set of genes present
or marginal in at least one of 12 arrays, expression of 18735, 7078, and 3161 probes
was significantly (corrected p-value < 0.05, n=3) dependent on cell type, force condition,
or an interaction of the two parameters. (C) 2-D principal component analysis showing
separation of cell type (principal component 1, horizontal) and force condition (principal
component 2, vertical) for MSCs (blue) and ECs (red) samples exposed to static (squares)
or shear (triangles) conditions.
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Figure 33: Volcano plots comparing significance and fold-change distributions of
gene expression changes due to applied shear stress. Red squares indicate genes
whose expression alters significantly (p < 0.05 or, inset, p < 0.001) by ≥1.5-fold in ECs
(A) or MSCs (B). In ECs, 462 and 5590 genes meet fold-change and either high or low
significance criteria, respectively. Fewer genes were identified in MSCs: 55 or 1775 genes
met fold-change and either high or low significance criteria.
Volcano plots, shown in Figure 33, show the distribution of significantly shear-responsive
genes in ECs (Figure 33A) or MSCs (Figure 33B). Approximately 10 times as many genes
are shear-responsive in ECs as MSCs at high significance cut-offs (p < 0.001 & |FC| > 1.5:
462 vs. 55). At lower significance cut-offs (p < 0.05 & |FC| > 1.5), approximately 5 times
as many genes were shear-responsive in ECs compared to MSCs (5590 vs. 1775). The
MSCs distribution on the volcano plot is narrower and includes more genes at low p-values
than the ECs distribution. Average gene variation in MSCs ranges from ±4-fold, in contrast
to ±16-fold in ECs. Shear-responsive genes change less significantly in MSCs than ECs
by two orders of magnitude (minimum p-values: 10−4.5 vs. 10−6.5). MSCs do respond to
shear stress above fold-change and significance thresholds, but in lower numbers, magni-
tude change, and peak significance compared to ECs.
6.3.3 Shear-responsive genes identified in MSCs and ECs
Two-tailed paired t-tests were used to identify shear-responsive genes in each cell type.
In ECs, paired t-test analysis with Benjamini-Hochberg MTC identified 361 genes signif-
icantly (corrected p-value< 0.05) altered by shear stress, 267 of which alter by at least
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Figure 34: Nested loops of MSCs and ECs shear-responsive genes identified via
paired t-test. Genes with expression levels differing by at least 1.5-fold between applied
shear and static samples are shown for three levels of increasing significance: p < 0.05,
outermost line; p < 0.01, middle shaded region; and p < 0.001, innermost dark shading.
MSCs (left, blue) and ECs (right, red) data represents three microarrays of pooled RNA
per shear and static group. Multiple testing corrections not applied because no genes
were identified in MSCs using this method. Circle size is proportional to gene number.
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1.5-fold regulation. Application of multiple testing corrections (Benjamini-Hochberg MTC;
Bonferroni FWER; FDR) resulted in a null set for MSCs significant shear-responsive genes.
Thus, in order to have consistent data analysis of all samples and allow subsequent cell
type comparisons, multiple testing corrections were not applied to either cell type. More
stringent significance levels in combination with fold change thresholds were applied to
decrease the number of false positives identified due to technical or statistical error or bi-
ological noise. Genes in MSCs and ECs with significance (p < 0.05) and magnitude fold
change ≥ 1.5 number 1775 and 5590, respectively. Increasing the significance threshold
narrows the list of shear-responsive genes at median stringency (p < 0.01: 487 genes in
MSCs vs. 2735 genes in ECs) and high stringency (p < 0.001: 55 genes in MSCs vs.
462 in ECs). The relative abundance of shear-responsive genes in ECs vs. MSCs and in
response to varied selection criteria are illustrated by a nested Venn diagram (Figure 34).
6.3.4 Global gene expression responses of MSCs and ECs to shear stress
Venn diagram overlays of the results of two factor ANOVA and paired t-tests in ECs and
MSCs were used to triangulate on a list of ‘conserved’ shear-responsive genes (i.e., the
intersection region of these three circles in the Venn diagram). At lowest t-test significance
values (p < 0.05), 574 probe names are identified in the conserved shear-responsive set
(Figure 35A). At the most stringent significance cut-offs (p < 0.001), no genes are identified
with conserved shear-response (Figure 35B). Furthermore, fewer shear-responsive genes
from the original list (p < 0.05) in MSCs meet this high stringency criteria (55/1775; 3%)
compared to ECs (462/5590; 8%). At the intermediate significance level (p ≤ 0.01), 2735
and 487 genes were significantly altered in ECs and MSCs, respectively. 100 genes of
this set were significant in both ECs and MSCs paired t-tests (p < 0.01; |FC| ≥ 1.5) and
two-factor ANOVA force-dependence (corrected p-value < 0.05). 15 genes were identified
as significant by both paired t-tests, but not two-factor ANOVA. These probe names may
be either false positives from the t-tests or genes whose shear-sensitivity is based on initial
conditions. In the latter case, only paired static/shear analysis would detect a significant
shear-response, while unpaired statistical tests such as the two-factor ANOVA might miss
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Figure 35: Venn diagram representation of shear-responsive genes in MSCs and
ECs. Genes were identified using two-factor ANOVA force-dependence corrected p-
value< 0.05 (green circle), paired fold change of at least 1.5-fold and significance cut-off
in ECs (red circle), and paired fold change≥1.5 and significance cut-off in MSCs (yellow
circle). Two significance levels for paired t-tests are shown: (A) paired t-test p < 0.05 and
(B) paired t-test p < 0.01. Multiple testing corrections were not applied since no genes
were identified in MSCs using this method.
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Figure 36: Distribution of conserved shear-responsive genes across chromosomes.
The set of 574 conserved shear-responsive probes are distributed across chromosomes
(µ = 23.8, σ = 12.7). Chromosomes 23 and 24 refer to the X and Y sex chromosomes,
respectively. As expected given the use of female cell sources in this analysis, no shear-
responsive genes were identified on the Y-chromosome (24).
this relationship. For subsequent signaling analysis, the set of conserved shear-responsive
genes was defined using a significance level of p < 0.05. A list of these genes is included
in Appendix D, Table 15.
6.3.5 Distribution of conserved shear-responsive genes across chromosomes
Shear-responsive genes are distributed across the set of 23 chromosomes, with an aver-
age of 23.8±12.7 genes per chromosome (Figure 36). No conserved shear-responsive
genes were present on the Y-chromosome in this analysis, consistent with the use of fe-
male donors for ECs and MSCs. To determine whether shear-responsive genes correlate
with chromosomal properties, a normal distribution was assumed for shear-responsive
genes per chromosome, per total gene, and per length of DNA. Significance correlation
of shear-responsive genes with these chromosomal properties was determined based on
68, 95, or 97% confidence intervals. Chromosome 1 (57 genes) contained more shear-
responsive genes per chromosome (95% C.I.); chromosomes 2 (37), 4 (39), 11 (37), 17
(37), 18 (9), and 21 (9) also varied from the average number of shear-responsive genes
per chromosome by more than one standard deviation (68%). The distribution of shear-
responsive genes per number of genes was 0.023±0.023 (1̃ shear-responsive gene/43
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total genes). Chromosomes 11 (0.098; 97% C.I.) and 4 (0.087; 95% C.I.) contained sig-
nificantly more shear-responsive genes per total number of genes. The distribution of
shear-responsive genes per total basepairs DNA was 1.97e-8±1.00e-8. Chromosomes
17 (4.70e-4) contained higher frequency shear-responsive gene per DNA length at the
95% C.I. level, as well as chromosomes 19 (3.44e-7) and 22 (3.03e-7) at the 68% C.I.
level.
6.3.6 Cellular and functional distribution of conserved shear-responsive molecules
GenBank Accession numbers for the set of conserved shear-responsive genes (574 origi-
nal probe names, minus 37 probes without GenBank Accession numbers) were analyzed
using Ingenuity Pathways Analysis. The resulting signaling network of 738 genes was cat-
egorized according to cellular location (Figure 37A) or molecular function (Figure 37B).
Molecules in this network were primarily found in the nucleus (28%) or cytoplasm (25%).
Molecules associated with the plasma membrane or extracellular space accounted for 12%
or 9% of the set, respectively. Molecular functions associated with the shear-responsive
signaling network included enzymes (15%), transcription regulators and group molecules
(9%), complexes (7%), and peptidases and kinases (5%). Translation regulators, ligand-
dependent nuclear receptors, ion channels, endogenous mammalian chemicals, trans-
membrane receptors, microRNAs, growth factors, and cytokines were represented at 1%
or less. This analysis could not be completed for all 738 molecules in the signaling net-
work, since many were not associated with either a cellular location (26%) or molecular
function (37%).
6.3.7 Direct interactions within conserved shear-responsive gene set
IPA analysis identified the most likely 25 signaling networks based on grouping the 574
conserved shear-responsive probes using both direct and indirect connections. To specif-
ically highlight direct connections between shear-responsive genes, 370 interactions within
the ‘conserved’ set were determined using GeneSpring signaling pathway analysis. Molecules
with direct interactions within the set grouped into two initial categories: the majority were
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Figure 37: Cellular locations and molecular functions associated with conserved
shear stress-responsive signaling network. A signaling network comprised of 785
molecules was generated using IPA software analysis of the set of conserved, shear-
responsive genes (574 microarray probes). (A) Cellular location distribution of molecules
in shear-responsive signaling network. (B) Functions associated with molecules in shear-
responsive signaling network.
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Figure 38: Direct signaling interactions between conserved shear-responsive
genes. Gene Spring software analysis determines signaling pathways based on the set of
574 conserved shear-responsive genes (p < 0.05 for both ECs and MSCs paired t-tests;
p < 0.05 for force-dependent expression based on ANOVA). Unconnected molecules are
not shown.
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connected in a single, multicomponent network (Figure 38, left) while a minority of genes
were connected as isolated pairs or trios (Figure 38, right). Molecules in the large direct
interaction network can be described by a local connectivity score, proportional to the num-
ber of connections a node has within the shear-responsive set. Seven distinct ‘hour-glass’
motifs appear in this interaction network. This suggests a subset of molecules act may as
convergence points for shear-responsive signaling and affect the shear-response of mul-
tiple downstream targets. These convergence nodes include: AURKA, BRCA1, BRCA2,
CNB1, E2F1, EGR1, FANCD2, FANCG, MCM2, PLK1, POLD1, PPARG, and SMAD3.
6.3.8 Molecular function clusters affected by conserved shear stress-responsive
genes
Two Gene Ontology (GO)-based analysis methods were employed to determine molecular
functions enriched in the set of conserved shear-responsive genes: GeneSpring software
and functional clustering analysis with the Database for Annotation, Visualization, and In-
tegrated Discovery (DAVID) tool. GO analysis in GeneSpring identified 30 functions sig-
nificantly (corrected p-value< 0.05) enriched in the conserved shear-responsive set, with
two additional functions identified by relaxing the significance cut-off to p < 0.10 (Table 11).
These functions relate to different aspects of cell proliferation: cell cycle, DNA replica-
tion, mitosis, chromosome maintenance and function (p ≤ 0.001). Few significantly-altered
functions affect processes unrelated to proliferation: non-membrane-bounded organelles
(p=0.004), organelle organization and biogenesis (p=0.062), and nucleic acid metabolism
(p=0.074).
Gene ontology analysis using the DAVID tool confirmed the enrichment of cell cycle-
and DNA replication-related functions seen with GeneSpring analysis. Functional cluster-
ing in DAVID clusters shear-responsive genes according to common associated functions
(i.e., GO terms), based on a calculated kappa score and subsequent fuzzy heuristic clus-
tering algorithm. 28 functional clusters with significant (p < 0.05) median values were
identified (Table 12). DAVID functional clusters related to cell proliferation include DNA
replication (clusters 1, 10, 12, 14-15, 20, 22, and 24), cell cycle (2, 8, 17, and 28), spindles
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and chromosomes (4, 6, 9, 15, 18-19, and 26), DNA damage and repair (3 and 11), and
nucleus and membrane-bound organelles (5). DAVID functional clustering identified other
functions enriched in the set of conserved shear-responsive genes relative to the whole
genome background set: BRCA1 signaling (7 and 29), anatomical structure development
(21), nucleotide binding (13), kinase activity (27), and GTPase/enzyme regulator activity
(25).
6.3.9 Predicted transcription factor regulators of conserved shear-responsive genes
Computational Ascertainment of Regulatory Relationships (Inferred from Expression) (CAR-
RIE) is an online tool enabling prediction of the transcription regulatory network affected
by microarray analysis of two different groups. Analysis of promoter regions is based on
GenBank Accession identifiers and their associated fold change (|FC| ≥ 3.0) and p-values
(p < 0.01), resulting in separate analysis for MSCs and ECs with the same set of GenBank
Accession numbers. Transcription factors and their predicted significance change between
microarray conditions (p < 0.05 for at least one cell type) are listed for MSCs and ECs in
Table 13. More transcription factors are significantly associated with ECs shear-response
than MSCs shear-response (139 vs. 75). 26 transcription factors were identified in both
cell types, representing 34% or 19% of the total number of significant transcription factors
in MSCs and ECs respectively.
6.4 Discussion
This study provides a snapshot of MSCs transcriptome changes due to vascular-relevant
fluid shear stress, in comparison to ECs shear-responsive signaling. Similarly to ECs,
MSCs respond to steady laminar shear stress on fibronectin-coated glass with changes in
gene expression detectable within 24 hours. However, unlike ECs, changes in gene ex-
pression in MSCs do not correlate with realignment parallel to the direction of applied fluid
flow. Whole human genome microarray analysis demonstrates signaling profiles can be
grouped according to cell type and force condition. MSCs gene expression changes due
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to shear stress are fewer in number, magnitude fold change, and significance range com-
pared to ECs. In spite of marked differences between MSCs andECs, a statistical approach
identified a set of genes whose gene expression is significantly (p < 0.05) force-dependent
in both cell types. Ontological assessment of conserved shear-responsive genes shows
(a) uneven chromosomal distribution, (b) enrichment of particular cellular locations (cyto-
plasm and nucleus) and molecular functions (enzymes), and (c) marked upregulation of
cell cycle and DNA replication-related signaling networks. This analysis predicts specific
molecules, either convergence nodes in a direct interaction model or transcription factors,
that may account for multiple aspects of the observed shear-responsive gene changes.
This comparison of shear stress between ECs and MSCs is biased by focusing on gene
expression at a single timepoint, single applied shear stress profile (magnitude, frequency),
and on a single underlying protein substrate. Additional information about cellular response
to shear stress would be gained by repeating these studies and varying the above shear
stress parameters or assessing signaling changes at chromosomal, miRNA, protein, or
post-translational modification levels. Use of publically available tools for ontology analysis
(e.g., GeneSpring, IPA, DAVID, and CARRIE) is convenient, but means that customized
analyses, with transparent algorithms and known assumptions, are rarely available. Since
biases resulting from each analysis method are inherent in the result, multiple methods
were used when possible to triangulate on reproducible themes (e.g., cell cycle regulation
due to shear stress). Finally, conclusions drawn from this work would be strengthened by
additional, single factor experiments to test these hypotheses.
Small regions of ECs, but not MSCs, align parallel to the direction of applied shear
stress (15 dyn/cm2) within 24 hours (Figure 31). This difference in cellular response to
shear stress may be related to differences in cell type morphology, specifically cell-cell and
cell-matrix connections [272, 104, 67]. MSCs occupy more surface area than ECs. More
gaps are present between spindle-shaped MSCs compared to the close-packed arrange-
ment of cobblestone-shaped ECs. Decreased alignment in MSCs compared to ECs is con-
sistent if remodeling occurs proportional to a balance between applied force and the net
force of cell-matrix attachment and/or coordination through direct cell contact mechanisms
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[272]. Other reports state that MSCs reorient in response to other types of mechanical
cues (e.g., applied cyclic strain [148] or combined pulsatile pressure, radial distension, and
shear stress [205]). This difference in MSCs remodeling following applied force may relate
to differences in initial cell density or matrix presentation (e.g., monolayer vs. 3-D gel) that
affect cell-cell and cell-matrix connections or to regulatory mechanisms that distinguish
between force type. Longer duration applied shear stress studies could also determine
whether MSCs undergo realignment to shear stress at a slower rate than ECs.
Although morphology of MSCs exposed to shear stress or static culture did not visibly
differ, samples can be distinguished from one another using principle component analysis.
Transcriptome profiles differ more between cell types than force condition, verified by both
greater separation on the PCA plot and expression of more genes dependent on cell type
than force condition based on two-factor ANOVA. Principal component 2 values decrease
in response to shear stress for both MSCs and ECs, but application of shear stress does
not shift MSCs samples towards ECs values (principal component 1). This suggests qual-
itatively that MSCs and ECs share similar responses to applied shear stress, but that 24
hours applied shear stress is not sufficient to induce endothelial-like signaling in MSCs.
ECs have greater average magnitude expression change in response to shear stress
(Figure 25) and three times as many shear-responsive genes at low (p < 0.05, n=3 and
|FC| > 1.5) (Figure 26). This trend is exaggerated at more stringent shear-response
cut-offs, with more than eight times as many highly significant (p < 0.001, n=3) shear-
responsive genes in ECs as MSCs. ECs may be more sensitive to shear stress than
MSCs because shear-response is an essential feature of endothelial function, not neces-
sarily MSCs. Innate mechanosensitivity of MSCs and other stem cells has been shown to
promote differentiation along specific lineages [71, 192, 136]. More recent work suggests
mechanosensitivity of MSCs may also develop as a function of differentiation, based on
responses of MSCs-like dental pulp cells differentiated along osteogenic lineages [142].
Additional studies, possibly including longer duration applied shear stress and inclusion of
intermediate cell types between undifferentiated MSCs and differentiated ECs, are needed
to determine the cause of mechanosensitivity differences observed in these studies.
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Genes whose expression was significantly force-responsive according to two-factor
ANOVA and changed significantly in both ECs and MSCs by at least 1.5-fold were defined
as ‘conserved’ shear-responsive genes. 574 genes, approximately 1% of the total number
assessed, met this criteria for significance cut-off of p < 0.05. When paired t-test signifi-
cance thresholds were increased to p < 0.01, no genes were conserved in both cell types.
However, 55 and 462 genes were highly conserved in either MSCs or ECs respectively.
Highly conserved mechanorepsonses present in only one cell type suggest that different
signaling networks are activated in each cell type in response to mechanical force.
Conserved shear-responsive molecules are located primarily in the nucleus and cyto-
plasm. Identification of fewer molecules associated with the plasma membrane and extra-
cellular space may be because these experiments focused exclusively on gene expression
changes. This could be because shear-responsive changes at locations further from the
nucleus occur at the protein or post-transcriptional level. Cellular location analysis high-
lights a limitation of current ontology software: the inability to classify the cellular location
of 26% of conserved shear-responsive genes limits the strength of conclusions drawn.
Molecular functions primarily associated with conserved shear-responses are enzymes,
transcription regulators, group, and complex molecules. Group molecules are those rep-
resenting a set with similar function (protein family, same function in signaling pathway,
same enzymatic activity). Complex molecules refer to multiprotein units comprised of mul-
tiple genes. As with cellular location, this functional analysis is limited by the inability to
classify 37% of molecules within the pre-defined set of 17 functional categories. Expres-
sion of signaling molecules can be regulated at many different stages from transcription
through degradation [2]. Enrichment of gene expression regulation in specific cellular loca-
tions or molecular functions could indicate an advantage of this level of regulation relative
to other modes. Such an advantage could be in terms of signaling or spatial efficiency,
kinetics of response, or metabolic demands [303]. Additional studies are necessary to test
this generalization.
This analysis of ‘conserved’ shear-responsive genes does not distinguish between
genes each independently force-sensitive or the downstream effectors of a few signaling
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nodes that amplify the initial force response. To explore this concept, signaling networks
generated in GeneSpring using direct only or combined direct and indirect connections
were compared. Direct interaction analysis of conserved shear-responsive genes identi-
fied here highlights a signaling pathway containing 134 molecules connected by one or
more links to one another (Figure 38). The presence of multiple hourglass motifs suggests
a small subset of genes may account for a much larger number of observed signaling
changes. Manipulating the expression or activity levels of these 13 identified convergence
nodes and assessing the subsequent shear-responses of linked molecules could be used
to determine the importance of the convergence nodes in shear stress response. All 13
convergence nodes affect DNA replication, cell cycle, and DNA repair functions, as de-
termined via GO biological process annotations. This redundancy in functional control
underscores the importance of cell proliferation and cell cycle regulation via shear stress.
This data demonstrate shear stress regulates cell proliferation in multiple cell types, not
only ECs.
Mechanoresponses may be regulated by both signaling networks and genome organi-
zation. Shear-responsive genes are not distributed uniformly across chromosomes, genes,
or DNA length. The increase in shear-responsive genes on Chromosome 1 is likely be-
cause this chromosome is larger than the others. Chromosomes 4 and 11 have increased
shear-responsive genes per chromosome and per total number of genes on the chromo-
some. Future analysis could determine if these genes correlate with a particular region
of the chromosome or share sequence or regulatory similarities. Chromosome 17 falls
outside the 68% confidence interval for shear-responsive genes per chromosome and the
95% confidence interval for genes per base pair. Chromosome 17 is not significant in
terms of shear-responsive genes/total genes. This suggests that non-coding regions, such
as cis-regulatory regions or miRNAs, may be involved in increased shear-sensitivity of
Chromosome 17. Chromosomes 2, 18, 19, 21, and 22 fall outside the lower confidence
internal bounds (65%) of only one of three analysis methods (chromosome, total genes,
length). Collectively, this analysis suggests chromosomes 4, 11, and 17 may have force-
sensitivity properties meriting future investigation, in contrast to chromosomes responsive
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at lower confidence levels (2,18,29,21,22) or of unusually large size (1).
Results of this mechanosignaling analysis are likely biased by two experimental con-
straints: underlying protein adhesion mechanism and media type [104, 67, 272]. Cells
were coated on fibronectin for these studies, to avoid the cellular remodeling observed in
MSCs in response to shear stress on Type I Collagen-coated surfaces. Since cell-matrix
attachment mechanisms alter both signaling and adhesion strength, though, the underly-
ing protein coating likely affects the specific signaling response triggered by mechanical
force. Comparison of shear stress signaling responses in the same cell type on different
protein substrates would determine these effects. The second factor inherently biasing the
specific mechanosignaling response observed is due to differences in media type (ECs or
MSCs). To isolate the signaling effects due to mechanical forces, ECs and MSCs were cul-
tured and exposed to applied force using standard growth media recommended for each
cell type. These media formulations differ in basal media (MCDB-131 vs. MSCs Basal
Media), growth factors, and serum. However, if mechanosignaling changes depend on the
initial culture media signaling environment, then these changes would appear in the anal-
ysis as cell type-specific mechanosignals. Normalizing the biochemical cues presented to
each cell type may identify additional conserved shear-responses that were masked by the
experimental design used in this study.
6.5 Conclusions
This work demonstrates that ECs and MSCs have markedly different morphology and gene
expression responses to applied shear stress in terms of the number, magnitude, and sig-
nificance of expression level change. Separation of samples using PCA indicates charac-
teristic profiles can be used to separate cell types and applied shear conditions for this 2x2
comparison; future studies are needed to define these profiles and potentially generalize
this method across a broader range of cell types or force conditions. Cell cycle, prolifera-
tion, and DNA replication are significantly shear-responsive. Future studies may determine
the evolutionary importance of this function, as well as the extent of mechanoregulation of
cell proliferation across other cell types and species. Finally, this work demonstrates that
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signaling changes can be triggered by applied mechanical cues, even in the absence of
visible morphological differences.
6.6 Materials and Methods
Supplies Cells and culture media were purchased from Lonza. Microarrays and associ-
ated materials were purchased from Agilent. Standard qPCR reagents were purchased
from Qiagen (RNA isolation), Invitrogen (cDNA synthesis), and ABI (qPCR mastermix).
Cell culture of MSCs &ECs Human adult bone marrow-derived mesenchymal stem
cells and aortic endothelial cells were cultured according to manufacturer’s recommenda-
tions (Lonza). MSCs were expanded to Passage 6 and characterized for expression of
protein surface markers and differentiation potential along osteogenic, chondrogenic, and
adipogenic lineages prior to experimental use. ECs expanded to Passage 5 were used for
experiments.
Applied shear stress Steady laminar fluid shear stress was applied using a parallel
plate shear system [155]. Cells were seeded on fibronectin-coated glass slides at 10,000
cells/cm2, calculated using a Coulter Counter Multisizer 3 (Beckman Coulter). Cells were
allowed to attach for two days prior to application of shear stress (5 or 15 dyn/cm2) or
parallel static culture for up to 48 hours. Cell morphology was determined with phase
microscopy (Axiovert microscope, Zeiss) immediately prior to and following exposure to
mechanical force.
Microarray sample preparation To minimize noise due to biological and experimental
variability, cell lysates were pooled from four independent samples per static or applied
strain replicate. Three independent experiments were completed per cell type. RNA was
isolated according to manufacturer’s protocols (Qiagen). All samples passed two levels of
quality control: first, the concentration, A 260
280
, and A 260
230
were measured using a Nanodrop
(Thermo Scientific) and second, the RNA integrity number (RIN) was determined using a
Bioanalyzer (Agilent). cDNA synthesized from high quality RNA samples was labeled for
one-color detection and run on a whole human genome 60-mer microarray (Agilent), four
arrays per slide. Microarray images were captured using Feature Extraction software and
112
passed manufacturer-recommended quality control metrics for image uniformity.
Microarray data analysis Feature Extraction data was imported into Gene Spring 10.0
for normalization and statistical assessment. 12 of 12 arrays passed quality control met-
rics within GeneSpring, enabling three replicates per group to be analyzed. Genes were
filtered to ensure present or marginal expression levels in at least one sample. ANOVA
with Benjamini-Hochberg multiple testing correction was applied to all sample groups de-
termined whether gene expression depended significantly on cell type or force condition.
Since an independent experiment yielded two microarray samples (one pooled shear sam-
ple and one pooled static sample), paired data analysis was used to compare static and
shear samples. P-values from two-tailed paired t-tests (p < 0.05) and paired fold change
cut-off thresholds (|FC| > 1.5) defined genes significantly altered in either ECs or MSCs.
No genes met significance criteria in MSCs when multiple testing corrections were ap-
plied. Thus, MTC were not used for either cell type, in order that final lists of shear-
responsive genes could be compared between cell types based on the same numerical
analysis method. Conserved strain-responsive genes were defined as those meeting three
criteria: two-way ANOVA significant dependence on applied force (p < 0.05), ECs paired
t-test significant difference between static and applied strain groups (p < 0.05) with fold
change ≥1.5, and MSCs paired t-test significant differences (p < 0.05) with fold change
≥1.5.
Ontological analysis of microarray results Functional, regulatory, and subcellular
location analysis of strain-responsive genes was completed using Ingenuity Pathways
Analysis (Ingenuity), the Database for Annotation, Visualization and Integrated Discovery
(DAVID) 2008 [107, 64], and the Computational Ascertainment of Regulatory Relation-
ships (Inferred from Expression) (CARRIE) software [93, 94]. For IPA analysis, GenBank
Accession Numbers for the set of conserved force-responsive molecules were uploaded
as a data set and analyzed for core analysis using direct and indirect relationships, en-
dogenous chemicals, and up to 25 networks per analysis, each with up to 35 molecules.
Descriptions for each molecule associated with the resulting 25 networks of direct and
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indirect interactions were exported from IPA into MS Excel and sorted according to molec-
ular function or subcellular location. GenBank accession numbers for conserved force-
responsive probes were uploaded to the DAVID interface as the gene list and compared to
the Homo sapiens background gene list. Functional annotation clustering was performed
via DAVID version 6.7b and results exported to MS Excel for table formatting. Both IPA and
DAVID analysis relied only on GenBank Accession numbers. For prediction of transcrip-
tional regulators, both GenBank Accession numbers, as well as fold change and p-values,
were uploaded for each cell type. Pre-processed array data in this format were uploaded
and analyzed using the TRANSFAC Human matrix list and HG-U133 promoter list. Pa-
rameter setttings used for conserved force-responsive molecules in this analysis were:
significant expression change defined as |FC| ≥ 3.0 and significance (p < 0.01). Sig-
nificant transcription factors were defined using default cutoffs for frequency of significant
sites in random promoters (prandom < 0.001) and binding site overabundance in one pro-
moter (poverabund < 0.01). Finally, chromosomal location analysis was completed by sorting
data output from GeneSpring for the conserved set of force-responsive probes. Reference
information on length and content of chromosomes was obtained from the Vega Genome
Browser.
Standard qPCR assessment Individual genes were assessed using standard qPCR.
RNA was isolated from kinetic experiments and quantified as above. cDNA was synthe-
sized using a FirstStrand III SuperScript Kit (Invitrogen) and prepared for qPCR with cus-
tom designed primers (Primer Express 3 software; Invitrogen custom primer synthesis;
ABI SYBR mastermix). qPCR samples were run on a StepOne Plus machine (ABI) and
baseline-subtracted Ct analyzed in Excel (Microsoft). Data were converted to molar con-
centrations using a standard curve and normalized to Gapdh expression. Fold-changes
were calculated as the ratio of applied shear/static relative expression. A 1.5-fold change
threshold was used to identify shear-responsive genes. Fold changes calculated from mi-
croarray or qPCR data were compared.
Statistical analysis Microarray data were analyzed with two-factor ANOVA and paired
t-test. Functional significance was determined using statistical methods inherent in IPA,
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DAVID, or CARRIE, respectively. qPCR data was analyzed in MS Excel with two-tailed
paired t-tests. Experimental design was employed to minimize the effect of biological vari-
ability (i.e., 4 pooled samples per microarray) and randomize the effect of experimental
variability (n≥3 independent experiments/comparison). Significance cut-offs, defined ex-
plicitly throughout the text, were at maximum p < 0.05.
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Table 11: Gene Ontology (GO) terms relatively upregulated in conserved shear-
responsive genes. Gene Spring software analysis of 32 significant (p < 0.10) molecu-
lar functions, cellular components, and biological processes based on the Gene Ontology
database. For highly conserved shear-responsive genes (list of 574 genes), only 2 GO
terms are significant (p < 0.10): DNA metabolic process and DNA replication.
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Table 12: Functional clusters significantly (p < 0.05) affected by conserved shear-
responsive genes. DAVID analysis of the set of 574 conserved shear-responsive probes
identified 28 functional clusters. General functions and associated conserved shear-
responsive genes areas listed in order of decreasing significance.
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Table 13: Transcription factor regulation of conserved shear-responsive genes.
CARRIE analysis of the set of 574 conserved shear-responsive probes identified transcrip-
tional regulators predicted to be involved in shear stress-triggered signaling. P-values and
fold-change data for the set of 574 conserved shear-responsive probes were analyzed us-
ing the CARRIE server for each cell type, MSCs and ECs. Transcription factors predicted
to be significantly (p < 0.05) involved appeared for one cell type (MSCs: 49 TFs, lower left;




The data presented here collectively describe MSCs vascular-relevant mechanosignaling,
with direct comparisons to signaling responses observed in SMCs or ECs exposed to
cyclic strain or shear stress, respectively. MSCs have muted responses to applied force,
compared with differentiated vascular cells, in terms of the number, magnitude fold change,
significance of difference, and/or rate of gene expression change (Chapters 3 and 5). Gene
profiles assessed using whole genome microarrays demonstrate that sample groups as-
sessed differ primarily in their overall expression profiles, and less so in terms of the ap-
plied force environment (Chapters 4 and 6). In all cases (Chapters 3-6), a limited set
of genes differ significantly in response to applied force in multiple cell types (MSCs and
SMCs or MSCs and ECs) and occasionally multiple types of applied force (cyclic strain
and steady laminar shear stress). These instances of molecular responses to applied
force that are significant and similarly altered in more than one cell type are defined as
‘conserved’ mechanoresponses. Conserved mechanoresponses related to immune and
inflammatory function and oxidative stress are detected using qPCR following either cyclic
strain (Chapter 3: Il8, Vcam1, Hmox1) or shear stress (Chapter 5: Cox2 and Hmox1).
Genome analysis of conserved strain- or shear-responsive molecules indicates conserved
force-responsive molecules can be found across multiple subcellular locations and affect a
broad range of molecular functions, but are unevenly distributed throughout the genome.
This suggests chromosomal location may be important for determining mechanosensitivity
at the transcript level. Functional analysis of conserved force-responsive genes predicts
that cell proliferation and regulation of oxidative stress are the most significant functions
commonly regulated by these mechanical strains and stresses.
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7.1 Limitations of Experimental Design
The objective of this dissertation was to contrast the signaling responses of MSCs and
differentiated vascular cells in response to applied mechanical cues. Experiments were
designed to provide paired data for each cell type and matched conditions between cell
types. However, based on the specific experiments completed, the resulting collection of
data focuses on changes in gene expression levels of specific types of mechanical cues
(equibiaxial cyclic strain or steady laminar fluid shear stress) at a few instances of force
magnitude, frequency and duration. Furthermore, the mechanoresponse of each cell type
was assessed using few donors: one donor each for SMCs and ECs, and two donors for
MSCs. These inherent experimental parameters (cell source, force condition, and gene-
based signaling assessment) limit the breadth of conclusions that can be drawn from this
work.
Gene expression is one means by which to assess changes in cell signaling. Cell
signaling changes also occur at the chromosomal, protein, and post-translational levels.
Changes in gene expression level are suggestive, but not definitive, of subsequent signal-
ing changes. Thus, determining the functional significance of the gene expression changes
observed throughout these studies requires additional studies assessing multiple regula-
tory stages. Inclusion of functional assessments when possible (e.g., leukocyte binding)
would strengthen conclusions regarding the impact of non-vascular-like mechanosignaling
of MSCs. Thus, conclusions made about cellular mechanosensitivity based on studies
included in this dissertation are limited to the gene expression level, with the exception
of protein quantification of VE-Cad, Pecam1, and vWF completed as part of shear stress
studies. Statements made about the functional impact of gene expression changes are
suggestive, not definitive.
In terms of mechanosignaling, work by others and presented here shows that cell sig-
naling responses to mechanical cues is a dynamic process. Force parameters including
duration, magnitude, frequency, 2-D versus 3-D presentation, and surface chemistry can
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influence cellular response to mechanical force. This limitation in terms of the range of me-
chanical parameters tested is typical of published mechanosignaling to date. Studies from
this dissertation compare disparate entities (e.g., stem cells versus differentiated cells;
cyclic strain versus shear stress) in an attempt to identify patterns of mechanosensitivity
and overcome the limitations of few applied force conditions. However, this pragmatic lim-
itation would be optimally addressed by finding a generalized understanding of how cell’s
interpret mechanical cues.
Use of primary cells introduces another variable: donor history. Properties of MSCs
can vary with donor. Work by others has shown that proliferation rate of MSCs and dif-
ferentiation potential decrease with donor age. Efficiency of differentiation along different
lineages can vary with donor. Harvest of MSCs can be reduced in diseased patients. Until
we have more definitive markers to identify MSCs, comparing results across MSCs de-
rived from multiple donors is necessary to separate properties of MSCs from biological
noise related to age, gender, ethnicity, genotype, or disease state of the donor. Differ-
ences in signaling are likely to vary more between different cell types (as supported by
microarray two-factor ANOVA) than between different donors of the same cell type. For
this dissertation, signaling differences were compared across different cell types derived
from different donors. Defining conserved force-responses based on data from different
cell types is theoretically a more stringent criterion than different donors within a single
cell type. It is still possible that some molecules, while exhibiting a conserved mechanore-
sponse in multiple cell types, vary from person to person in their basal expression levels
of these molecules. Repeating studies included in this dissertation with cells derived from
different donors could confirm the conserved nature of the mechanoresponses observed
and clarify donor-to-donor variability.
Another challenge related to heterogeneity of MSCs, independent of individual donor
charateristics, is the phenotypic variation in isolated MSCs. The lack of unique selec-
tion markers for MSCs and highly heterogeneous cell population within the bone marrow
permit a broader range of cells to be isolated even with standard isolation procedures.
Mesenchymal stem cell-like cells have been isolated using a range of methods, including
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gradient separation and mononuclear cell plating and immunoselection, and have been
isolated from a range of tissues. Lack of standard source, isolation, and definition make
forming generalizable conclusions about MSCs difficult [302]. Finally, in vitro culture may
trigger additional phenotypic changes in MSCs compared to their in vivo responses. For
these studies, the variability within MSCs populations is predicted to be similar or less than
the variability in cell signaling between MSCs and differentiated vascular cells. Compar-
ing inherently heterogeneous populations of MSCs with differentiated vascular cells is thus
a more stringent method of identifying force-repsonsive molecules conserved across cell
type. Since molecular assessments were completed at the population level, heterogeneity
in MSCs implies that force-responses specific to MSCs could be either a property of the
entire population or of a subset of cells.
These limitations trigger follow-up questions to more explicitly test trends observed in
these studies. Multiple follow up studies will be required to determine the significance and
broad applicability of the numerous specific gene expression changes detected in this dis-
sertation. The limitations of this work mean that this assessment of mechanoresponse is
not comprehensive. Based on the study design though, comparing signaling data across
multiple experiments for multiple cell types, conclusions about conserved mechanore-
sponse genes are anticipated to include more false negatives (incomplete ‘mechanome’)
than false positives.
7.2 Responses to Cyclic Strain
Cyclic strain mechanosignaling comparisons of MSCs and SMCs identify specific molecules
whose expression varies with applied cyclic strain. These cell types differ in terms of basal
gene expression and strain-responsive transcriptome changes. A subset of molecules are
conserved strain-responsive in MSCs and SMCs. Signaling responses of MSCs and SMCs
to cyclic strain were compared in terms of signal transduction genes (PCR arrays, Chap-
ter 3) and strain-responsive transcriptomes (microarrays, Chapter 4). Data from Chapters
3 and 4 corroborates the marked differences in basal gene expression profiles of MSCs
and SMCs (Figures 7 and 16). Accuracy of microarray results could be confirmed using
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qPCR results (Chapter 3) for strain-responsive genes in SMCs (Cebpb, Il1α, Il8, Hmox1,
Rbp1, and Tfrc). For SMCs, discrepancies in microarray versus standard qPCR strain-
responsive genes could often be eliminated by including molecules from the same protein
family (N-Cam and Pecam1 vs. Vcam1; Irf-2,-3,-7, and -9 vs. Irf1; Mmp19 vs. Mmp7).
Some discrepancies in data indicate gene expression assessment does not have 100%
fidelity across detection method. For example, Il1α strain-responsiveness was significant
by both PCR array and microarray, but could not be verified with subsequent qPCR. Strain-
responsive genes in MSCs verified with PCR arrays and microarrays included Vcam1,
Bmp4, Selplg, and members of the Hox (Hox-A9, -B3, -B4, -B6, -C6, -C10, -D3, and -D9
and vs. Hox-A1) and Interleukin (related to Il-1, -3, -6, -7, -10, -13, -15, -17, -20, -21,
and -22 versus Il8) families. Magnitude expression changes were greater in SMCs than
MSCs (Figures 1 and 17). Conservation of fold-change response, rather than absolute
expression level, has been proposed as a regulatory mechanism in other systems [82, 83];
data presented in Chapter 3 indicates this mechanism applies to mechanosignaling as well
(Figure 9).
Results from Chapter 3 suggested more genes in SMCs than MSCs may alter expres-
sion levels in response to applied strain, based on larger numbers of genes identified using
graded p-value thresholds (Figure 9). However, similar analysis performed on microarray
results contradicts this conclusion, suggesting instead that MSCs and SMCs have simi-
lar total numbers of significantly strain-responsive genes (p < 0.001: 176 vs. 109; with
|FC| > 1.5 applied, 36 vs. 39). This difference could be due to the larger sample pool
in microarrays compared to PCR arrays: 4̃4,000 probes versus 84 genes. In this case,
both cell types appear similarly mechanosensitive in terms of the number of genes with
expression significantly (p < 0.05) altered by force. An alternate explanation is that signal
transduction genes specifically are more sensitive to cyclic strain in SMCs than MSCs.
7.3 Responses to Shear Stress
Signaling responses to fluid shear stress were compared between MSCs and ECs using
a panel of immune and inflammatory markers (Chapter 5) and whole genome microarrays
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(Chapter 6). MSCs rearranged to form gaps between cells in response to shear stress
on Type I Collagen-coated layers (Figure 22). To ensure a homogenous cell monolayer,
and therefore more uniform application of shear stress in microarray experiments, MSCs
were exposed to shear stress on fibronectin-coated surfaces since fewer gaps between
cells appeared following applied shear stress (Figures 28 and 31). No marked difference
in alignment to shear stress was observed in ECs on fibronectin versus type I collagen
surfaces, suggesting the change in protein adhesive surface does not affect the rate of
endothelial cell rearrangement.
In spite of a difference in underlying protein substrate, signaling changes detected in
samples exposed to shear stress were reproduced on both fibronectin- and type I collagen-
coated surfaces. In ECs, shear-responsive genes identified in microarrays and qPCR in-
cluded Pecam1, vWF, Cox2, eNos, Hmox1, Klf2, and Mcp1 (Ccl2), and members of the
Cadherin family (Cdh-3, -4, -10, -11, -13, -19 and several protocadherins versus VE-Cad).
In MSCs, Hmox1, Mcp1, and Klf2 family members (Klf-9, -11, and -15 versus Klf2) altered
gene expression in response to applied shear stress. Lack of Pecam1 shear-response
detected by microarrays is consistent the biphasic shear-response of Pecam1 detected
with qPCR. On type I collagen surfaces, Pecam1 expression significantly increased fol-
lowing 12 hours of applied shear stress, but significantly decreased following 48 hours of
applied shear (Figure 24). Genes whose expression did not significantly alter in qPCR
assessments, including VE-Cad, Cox2, and eNos, also were not significantly altered in
microarray assessment. Matched shear-responses in Chapters 5 and 6 corroborate the
conclusion made in Chapter 5, that lower expression of Pecam1 and VE-Cad in MSCs
than ECs exposed to shear stress may result in reduced immune activation.
Single factor studies included in Chapter 5 highlighted the force magnitude-dependence
of some shear stress gene responses (ECs: eNos, Klf2, vWF; MSCs: Mcp1; Both: Cox2).
Immunocytochemistry studies also contrasted gene and protein shear stress responses,
suggesting Pecam1 and VE-Cad gene changes also affect downstream protein levels. In
contrast to these single factor studies, microarray comparison of shear-responsive tran-
scriptomes suggests shear stress affects signaling in ECs more than MSCs in terms of
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number, magnitude fold-change, and significance of gene expression changes (Figures 33
and 34). High-throughput signaling data generated with microarrays enabled identification
of potential convergence nodes controlling shear stress responses and uncovered strong
correlation between conserved shear-responsive molecules and cell cyclic and DNA repli-
cation control. Shear stress regulation of cell cycle correlates with previous reports of
endothelial cell shear responses and with the decrease in cell number observed in MSCs
(Figure 23).
7.4 Comparison of Cyclic Strain and Shear Stress Mechanosensitive Gene
Expression
Four mechanosensitive transcriptomes were generated as part of these studies, represent-
ing three cell types (MSCs, SMCs, ECs) and two force types (cyclic strain, shear stress).
PCA analysis was able to separate samples based on cell type for both cyclic strain and
shear stress. PCA analysis separated samples based on force condition (static versus
applied force) more so in shear stress comparisons, for both MSCs and ECs, than strain
comparisons, although SMCs static and strain samples separated more than MSCs static
and strain samples. MSCs and SMCs strain responses appeared to vary in opposite direc-
tions in terms of principal component 3. More samples, preferably incorporating additional
cell donors, would verify this preliminary data.
For high-stringency force-responsive criteria (p < 0.001, n=3; |FC| ≥ 1.5), strain re-
sponses identified genes in MSCs (36) and ECs (39), compared to shear responses in
which MSCs (55) and ECs (462) genes were identified. A greater number of significant
gene expression changes were observed following shear stress than cyclic strain at both
lower stringency force responsive criteria (p < 0.05) and when considering only MSCs. Un-
like SMCs or ECs, MSCs are not preconditioned to these particular mechanical cues. This
indicates the pattern of more genes significantly affected by shear stress than cyclic strain
could apply beyond differentiated vascular cells. The biological importance of specific gene
mechanosignals, or of many or few gene expression changes, remains unknown.
Two sets of conserved force-responsive genes were defined: conserved strain-responsive
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molecules (442 microarray probes with p < 0.05 for MSCs, SMCs, and two-factor ANOVA
force-dependence) and conserved shear-responsive molecules (574 microarray probes for
p < 0.05, |FC| > 1.5 for MSCs, ECs, and two-factor ANOVA force-dependence). Compar-
ing set lists of conserved strain-responsive molecules with conserved shear-responsive
molecules reveals that approximately 7% of these molecules (34 probes) have expres-
sion sensitive to both force types in all three cell types. Although only a few genes were
mechanosensitive compared to the total number assessed, recurring gene expression
changes following applied mechanical force may indicate these molecules are biologically
important regulators of cell physiology.
To highlight patterns in mechanosignaling, conserved gene lists for shear stress and
cyclic strain were abstracted in terms of predicted transcriptional regulatory pathways,
chromosomal distribution, signaling networks, and GO terms (biological processes, molec-
ular functions, and cellular locations). More transcription regulators were predicted to be
significantly involved in shear response than strain response, although some factors were
predicted to regulate responses to both forces (e.g., myogenic enhancing factor 2). Distri-
bution of conserved force-responsive genes throughout the chromosomes was not uniform.
In shear stress comparisons, but not strain, a signaling network directly connecting many
conserved shear responsive molecules was identified. This network highlighted multiple
hourglass motifs, suggesting shear-responses may be funneled through a limited set of
regulatory molecules.
To eliminate effects due to variation in chromosome length, the number of force-responsive
molecules was normalized to either DNA length, number of genes, or protein coding
length. In both strain and shear stress, chromosomes 4 and 11 had unusually high force-
responsive genes per total number of genes (ratios above 95% confidence interval for both
chromosomes and both force types) and per coding length (ratios above 97% for chromo-
some 11 in both shear and strain; above 95% or 68% for chromosome 4 response to shear
or strain). This inhomogeneity suggests the increase in force-responsive genes present
on chromosomes 4 and 11 does not occur by chance. Increased force-sensitivity of a
chromosome could be due to a particular nuclear architecture, chromosome structure, or
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a sequence of DNA that is more sensitive to applied physical forces.
Approximately 50% of genes with force-responsive expression localized to the nucleus
and cytoplasm, suggesting these locations are enriched for mechanoregulation at the gene
level. Enzymes, transcription regulators, and multi-protein complex molecules were the
primary molecular functions represented in both conserved strain and shear stress gene
sets. Regulating transcription regulatory molecules through gene expression itself is a po-
tentially efficient signaling control since transcript machinery is already engaged. These
studies suggest enzymes may also be regulated by mechanical force through a transcrip-
tional mechanism.
Biological functions associated with strain versus shear stress differ. Cyclic strain al-
tering gene expression associated with oxidative stress signaling, ion homeostasis, and
growth and metabolism regulation. Shear stress signals were strongly associated with cell
cycle, DNA replication, spindles and chromosomes. Differences in functions regulated by
applied force could be characteristic of the applied force type or could be related to reg-
ulation of different physiologic processes depending on anatomical function and location.
Molecules defined as conserved strain-responsive or conserved shear stress-responsive,
but not both, provide a mechanism by which cells can distinguish between different types
of mechanical force. Conversely, the fact that a subset of conserved mechanoresponsive
molecules respond to both cyclic strain and shear stress, in spite of different functional
outcomes regulated by these mechanical forces, suggests these molecules may act as
conduits for a mechanical signal instead of determinants of a functional output.
7.5 Mechanoresponse Varies with Underlying Protein Substrate
Cyclic strain or fluid shear stress were applied to MSCs seeded on a variety of underly-
ing protein substrates. For cyclic strain, this list included gelatin, type I collagen, type IV
collagen, and fibronectin. Shear stress studies of MSCs signaling occurred on type I col-
lagen, type IV collagen, or fibronectin. MSCs appeared to remodel when seeded on type
I collagen-coated surfaces and subjected to either strain [67] or shear stress (Figure 22).
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These rearrangement effects were abolished or reduced when MSCs were exposed to me-
chanical cues seeded on type IV collagen-coated or fibronectin layers. These studies show
that underlying protein substrate can affect the morphological response of cells to mechan-
ical cues. Analysis completed as part of Specific Aim 1 (Chapter 3) also demonstrate that
changes in underlying protein substrate can alter the signaling profiles within both MSCs
and SMCs. This signaling study demonstrates that significant differences in expression
of specific genes between MSCs and SMCs change, depending on the underlying protein
(Table 4).
Work completed by others has shown that adhesion to particular extracellular matrix
molecules such as fibronectin can alter cell signaling. Others have shown that changes in
substrate stiffness affect cell signaling, in particular altering differentiation of mesenchymal
stem cells and embryonic stem cells [71, 69, 180]. Thus, the changes in cell signaling
and mechanoresponses observed here due to underlying protein substrate could result
from chemical signaling changes or from differences in adhesive strength and elasticity.
Age, body mass index, and differentiation state can also affect cell signaling response to
mechanical force [85]. While the first two factors were not directly assessed in this work, the
overall increase in mechanosensitivity of differentiated vascular cells compared to MSCs
observed here supports a role for differentiation in determining mechanosensitivity.
7.6 Cellular Mechanisms to Sense Physical Forces
Several mechanisms have been proposed by which cells may convert environmental phys-
ical cues, including static and dynamics forces, into biochemical signals capable of im-
pacting cell function. Quantitative computational and mathematical models have been
developed to describe specific properties such as cell shape or growth [253, 173]. Con-
ceptual models also exist, such as the tensegrity theory that relates cell behavior to the
balance of hydrostatic and tensile forces acting on the cell [111]. Many recent studies
have focused on the role of substrate stiffness in determining cell function [70], ranging
from stem cell [69] to tumor [310] biology. Vogel recently provided a linguistic model for
mechanobiology, in which components of the mechano-chemical signaling cascades are
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classified as sensors, transducers, or responders [296]. The studies presented here fo-
cus on signaling effects of mechanical cues, rather than physics-based descriptions of
molecular changes. High-throughput studies were intended to highlight potential network
organization and/or key regulators of mechanosignaling, but a greater number of similar
studies are needed before a model of high-throughput mechanosignaling can be devel-
oped and tested. Furthermore, this work address a gap in mechanobiology research to
date: comparison of mechanosensing across disparate conditions (species, cell type, nat-
ural environment, etc.).
These studies focused primarily on changes in gene expression level. Since gene ex-
pression is typically downstream of a signaling regulatory network, the genes identified as
force-responsive in this work may not necessarily directly sense force, but may be down-
stream of a signaling cascade containing force-detecting elements. Molecular categories
with reported direct force-sensitivty include: stretch-sensitive ion channels [186]; G-protein
coupled receptors and other membrane-bound proteins [172, 34]; the actin and interme-
diate filaments cytoskeleton [307]; cell-cell and cell-matrix adhesion molecules such as
integrins and focal adhesions [17, 46]; and the nuclear membrane and DNA [284]. In many
cases, a mechanical cue triggers a conformational change in the molecule and thereby al-
ters the signaling state [174]. Mechanosensors in the vascular system have been studied in
single-factor studies for several decades. Stretch-activated ion channels regulate vascular
physiology [270, 75]. A trio of shear-responsive molecules including PECAM, VEGF, and
VE-CAD interact with one another and directly sense applied shear stress in endothelial
cells [290]. These molecules in turn can regulate G-protein coupled receptors, the initia-
tor of many intracellular signaling cascades [324]. In addition, the glycocalyx has been
proposed as a regulator of mechanosensing in endothelial cells [281]. While mechanical
forces are known to affect smooth muscle cell functions including proliferation, differentia-
tion, and extracellular matrix expression [116], less is known about the direct mechanosen-
sors controlling these physiologic responses. Recent work has shown Rho GTPases to be
involved of mechanosensing of both vascular cells and MSCs [20, 220]. For the conserved
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gene expression targets of cyclic strain or shear stress identified in these studies, the di-
rect mechanosensors are rarely known. In instances of both gene and protein expression
changes (e.g., PECAM or VE-CAD in endothelial cells), mechanosensing may be autoreg-
ulated, sensing and affecting the same molecule. For other molecules, bioinformatics tools
such as GeneSpring and IPA connected conserved force-responsive genes via indirect
connections and relationships beyond the gene expression level. These associations may
be suitable targets for follow up studies to identify the actual mechanosensing molecules.
Finally, incorporation of new techniques, such as protein-coated magnetic bead manipula-
tion, provides a new way to distinguish between mechanoresponsive and mechanosensing
molecules [1].
7.7 Future directions
Results from this work could be used to motivate a range of future experiments. Proteomic
studies matched to the microarray data conditions would enable correlation of gene ex-
pression changes with protein or post-translational modification. More specific follow up
studies related to results from each chapter are listed below.
Cyclic Strain Response. Evaluate the functional importance of novel strain-responsive
genes in SMCs. Determine if gene expression changes in Il8, Hmox1, and Vcam1
correlate with protein expression and activity. Determine whether altered levels of
Il8 or Hmox1 gene or protein expression alters Vcam1 gene expression, confirming
the regulatory triad predicted by Chapter 3. Determine whether signaling regulation
occurs via direct contact or through other signaling intermediates.
Shear Stress Response. Correlate gene expression changes of panel of 8 immune and
inflammatory markers to protein expression and activation. Compare functional dif-
ferences of MSCs and ECs exposed to shear stress, in order to verify if MSCs have
a reduced inflammatory environment and lower immune activation than ECs. Alter
shear stress profiles, adding oscillatory and/or turbulent flow, to determine whether
known variations in ECs shear-response are present in MSCs. Determine whether
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differences in protein spatial localization between cell types relate to functional differ-
ences of Pecam1, VE-Cad, and vWF.
High-throughput mechanoresponse. Verify force-responsiveness of conserved, signifi-
cantly force-responsive genes identified using microarrays. Repeat high-throughput
studies using alternative assessments to mRNA, such as miRNA, protein expression,
post-translational modifications, and metabolites; match resulting multi-level signal-
ing data to determine whether trends seen at gene expression level are consistent.
Assess Nrf2 oxidative stress signaling pathway to determine activity in MSCs and
SMCs and alterations in reponse to applied cyclic strain. Quantify proliferation rates
in MSCs and ECs exposed to shear stress, compared to static culture. Determine
whether applied shear stress regulates cell cycle and DNA replication in other cell
types.
The breadth of mechanoresponse data, ranging cell type to extracellular matrix substrate to
high-throughput gene assessment, could be used to motivate other studies on molecules
or functions of interest. Addition of more high-throughput, comparative mechanobiology
studies to the literature will provide a foundation from which to build a generalized descrip-




Mesenchymal stem cells are a promising therapeutic tool for a wide range of applications.
In the clinic, they have already been used as part of bone marrow transplants and immune
acceptance strategies (to avoid transplant graft-vs.-host rejection). Recent clinical trials are
investigating MSCs use to treat a range of disorders: Graft versus Host Disease (GvHD),
liver disease, diabetic foot ulcers, bone marrow transplantation, and myocardial infarcion
(MI) [300, 80]. Cardiovascular disease remains a major burden on the healthcare system in
terms of morbidity, patients affected, and cost of treatment. Biological repair mechanisms
enabled by cell-based therapies are proposed to more effectively address multifactorial
problems such as vessel occlusion, impaired vasoactivity, infarcted muscle, and promote
angiogenesis. Previous studies have shown that MSCs may contribute to these effects
via both paracrine and differentiation mechanisms. In addition, the potential of MSCs for
autologous or allogeneic therapy; relative ease of cell harvest; prior FDA approval; and
fewer ethical hurdles compared to embryonic-derived cell types are practical benefits of
MSCs-based therapies.
This dissertation was designed to fill a gap in the knowledge about MSCs suitability
for cardiovascular therapies: specifically, to determine whether MSCs respond to vascular-
relevant applied physical forces similarly or differently from differentiated vascular cells.
Signaling responses to equibiaxial cyclic strain were compared between MSCs and SMCs
(Chapters 3 & 4). Responses to steady laminar fluid shear stress were compared between
MSCs and ECs (Chapters 5 & 6). A combination of single factor assessment and multiple
force conditions (Chapters 3 & 5) and single force condition with high-throughput assess-
ments (Chapters 4 & 6) were employed to study vascular-relevant mechanosignaling. The
original hypothesis, that signaling responses would be conserved between MSCs and dif-
ferentiated vascular cells, was true for a minority of total force-responsive genes for both
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cyclic strain and shear stress studies. This work highlights specific similarities and dif-
ferences between MSCs and differentiated vascular cell response to applied mechanical
forces.
8.1 MSCs Cyclic Strain Response Compared to SMCs
For this study, MSCs and SMCs were compared on fibronectin-coated silicione in response
to equibiaxial strain (10%, 1 Hz) for up to 24 hours. Assessment of signaling transduc-
tion genes demonstrated that MSCs respond to strain with fewer number, magnitude, and
speed of altered gene expression levels. The similarity of Il8, Vcam1, and Hmox1 strain-
responses in both cell types, subsequently referred to as a ‘conserved’ mechanoresponse,
indicated immune and inflammatory-related functions may be regulated by similar force-
responsive mechanisms in both cell types. Microarray comparison of MSCs and SMCs
strain-responses after 24 hours applied force confirmed the marked differences in signal-
ing profiles observed between cell types and the limited number of strain-responsive genes
relative to the total number of assessed genes (< 10%). Functional analysis using bioin-
formatics software highlighted the Nrf2 oxidative stress response as the most significantly
involved strain-responsive signaling pathway in each cell type. These cyclic strain stud-
ies indicates MSCs may mimic beneficial SMCs mechanoresponses related to immune,
inflammation, and stress responses. Areas in which MSCs and SMCs mechanoresponses
differ suggest that MSCs may adhere to sites of injury more than SMCs (based on in-
creased P-selectin expression) and highlight new genes whose function and importance in
SMCs biology is unknown.
8.2 MSCs Shear Stress Response Compared to ECs
MSCs and ECs were compared on either type I collagen- or fibronectin-coated glass in
response to applied steady laminar fluid shear stress (5 or 15 dyn/cm2) for up to 48 hours.
Gene expression levels were markedly different between the two cell types under basal
and shear stress conditions. On type I collagen-coated surfaces, MSCs and ECs response
to shear stress differed in terms of cell alignment, gene and protein expression changes
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in response to applied shear stress, and kinetics of expression change. Signaling differ-
ences for a panel of genes assessed at multiple shear stress magnitudes and durations
indicates MSCs promote a reduced inflammatory or immunogenic environment compared
to ECs. The significance of morphologic differences (e.g., cobblestone- versus spindle-
shaped cells; appearance of gaps in response to shear stress) necessitates more work
before MSCs can be used as a lumenal layer. Microarray comparison of MSCs and ECs
shear response were completed on fibronectin-coated surfaces, since MSCs cellular re-
arrangements of MSCs were reduced compared to collagen type I surfaces. MSCs and
ECs differed in terms of number, magnitude, and significance level of shear-sensitive gene
expression changes. Samples could be clustered in separate cell type and shear stress
specific groups, even more distinct than in the case of cyclic strain. Through multiple anal-
ysis methods, proliferation-related functions were identified as the most significant con-
served shear stress response. This data indicate MSCs do not differentiate towards ECs
within 48 hours applied shear stress, nor do they recapitulate many of the characteristic
endothelial gene expression responses to shear stress. However, a reduced inflammatory
environment may still mean MSCs can benefit vascular therapies.
8.3 Vascular-relevant Mechanobiology
These studies demonstrate that cells can respond to applied mechanical cues with changes
in cell signaling, in spite of apparently unchanged visible morphology. When high-throughput
(microarray) or semi-high-throughput (PCR array) approaches were used, a minority of
genes were force sensitive (1̃0%). This is not because few genes were expressed, since
a much larger fraction of the total set (5̃0%) significantly varied between cell types (MSCs
vs. SMCs or MSCs vs. ECs). Of the force-sensitive genes, a fraction (2̃0%) were force-
responsive in both cell types. We referred to these molecules as having ‘conserved’
mechanosensitivity, since this is a parsimonious explanation for the appearance of force-
responsiveness in disparate cell types. The concept of mechanosensitivity as a function
critical to normal cell physiology, and therefore under evolutionary selection pressure, has
not been thoroughly investigated. Such evolutionary selection pressure, if it exists, may
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‘conserve’ mechanoresponses based on sequence and domain homology, cell and tissue
type (as shown here), or species type.
For both cyclic strain and shear stress comparisons, MSCs were observed to have
reduced gene mechanosensitivity than differentiated vascular cells. Future studies could
determine whether this is a function of differentiation state or merely these particular cell
type comparisons (as would be suggested if MSCs and osteocytes or chondrocytes shared
more similar mechanoresponse profiles). Finally, this work demonstrates that mechanore-
sponses can be conserved in terms of fold change, rather than absolute level of expression;
do not rely solely on initial expression levels to determine output response; and suggests
both median and variance may be used to track force-responsive genes. These studies
used cell type-specific culture media. This approach was intended to reduce the effect of
biochemical cues altering cell signaling, meaning that observed signaling changes were
theoretically due only to the applied force condition. However, this means that cell type-
specific mechanorespones, if dependent on initial biochemical conditions (e.g., a particular
receptor in the media), could result from differences in cell culture media. Future studies
are necessary before these examples of conserved mechanosensitivity can be generalized
to broader mechanical or biological conditions.
8.4 Closing Remarks
This work has generated data contributing to vascular mechanobiology, biology and thera-
peutic potential of MSCs, and potential for a ‘conserved’ subset of mechanoresponses. Fu-
ture studies to verify results from this work could address specific limitations of these stud-
ies: (1) incorporation of more cell type donors to confirm reproducibility of mechanoresonses
within a specific cell type, (2) incorporation of additional cell types or species types to de-
termine the extent of mechanosignaling conservation, and (3) assessment of cell signaling
parameters other than gene expression levels (e.g., protein expression; protein activity; rel-
ative component levels). Studies focusing on one or a few mechanoresponsive molecules
identified here are necessary to confirm the mechanism of force-sensitivity, associated sig-
naling cascade, and ultimate functional impact. Finally, the focus of this particular work has
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been to highlight mechanoresponses that are similar across disparate cell or force types.
The experimental data set generated for this dissertation though could also be mined to ex-
amine cell type-specific mechanoresponses. Future studies could determine whether cell
type-specific mechanoresponses are part of the essential traits that distinguish different
cell types from one another.
This work indicates mesenchymal stem cells may be beneficial for specific aspects
of a vascular therapy, such as modulating the immune or inflammatory response. These
studies are among the first to describe MSCs sensitivity to vascular-relevant mechanical
forces. Marked differences in signaling observed in these studies indicates MSCs are
unlikely to adopt all vascular-like signaling patterns upon implantation. Systematic study
of mechanoresponses, and prioritization of the benefits and risks of specific signaling re-
sponses, will help refine how MSCs can best contribute to vascular cell-based therapies.
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APPENDIX A
CHARACTERIZATION OF MESENCHYMAL STEM CELLS
Human adult bone marrow-derived mesenchymal stem cells were purchased from Lonza
(Catalog No. PT-2501). One lot of MSCs was used for experiments per force type. Lonza
MSCs are characterized prior to sale for adipogenic (Oil Red O assay), chondrogenic
(Proteoglycans-Safranin stain and Type II Collagen on Day 14 or 21), and osteogenic (Cal-
cium deposition) differentiation. Cells are also tested for positive expression of CD105,
CD166, CD29, and CD44 and negative for expression of CD14, CD34, and CD45.
The following information summarizes donor characteristics of lots used for these stud-
ies. Results from biochemical differentiation studies and flow cytometry are based on cells
at experimental use passage (≤ 7 passages post-thaw).
A.1 Donor 1. Cyclic Strain Experiments
A.1.1 Background information
One lot of MSCs, representing cells harvested from a single donor, was expanded and
used for cyclic strain experiments.
Donor traits





Passage on thaw: P.2
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A.1.2 Flow cytometry characterization
Figure 39: Flow cytometry characterization of Lot . Surface protein expression was
assessed at experimental use passage P.6 for three positive markers, CD73, CD105, and
CD166, and three negative markers, CD34, CD45, and CD133. Negative markers distin-
guish MSCs from other marrow-derived and hematopoeitic cell types. CD166 expression
was determined using binding to its ligand CD6. Red = stained sample. Black = secondary
or cells only control.
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A.1.3 Biochemical Differentiation Results
A.1.3.1 Osteogenic
Figure 40: Osteogenic differentiation of Lot . MSCs were cultured in either osteogenic
or standard MSC growth media. Deposition of calcium, an indicator of osteogenic differ-
entiation, was assessed qualitatively with von Kossa staining and quantitatively using a
Calcium (CPC) LiquiColor test (Stanbio). Nuclei were counterstained with nuclear fast red.
Significance was determined using a two-tailed t-test.
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A.1.3.2 Adipogenic
Figure 41: Adipogenic differentiation of Lot . MSCs were cultured in adipogenic or
standard MSC growth media. Adipogenic culture media alternated between induction and
maintenance media. Adipogenic differentiation was inferred from accumulation of lipid
droplets, qualitatively and quantitatively assessed using Oil Red O staining and dye re-
suspension, respectively. Nuclei were counterstained with hematoxylin. Significance was
determined using a two-tailed t-test. Scale bars = 100µm.
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A.2 Donor 2. Shear Stress Experiments
A.2.1 Background information
One lot of MSCs, representing cells harvested from a single donor, was expanded and
used for shear stress experiments.
Donor traits





Passage on thaw: P.2
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A.2.2 Flow cytometry characterization
Figure 42: Flow cytometry characterization of Lot . Surface protein expression was
assessed at experimental use passage P.6 for three positive markers, CD73, CD105, and
CD166, and three negative markers, CD34, CD45, and CD133. Negative markers distin-
guish MSCs from other marrow-derived and hematopoeitic cell types. CD166 expression
was determined using binding to its ligand CD6. Red = stained sample. Black = secondary
or cells only control. Note: Weakly positive CD105 signal due to old antibody.
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A.2.3 Biochemical Differentiation Results
A.2.3.1 Osteogenic
Figure 43: Osteogenic differentiation of Lot . MSCs were cultured in either osteogenic
or standard MSC growth media. Deposition of calcium, an indicator of osteogenic differ-
entiation, was assessed qualitatively with von Kossa staining and quantitatively using a
Calcium (CPC) LiquiColor test (Stanbio). Nuclei were counterstained with nuclear fast red.
Significance was determined using a two-tailed t-test.
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A.2.3.2 Adipogenic
Figure 44: Adipogenic differentiation of Lot . MSCs were cultured in adipogenic or
standard MSC growth media. Adipogenic culture media alternated between induction and
maintenance media. Adipogenic differentiation was inferred from accumulation of lipid
droplets, qualitatively and quantitatively assessed using Oil Red O staining and dye re-
suspension, respectively. Nuclei were counterstained with hematoxylin. Significance was
determined using a two-tailed t-test. Scale bars = 100µm.
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A.3 Methods Development: Mesenchymal Stem Cell PCR Array
In the course of this dissertation, a PCR array to quantify expression of characteristic genes
in MSCs was developed in collaboration with SA Biosciences (Frederick, MD). The RT2
ProfilerTM PCR Array Human Mesenchymal Stem Cell is commercially available through
SA Biosciences (Catalog number PAHS-082A).
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B.1 Protein Coating of Cell Culture Surfaces
1. Make a sterile diluted extracellular matrix protein solution at desired concentration
(typically 5µg/cm2 or 1% w/v for gelatin) using manufacturer-recommended solvent.
Mix solution well.
2. To sterile surfaces on which cells are to be seeded, add diluted protein coating solu-
tion (3 ml/10 cm2 seeding ring for strain MHC or 2 ml/28.5 cm2 for parallel plate glass
slides).
3. Allow protein to adsorb to surface at 37◦C for 2 hours. (For glass slides that are
difficult to move, let sides sit for 30 minutes, flip horizontally 180◦, sit again for 30
minutes.)
4. Aspirate protein coating solution. Immediately seed cells at desired concentration
(cells/cm2).
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B.2 Application of Equibiaxial Cyclic Strain
Day 1: Preparation
Estimated time: 4 hours
1. UV spacers 30 on each side in UV box in hood.
2. Prepare membrane holder chambers (MHCs), wearing gloves the entire time.
3. Etch silicone membranes 20 with 1N H2SO4 (diluted with milliQ or nanopure H2O) in
chemical hood.
4. Wash both sides well with dH2O, keeping track of etched side. Tip: Place etched side
facing right palm or, if putting piece down, etched side faces up.
5. Autoclave all supplies.
• Glass dishes, 150 mm glass petri 1 dish/MHC
• MHCs 1 per sample; for each group, need at least 1 static and 1 strain. Max.
16 MHCs.
• Paper inserts 1/MHC on which to put MHC so that silicone doesnt stick to glass
petri dish.
• Metal tray useful for transferring dishes back and forth between hood and incu-
bator.
• Instruments as needed. At least two pairs of forceps are required (long thin,
curved ones for manipulating seeding rings and large, heavy duty ones for mov-
ing MHCs onto glass dish).
Day 2: Cell Seeding
Estimated Time: 4 hours
1. Prepare coating solution.
2. Image cells before trypsinizing.
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3. Record desired length of static incubation, actual start time, actual stop time.
Day 3:
No tasks.
Day 4: Application of strain
Estimated Time: 4 hours
1. Image cells before putting on strain device (t=0 pictures).
2. Transfer 1 MHC to the equibiaxial strain device (maximum of 4/experiment), threading
MHC into one of the four available slots. For each MHC subjected to strain, transfer
1 MHC to the same incubator and leave the MHC in the petri dish for continued static
control culture.
3. Record desired magnitude, desired frequency, desired length of strain (protocol writ-
ten as if 48 hr static/strain desired), actual start time, and actual stop time.
Day 5:
No tasks.
Day 6: Stop strain
1. Remove samples from bioreactor.
2. Image samples and/or harvest cells, depending on desired experimental assess-
ments.
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B.3 Application of Steady Laminar Fluid Shear Stress
This protocol employs parallel plate shear chambers to apply shear stress to monolayers
of cells seeded on glass slides. Day 1: Prepare for shear
1. UV spacers 30 on each side in UV box in hood. Store in sterile location until ready to
use.
2. Autoclave all supplies.
• Shear blocks (base, top, rubber gasket)
• Flow loops (media reservoir, tubing, pulse dampener, tubing with double luer
entry point for shear block)
• Glass slides 28.5 cm2 slides for flow block
• Metal tray useful for adding blocks into flow loop on sterile surface and for
transferring loops between hood and incubator.
• Instruments as needed. Three pairs of forceps (at least two long-handled), one
pair slide forceps, one pair forceps.
Day 2: Seed cells
1. Place 1-2 glass slides in a square petri dish up to total number of slides needed.
2. Protein coat glass slides as described above.
3. Trypsinize cells and concetrate to desired cells/ml density. Assume 1 ml seeding
volume of 28.5 cm2. MSCs and ECs seeded at 10,000 cells/cm2.
4. Seed cells in 1 ml volume for 20 min on each side at room temperature, flipping slides
horizontally 180◦.





Day 4: Set up shear
For each flow loop (1 per shear sample):
1. Construct flow loop in sterile environment.
2. Add 125 ml culture media per loop.
3. Prewarm media in flow loop by running on pulsatile pump in large incubator without
shear block attached.
4. Prepare shear block under sterile conditions: base, rubber gasket, slide seeded with
cells, spacer, top, and then add 6 screws. Be sure to tighten screws in consistent al-
ternating fashion (e.g., top right, bottom left, top left, bottom right, top middle, bottom
middle) so that shear block series is tightened uniformly.
5. Transfer flow loop with shear block to incubator. Begin pulsatile flow at speed (rpm)
predetermined for each flow block to equate to desired theoretical shear stress across
slide (e.g., 44 rpm 15 dyn/cm2 for some McMaster-Carr pulsatile pumps).
6. Incubate blocks at 37◦C for desired duration of shear stress. Check blocks frequently
to ensure no leaks.
7. Parallel static samples are placed in 125ml prewarmed media in 15 mm petri dish
and kept in same incubator for duration of shear.
Day 5: Take down shear
1. Assuming a 24 hour applied shear (or modify, as needed), take 1 static and 1 shear
sample down at the same time. Obtain slide from flow block using reverse of set-up
procedure.
2. Phase image slides.
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3. Harvest or fix cells as desired, depending on assessment.
4. Wash all parts of shear system at least 2x each side/port. Let parts hang to air
dry. Be sure flow blocks not scratched at any point. Avoid crimping of tubing during
storage.
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B.4 Gene Expression Assessment
B.4.1 RNA Isolation
Protocol modified from Qiagen RNeasy Mini Isolation kit (Cat. No. 74104).
Reagents and supplies:
• RNeasy Mini Isolation kit - Qiagen 74104
• Qiashredders - Qiagen 79654
• RNase-free DNase Kit - Qiagen 79254
• RNase/DNase Free Water - Sigma W-4502
• RNase/DNase free B-mercaptoethanol - Sigma M3148
• Ethanol molecular biology grade - Sigma E702-3
• RNase/DNase free tubes
• Clean forceps to remove tubes from bag
Working Solutions
• Lysis Buffer (from RNeasy kit): Mix RLT buffer (10mL) with 100 µL B-ME. Protect
from light and store at RT for up to one month.
• RPE Buffer Solution (from RNeasy kit): Add 4 volumes of ethanol (96-100%), per
instructions on bottle
• DNase Stock (DO NOT VORTEX): Mix lyophilized DNase powder with 550 µl water
in kit to get DNase stock solution then aliquot 100 µl. Mix by inverting DO NOT
VORTEX. Store at -20◦C for up to 9 mo. Once thawed, store at 4◦C for up to 6
weeks. Do not refreeze.
• 70% Ethanol: Mix 200 proof ethanol for molecular biology with RNase/DNase Free
Water. Store at RT.
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Method:
Work can be done on any bench. Clean surfaces with dehydration alcohol or RNase Away.
Use clean, well-calibrated pipetmans with barrier pipet tips. All steps are at room temper-
ature. Wear gloves at all times. Record data, experiment number, and samples isolated.
Prepare cells
1. As quickly as possible, obtain a cell pellet and put on ice. [Wash, trypsin, quench,
spin, aspirate, continue with lysis below.]
Lyse Cells
1. Loosen cell pellets and add 350 µl of lysis buffer to each tube. Mix well.
2. Transfering mixture to Qiashredder column and spin in centrifuge at max (10,000
RPM) for 2 minutes to homogenize lysate. (This can be done after freezing, if prefer.)
3. Freeze at -70◦C until ready to isolate RNA.
Isolate RNA
Record date.
1. Prepare DNase mix. 10 µl to 70 µl RDD for 80 µl/sample. (Make 1 sample extra.)
2. Warm samples at 37◦C for 10 minutes
3. Add 350 l of 70% ethanol and mix well by pipetting.
4. Transfer the 700 µl to RNeasy mini column. Optional: If prefer, can rerun effluent
back through column to max RNA binding.
5. Centrifuge at 14,000 rcf for 1 min. Discard flow through.
6. DNase Treatment
• Add 350 µl RW1 solution to RNeasy column.
• Centrifuge at 14,000 rcf for 1 min. Discard flow through.
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• Add 80 µl of DNase solution directly to membrane and incubate at RT for 15
min.
• Add 350 µl RW1 solution to RNeasy column.
• Centrifuge at 14,000 rcf for 1 min. Discard flow through.
7. Add 700 µl RW1 solution to RNeasy column.
8. Centrifuge at 10,000 RPM for 30 sec. Discard flow through.
9. Add 500 µl of RPE Buffer.
10. Centrifuge at 14,000 rcf for 1 min. Discard flow through.
11. Add another 500 µl of RPE buffer.
12. Centrifuge at 14,000 rcf for 2 min. Discard flow through.
13. Place column in new 2 ml tube (supplied) and centrifuge column empty for 1 min.
14. Place the columns in the 1.5 ml tubes.
15. Add 30 µl of RNase free water and incubate for 1 min at RT
16. Centrifuge at 14,000 rcf for 1 min.
17. Discard the columns and place the samples on ice or freeze at -70◦C until ready
to use RNA. (Try to spec on Nanodrop and/or run bioanalyzer on this day and then
freeze. Thaw to continue.)
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B.4.2 cDNA Synthesis for PCR Arrays
Protocol is based on SA Biosciences First Strand cDNA synthesis kit (Cat. No. C-03).
cDNA is synthesized using the SA Biosciences kit in order to be able to use positive PCR
controls included on the PCR arrays.
1. Briefly (10-15 seconds) spin down all reagents.
2. Prepare the Genomic DNA Elimination Mixture:
a For each RNA sample, combine the following in a sterile PCR tube:
• 25.0 ng to 5.0 µg total RNA
• 2.0 µl GE** (5X gDNA Elimination Buffer)
• H2O to a final volume of 10.0 µl
b Mix the contents gently with a pipettor followed by brief centrifugation.
c Incubate at 42◦C for 5 min.
d Chill on ice immediately for at least one minute.
e Prepare the RT Cocktail:
RT Cocktail 1 reaction
• 4 µl BC3 (5X RT Buffer 3)
• 1 µl P2 (Primer & External Control Mix)
• 2 µl RE3 (RT Enzyme Mix 3)
• 3 µl H2O
• 10 µl Final Volume
3. First Strand cDNA Synthesis Reaction:
a Add 10 µl of RT Cocktail to each 10-µl Genomic DNA Elimination Mixture.
b Mix well but gently with a pipettor.
c Incubate at 42◦C for exactly 15 min and then immediately stop the reaction by
heating at 95◦C for 5 minutes.
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d Add 91 µl of H2O to each 20-µl of cDNA synthesis reaction. Mix well.
e Hold the finished First Strand cDNA Synthesis Reaction on ice until the next step
or store overnight at -20◦C.
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B.4.3 cDNA Synthesis for Standard qPCR
The following procedure is designed to convert 1 pg to 5 µg of total RNA or 1 pg to 500
ng of poly(A)+ RNA into first-strand cDNA. Protocol modified from Invitrogen First-Strand
cDNA Synthesis kit (Cat. No: 18080-051).
1. Mix and briefly centrifuge each component before use.
2. Combine the following in a 0.2- or 0.5-ml tube:
Component Amount
• n µl up to 5 µg total RNA
• 1 µl 50 µM oligo(dT)20 primer
• 1 µl 50 ng/µl random hexamers primer
• 1 µl 10 mM dNTP mix
• DEPC-treated water to 10 µl
3. Incubate at 65◦C for 5 min, then place on ice for at least 1 min.
4. Prepare the following cDNA Synthesis Mix, adding each component in the indicated
order.
Component
• 2 µl 10X RT buffer
• 4 µl 25 mM MgCl2
• 2 µl 0.1 M DTT
• 1 µl RNaseOUT (40 U/µl)
• 1 µl SuperScript III RT (200 U/µl)
5. Add 10 µl of cDNA Synthesis Mix to each RNA/primer mixture, mix gently, and collect
by brief centrifugation. For a reaction primed with random hexamers and oligodT,
incubate tubes 10 min at 25◦C, followed by 50 min at 50◦C.
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6. Terminate the reactions at 85◦C for 5 min. Chill on ice.
7. Collect the reactions by brief centrifugation. Add 1 µl of RNase H to each tube and
incubate for 20 min at 37◦C.
8. cDNA synthesis reaction can be stored at -20◦C or used for PCR immediately.
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B.4.4 Gene Expression Quantification
B.4.4.1 Standard qPCR
This protocol assumes use of Applied Biosystems Power 2x SYBR Green mastermix (Cat.
No. 4309155).
1. Prepare standard curve solutions, using nine 1/10 serial dilutions of initial concen-
trated standard solution.
2. For each well, aliquot 1 µl template, forward and reverse primers to desired final
concentration (e.g., 800 nM), 12.5 µl 2x Power SYBR Green mastermix, and H2O up
to 25 µl.
3. Once PCR plate loaded, cover wells with clear film covers. Spin plate briefly to ensure
liquid is located at the base of each well.
4. Run plate on ABI Step One Plus qRT-PCR machine, using default protocol.
5. Analyze qRT-PCR results in ABI Step One Plus software.
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B.4.4.2 PCR Array
This protocol is based on SA Biosciences PCR Array instructions.
1. Briefly (10-15 seconds) spin down all reagents.
2. Experimental Cocktail Preparation (for Custom PCR Arrays & Plate H (BioMark) PCR
Arrays, see NOTES below). Mix the following components in a 5-ml tube or a multi-
channel reservoir:
96-well Plate Format, Plate Format Designation A,C,D, or F:
• 1350 µl 2X SABiosciences RT2 qPCR Master Mix
• 102 µl Diluted First Strand cDNA Synthesis Reaction
• 1248 µl H2O
• 2700 µl Total Volume
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B.4.4.3 cDNA Microarray
Agilent whole human genome microarrays were run at the Morehouse School of Medicine
microarray core facility. Contact person: Dr. Leonard Anderson.
• Briefly, RNA samples were analyzed for RNA quality using a Bioanalyzer.
• Samples were labeled and hybridized to microarrays using a one-color reaction.
• Microarray images were captured using Feature Extraction. Quality control of mi-
croarray images was completed in Feature Extraction, prior to exporting intensity
data per probe spot.
• Intensity data per probe spot for all microarrays were analyzed using GeneSpring
software.
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B.4.5 Protein Expression Quantification
B.4.5.1 Flow Cytometry
Reagents:
• 4% Formaldehyde - Dilute 10% ultrapure formaldehyde with sterile filtered PBS with
Ca and Mg.
• Working Buffer Solution (WBS) - Dilute 0.3 g BSA in 100 ml PBS. Add 1 µl Tween-20
per 100 ml WBS. Store at 4◦C.
• Blocking solution (Serum of secondary antibody donor species): 1:10 dilution of
serum to working buffer solution.
• Permeabilitizing solution (0.5% Triton): 1 ml of 100% Triton diluted in 200 ml sterile
water. Store at 4◦C.
• Fixing solution (4% Formaldehyde): Dilute 20% Formaldehyde in sterile filtered PBS
with Ca and Mg in a 1 part:3 part ratio.
Prepare cells for flow cytometry:
1. Phase image cells at 5x for record keeping purposes.
2. Wash t75 flask in 6 ml DPBS.
3. Trypsinize cells with 3 ml at 37◦C for 3 min.
4. Gently tap flask to dislodge remaining adherent cells. Quench with 9ml cell culture
medium. Pipet up and down to remove remaining adherent cells.
5. Transfer 12ml to 15ml Falcon tube. Pellet cells by centrifuging 5 min at 200 rcf.
6. Aspirate supernatant. Resuspend in 4 ml 4% paraformaldehyde. Fix 15 min at 4◦C,
mixing occasionally with gentle flicking of tube.
7. Add 4ml WBS (working buffer solution; not more than 1 month old, ideally). Homog-
enize well.
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8. Take 100ul for Coulter Count measurement of cell number.
9. Pellet cells spin 5 min at 200 rcf.
10. Calculate cell number per flask.
11. Resuspend in WBS with appropriate volume to prepare for flow cytometry.
12. Store at 4◦C until ready to proceed with flow cytometry staining.
Stain cells and image for flow cytometry:
1. PREPARE CELLS: Wash, trypsinize, and quench cells as normal.
2. PELLET: Spin 5 min at 1000 rpm. Aspirate supernatant.
3. FIX: Add 4 ml 4% formaldehyde for 15 min at 4◦C.
4. PELLET: Dilute with working buffer solution, centrifuge and aspirate.
5. PERMEABILIZE: (For intracellular markers only) Add 2 ml of permeabilizing solution
for 30 min (vortex every 15 min to prevent cell settling) at 4◦C.
• PELLET: (Intracellular markers only.) Dilute w/ working buffer solution, cen-
trifuge and aspirate.
6. BLOCK: Add 1 ml of blocking solution for 1 hr (vortex every 15 min to prevent cell
settling).
7. PELLET: Dilute with working buffer solution, centrifuge and aspirate.
8. STAINING PREPARATION: Add 400 µl of working buffer solution and split tubes if
appropriate.
9. PRIMARY STAINING: To all tubes, except controls, add primary antibody in 400ul
(optimized dilution amount). Incubate at 4◦C for 30 min.
10. PELLET: Dilute w/ working buffer solution, centrifuge and aspirate.
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11. SECONDAY STAINING: To all tubes, except appropriate controls, add secondary
antibody (optimized dilution amount). Incubate at 4◦C for 30 min.
12. PELLET: Dilute w/ working buffer solution, centrifuge, and aspirate.
13. WASH: Add 1 ml working buffer solution, centrifuge and aspirate.
14. FINAL SAMPLE PREPARATION: Reconstitute all tubes to 0.5 ml with working buffer
solution. Filter to remove particles ≥0.5µm using blue-capped filter sterilizing test
tubes.
15. Run samples on BD LSR. Normalize FSC and SS voltages to ensure the cell pop-
ulation falls within the scale. Normalize fluor voltage to ensure signal is distributed




Basic immunostain protocol for monolayer cells:
1. Wash slides with PBS (3 x 5 min in excess PBS)
2. Permeabilize if needed (if antigen is intracellular and/or if you want to use a nuclear
counterstain) (0.05% triton-x detergent solution used for cell monolayers; incubate at
RT. For tissue sections, can boil in sodium citrate solution to unmask antigen (e.g.,
using a pressure cooker).
3. Wash well with PBS. (3 x 5 min in excess PBS)
4. Pap pen [hydrophobic barrier pen, e.g., available from Vector Labs, etc.] around
section (can be done during PBS washes or, if crunched for time, after the block
step). Be sure pap pen holds liquid within boundary well.
5. Block with 5% serum in PBS, using serum from the species in which your secondary
antibody was made.
6. There is no need to wash between block and primary, since these are in the same
diluent.
7. Primary incubation. Use as little volume as possible so you are confident sample is
uniformly covered, but that you dont need to waste any primary antibody. In Nerem
lab, 1/100 standard primary dilution often used; can get better staining and resulting
images though (and save on antibody use) by optimizing the dilution used. (2 hr at
RT or o/n at 4◦C)
8. Wash well. (3 x 5 min in excess PBS)
9. Secondary incubation. Standard AlexaFluor secondaries can be diluted 1/100. Nu-
clear counterstain such as DAPI or Hoechst 33258 can be included at this time.
1/1000 works ok if you want only dull Hoechst counterstain; for brighter counterstain,
use 1̃/200 dilution. (1 hr at RT)
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10. Wash well. (3 x 5 min in excess PBS)
11. Remove pap pen with clean, sharp razor blade.
12. Coverslip. Add coverslipping media. Add coverslip (If using confocal imaging, make
sure you have thin coverslips on, otherwise, focal plane will be in coverslip rather
than in area of cells.). Use forceps to push out any air bubbles trapped between slide
and cover slip.
13. Image (fluorescence: confocal, multi-photon confocal, histology; brightfield: histol-
ogy)
14. If desired, after slides have dried completely, nailpolish around the outside of the
coverslip area to ensure further evaporation doesnt happen.
15. Store fluorescent-stained slides at 4◦C. Store visible light-stained slides at RT.
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APPENDIX C
SUPPORTING DOCUMENTATION: MESENCHYMAL STEM CELLS
REARRANGE INTO MULTICELLULAR CLUSTERS IN RESPONSE TO
EQUIBIAXIAL CYCLIC STRAIN
For additional information on the response of MSCs to applied equibiaxial cyclic strain,
please refer to:
Doyle, A.M. textitet al). underlineHuman mesenchymal stem cells form multicellular
structures in response to applied cyclic strain. Ann Biomed Eng. 2009. Apr; 37(4):783-93.
[67]
This study describes cellular rearrangements of MSCs into multicellular ‘knobs’ or ‘clus-
ters’ with 48 hours applied cyclic strain (10%, 1 Hz) on gelatin-coated silicone. No marked
changes in cytoskeletal filament expression or organization were visible in samples ex-
posed to strain, suggesting other signal transduction mechanisms may regulate multicel-
lular structure formation. This finding motivated subsequent MSCs and SMCs compara-
tive signaling studies (Chapers 3 and 4), to better determine which networks are involved
in MSCs response to cyclic strain. Doyle et al also demonstrated the dependence of
MSCs response to cyclic strain on the underlying protein substrate. Dependence of cell
mechanoresponse on underling protein substrate was also observed in MSCs exposed to




D.1 Cyclic Strain-Responsive Microarrays
D.1.1 Conserved Strain-Responsive Genes
Table 14: Genes with conserved strain-responses in MSCs and SMCs. 442 genes
were significantly (p < 0.05) strain-responsive according to ANOVA force-dependence,
SMC paired t-test, and MSC paired t-test calculations. Genbank accession numbers,
gene descriptions, chromosome locations, and Gene Ontology categorizations are listed















A_23_P131375 NM_152391 PQLC3 NM_152391 Homo sapiens PQ loop repeat containing 3 
(PQLC3), mRNA [NM_152391]
chr2 GO:0016020(membrane);GO:0016021(integral to membrane)















A_24_P127051 A_24_P127051 A_24_P127051 chr6
































A_23_P250982 NM_016048 ISOC1 NM_016048 Homo sapiens isochorismatase domain containing 
1 (ISOC1), mRNA [NM_016048]
chr5 GO:0008152(metabolic process) GO:0005777(peroxisome) GO:0003824(catalytic activity)


































A_23_P94533 NM_001912 CTSL1 NM_001912 Homo sapiens cathepsin L1 (CTSL1), transcript 
variant 1, mRNA [NM_001912]
chr9 GO:0006508(proteolysis) GO:0005576(extracellular region);GO:0005764(lysosome) GO:0004197(cysteine‐type endopeptidase 
activity);GO:0004217(cathepsin L activity)
A_24_P68908 BX640843 LOC344887 BX640843
Homo sapiens mRNA; cDNA DKFZp686B14224 
(from clone DKFZp686B14224). [BX640843] chr3
Homo sapiens KIT ligand (KITLG) transcript
GO:0007155(cell adhesion);GO:0007165(signal 
t d ti ) GO 0008283( ll
GO:0005886(plasma  GO:0005173(stem cell factor receptor 
A_24_P133253 NM_000899 KITLG NM_000899
        ,   
variant b, mRNA [NM_000899] chr12




















































A_23_P14458 NM_144581 C14orf149 NM_144581
Homo sapiens chromosome 14 open reading 
frame 149 (C14orf149), mRNA [NM_144581] chr14
























A_32_P38637 NM_032534 KRBA1 NM_032534 Homo sapiens KRAB‐A domain containing 1 
(KRBA1), mRNA [NM_032534]
chr7 GO:0006355(regulation of transcription, DNA‐dependent) GO:0005622(intracellular) GO:0003676(nucleic acid binding)
A_23_P81811 NM_080604 TJAP1 NM_080604
Homo sapiens tight junction associated protein 1 
(peripheral) (TJAP1), mRNA [NM_080604] chr6 GO:0005923(tight junction) GO:0005515(protein binding)





A_23_P370682 NM_138456 BATF2 NM_138456
Homo sapiens basic leucine zipper transcription 
factor, ATF‐like 2 (BATF2), mRNA [NM_138456] chr11 GO:0006355(regulation of transcription, DNA‐dependent) GO:0005634(nucleus)
GO:0003700(transcription factor 
activity);GO:0046983(protein dimerization activity)



























A_24_P271527 NM_014876 JOSD1 NM_014876 Homo sapiens Josephin domain containing 1 
(JOSD1), mRNA [NM_014876]
chr22














A_23_P127484 NM_018219 CCDC87 NM_018219
Homo sapiens coiled‐coil domain containing 87 
(CCDC87), mRNA [NM_018219] chr11































A_24_P110201 A_24_P110201 A_24_P110201 chr4













A_24_P186664 A_24_P186664 A_24_P186664 chr1



















A_23_P18082 NM_032806 C3orf39 NM_032806
Homo sapiens chromosome 3 open reading frame 
39 (C3orf39), mRNA [NM_032806] chr3 GO:0016740(transferase activity)
A_24_P170983 NM_194312 ESPNL NM_194312 Homo sapiens espin‐like (ESPNL), mRNA 
[NM_194312]
chr2
A_23_P121898 NM_024615 PARP8 NM_024615
Homo sapiens poly (ADP‐ribose) polymerase 










































































A_23_P15450 NM_018286 TMEM100 NM_018286 Homo sapiens transmembrane protein 100 
(TMEM100), mRNA [NM_018286]
chr17 GO:0016020(membrane);GO:0016021(integral to membrane)
A_24_P305678 NM_012399 PITPNB NM_012399
Homo sapiens phosphatidylinositol transfer 
protein, beta (PITPNB), mRNA [NM_012399] chr22 GO:0006629(lipid metabolic process);GO:0006810(transport) GO:0005622(intracellular)
GO:0008289(lipid binding);GO:0008526(phosphatidylinositol 
transporter activity)






























process) GO 0006916(anti apoptosis) GO 0006979(response GO 0000287(magnesium ion binding) GO 0004357(glutamate


























































































A_23_P204511 NM_017842 FLJ20489 NM_017842 Homo sapiens hypothetical protein FLJ20489 
(FLJ20489), mRNA [NM_017842]
chr12
A_23_P211561 NM_152513 RP5‐821D11.2 NM_152513 Homo sapiens meiosis defective 1 (MEI1), mRNA 
[NM_152513]
chr22













































A_24_P281683 XR_018569 LOC441623 XR_018569
PREDICTED: Homo sapiens hypothetical 
LOC441623 (LOC441623), mRNA [XR_018569] chr11
A_24_P171983 NM_014165 C6orf66 NM_014165
Homo sapiens chromosome 6 open reading frame 
66 (C6orf66), mRNA [NM_014165] chr6

































































































A_23_P309361 NM_144584 C1orf59 NM_144584
Homo sapiens chromosome 1 open reading frame 
59 (C1orf59), mRNA [NM_144584] chr1




































































































A_23_P23669 NM_017734 PALMD NM_017734 Homo sapiens palmdelphin (PALMD), mRNA 
[NM_017734]
chr1 GO:0008360(regulation of cell shape) GO:0016020(membrane)









































A_24_P296808 NM_018215 FLJ10781 NM_018215 Homo sapiens hypothetical protein FLJ10781 
(FLJ10781), mRNA [NM_018215]
chr19
A_23_P352402 NM_153256 C10orf47 NM_153256
Homo sapiens chromosome 10 open reading 
frame 47 (C10orf47), mRNA [NM_153256] chr10


































A_23_P325690 NM_144698 ANKRD35 NM_144698 Homo sapiens ankyrin repeat domain 35 
(ANKRD35), mRNA [NM_144698]
chr1
























































































































































































A_23_P256231 NM_032145 FBXO30 NM_032145 Homo sapiens F‐box protein 30 (FBXO30), mRNA 
[NM_032145]
chr6 GO:0006512(ubiquitin cycle) GO:0008270(zinc ion binding);GO:0046872(metal ion binding)





















































A_24_P659113 NM_152523 CCNYL1 NM_152523 Homo sapiens cyclin Y‐like 1 (CCNYL1), mRNA 
[NM_152523]
chr2 GO:0000074(regulation of progression through cell cycle)













A_24_P503669 AK093628 AK093628 AK093628 Homo sapiens cDNA FLJ36309 fis, clone 
THYMU2004986. [AK093628]
chr15



















































A_24_P941649 AL834189 VPS37A AL834189 Homo sapiens mRNA; cDNA DKFZp762I185 (from 
clone DKFZp762I185). [AL834189]
chr8



































A_23_P103232 NM_017823 DUSP23 NM_017823
Homo sapiens dual specificity phosphatase 23 


























































































A_23_P416289 NM_033425 DIXDC1 NM_033425
Homo sapiens DIX domain containing 1 (DIXDC1), 
transcript variant 2, mRNA [NM_033425] chr11 GO:0007275(multicellular organismal development) GO:0005622(intracellular) GO:0004871(signal transducer activity)
A_23_P85952 NM_024901 DENND2D NM_024901
Homo sapiens DENN/MADD domain containing 2D 
(DENND2D), mRNA [NM_024901] chr1











































A_24_P924697 AK055915 AK055915 AK055915 Homo sapiens cDNA FLJ31353 fis, clone 
MESAN2000264. [AK055915]
chr2
A_24_P21831 NM_019591 ZNF26 NM_019591 Homo sapiens zinc finger protein 26 (ZNF26), 
mRNA [NM_019591]
chr12 GO:0006355(regulation of transcription, DNA‐dependent) GO:0005622(intracellular);GO:0005634(nucleus) GO:0003676(nucleic acid binding);GO:0008270(zinc ion 
binding);GO:0046872(metal ion binding)
A_23_P36266 NM_003477 PDHX NM_003477
Homo sapiens pyruvate dehydrogenase complex, 
component X (PDHX), mRNA [NM_003477] chr11 GO:0008152(metabolic process) GO:0005739(mitochondrion)
GO:0005515(protein binding);GO:0008415(acyltransferase 
activity);GO:0031405(lipoic acid binding)



















































A_32_P167212 A_32_P167212 A_32_P167212 chr6
















chr6 GO:0006810(transport) GO:0016020(membrane);GO:0016021(integral to membrane) GO:0005215(transporter activity)
































































































A_23_P205713 NM_014178 STXBP6 NM_014178 Homo sapiens syntaxin binding protein 6 (amisyn) 
(STXBP6), mRNA [NM_014178]
chr14 GO:0016192(vesicle‐mediated transport) GO:0016021(integral to membrane)

















































A_23_P88163 NM_018036 C14orf103 NM_018036
Homo sapiens chromosome 14 open reading 
frame 103 (C14orf103), mRNA [NM_018036] chr14




chr11 GO:0007154(cell communication) GO:0005622(intracellular) GO:0003674(molecular_function)
A_23_P61371 NM_198282 TMEM173 NM_198282 Homo sapiens transmembrane protein 173 
(TMEM173), mRNA [NM_198282]
chr5 GO:0016020(membrane);GO:0016021(integral to membrane)



































A_23_P212339 NM_024513 FYCO1 NM_024513
Homo sapiens FYVE and coiled‐coil domain 
containing 1 (FYCO1), mRNA [NM_024513] chr3 GO:0006810(transport) GO:0016021(integral to membrane) GO:0008270(zinc ion binding);GO:0046872(metal ion binding)







A_32_P111524 BC033539 BC033539 BC033539 Homo sapiens cDNA clone IMAGE:4819052. 
[BC033539]
chr12














































































































A_24_P36868 NM_025160 WDR26 NM_025160 Homo sapiens WD repeat domain 26 (WDR26), 
mRNA [NM_025160]
chr1 GO:0005737(cytoplasm)
A_23_P22614 NM_145802 6‐Sep NM_145802
Homo sapiens septin 6 (SEPT6), transcript variant 
V, mRNA [NM_145802] chrX GO:0000910(cytokinesis);GO:0007049(cell cycle) GO:0005575(cellular_component)
GO:0000166(nucleotide binding);GO:0005515(protein 
binding);GO:0005525(GTP binding)

























































A_24_P150874 BX647930 BX647930 BX647930
Homo sapiens mRNA; cDNA DKFZp686I20201 
(from clone DKFZp686I20201). [BX647930] chr17
A_32_P151933 THC2638232 THC2638232 Q7RQ28_PLAYO (Q7RQ28) Nuclear protein snf7, 
partial (7%) [THC2638232]
chr18













A_24_P329795 NM_007021 C10orf10 NM_007021
Homo sapiens chromosome 10 open reading 
frame 10 (C10orf10), mRNA [NM_007021] chr10 GO:0005739(mitochondrion)
A_23_P255331 NM_032623 OSAP NM_032623 Homo sapiens ovary‐specific acidic protein 
(OSAP), mRNA [NM_032623]
chr4

























A_23_P137035 NM_003662 PIR NM_003662
Homo sapiens pirin (iron‐binding nuclear protein) 
(PIR), transcript variant 1, mRNA [NM_003662] chrX GO:0006366(transcription from RNA polymerase II promoter) GO:0005634(nucleus)
GO:0003712(transcription cofactor activity);GO:0005506(iron 
ion binding);GO:0046872(metal ion binding)









A_32_P4882 A_32_P4882 A_32_P4882 chr4
A_23_P324340 NM_033510 DISP2 NM_033510 Homo sapiens dispatched homolog 2 (Drosophila) 
(DISP2), mRNA [NM_033510]
chr15





















































A_23_P6762 NM_032492 JAGN1 NM_032492 Homo sapiens jagunal homolog 1 (Drosophila) 
(JAGN1), mRNA [NM_032492]
chr3





























A_24_P916288 AK026497 AK026497 AK026497 Homo sapiens cDNA: FLJ22844 fis, clone 
KAIA5181. [AK026497]
chr14




A_23_P39766 NM_014905 GLS NM_014905 Homo sapiens glutaminase (GLS), mRNA 
[NM_014905]
chr2 GO:0006543(glutamine catabolic process) GO:0005739(mitochondrion) GO:0004359(glutaminase activity);GO:0016787(hydrolase 
activity)

































A_24_P825942 AK001796 LOC541471 AK001796 Homo sapiens cDNA FLJ10934 fis, clone 
OVARC1000640. [AK001796]
chr2

























































A_24_P40551 NM_001080425 BEXL1 NM_001080425 Homo sapiens brain expressed X‐linked‐like 1 
(BEXL1), mRNA [NM_001080425]
chrX GO:0005634(nucleus)
A_23_P390744 NM_144600 C16orf63 NM_144600
Homo sapiens chromosome 16 open reading 
frame 63 (C16orf63), mRNA [NM_144600] chr16
























A_23_P374322 NM_153218 C13orf31 NM_153218
Homo sapiens chromosome 13 open reading 
frame 31 (C13orf31), mRNA [NM_153218] chr13












A_23_P136724 BX640843 LOC344887 BX640843
Homo sapiens mRNA; cDNA DKFZp686B14224 
(from clone DKFZp686B14224). [BX640843] chr3
A_32_P157671 A_32_P157671 A_32_P157671 chr17
















A_23_P10232 NM_017935 BANK1 NM_017935
Homo sapiens B‐cell scaffold protein with ankyrin 
repeats 1 (BANK1), mRNA [NM_017935] chr4 GO:0042113(B cell activation)
A_23_P78685 NM_004461 FARSA NM_004461
Homo sapiens phenylalanyl‐tRNA synthetase, 

























































A_24_P887092 THC2645879 THC2645879 chr11






























A_23_P163306 NM_032866 CGNL1 NM_032866 Homo sapiens cingulin‐like 1 (CGNL1), mRNA 
[NM_032866]
chr15 GO:0016459(myosin complex) GO:0003774(motor activity)





A_23_P134395 NM_012453 TBL2 NM_012453 Homo sapiens transducin (beta)‐like 2 (TBL2), 
mRNA [NM_012453]
chr7 GO:0008150(biological_process) GO:0005575(cellular_component) GO:0003674(molecular_function)















































A_23_P21785 NM_022072 NSUN3 NM_022072
Homo sapiens NOL1/NOP2/Sun domain family, 
member 3 (NSUN3), mRNA [NM_022072] chr3















































































A_23_P302005 NM_006873 STON1 NM_006873 Homo sapiens stonin 1 (STON1), mRNA 
[NM_006873]
chr2









A_23_P132560 NM_145037 FAM55C NM_145037
Homo sapiens family with sequence similarity 55, 
member C (FAM55C), mRNA [NM_145037] chr3
A_32_P300427 NM_153360 APCDD1L NM_153360
Homo sapiens adenomatosis polyposis coli down‐
regulated 1‐like (APCDD1L), mRNA [NM_153360] chr20 GO:0016020(membrane);GO:0016021(integral to membrane)
























































A_24_P409881 XM_291989 LOC338756 XM_291989
PREDICTED: Homo sapiens similar to nucleolar 
protein 5A (LOC338756), mRNA [XM_291989] chr12




























































































A_23_P40548 NM_013313 YPEL1 NM_013313 Homo sapiens yippee‐like 1 (Drosophila) (YPEL1), 
mRNA [NM_013313]
chr22 GO:0005634(nucleus)
A_23_P203115 NM_032780 TMEM25 NM_032780 Homo sapiens transmembrane protein 25 
(TMEM25), mRNA [NM_032780]
chr11 GO:0016020(membrane);GO:0016021(integral to membrane)





















A_32_P226858 THC2557016 THC2557016 Q3F710_9BURK (Q3F710) Inner‐membrane 
translocator, partial (6%) [THC2557016]
chr1
A_23_P63459 NM_001012985 C1orf31 NM_001012985
Homo sapiens chromosome 1 open reading frame 
31 (C1orf31), mRNA [NM_001012985] chr1 GO:0006118(electron transport) GO:0005739(mitochondrion) GO:0004129(cytochrome‐c oxidase activity)
A_32_P82293 A_32_P82293 A_32_P82293 chr6
A_23_P33511 AX721087 AX721087 AX721087 Sequence 47 from Patent WO0220754. 
[AX721087]
chr8















A_24_P298179 A_24_P298179 A_24_P298179 chr9
A_32_P13823 THC2719076 THC2719076 chr3







A_32_P190316 THC2645336 THC2645336 chr6












A_32_P188860 NM_017563 IL17RD NM_017563
Homo sapiens interleukin 17 receptor D (IL17RD), 
transcript variant 2, mRNA [NM_017563] chr3 GO:0016020(membrane);GO:0016021(integral to membrane) GO:0004888(transmembrane receptor activity)































































A_23_P337729 NM_024789 TMEM180 NM_024789 Homo sapiens transmembrane protein 180 
(TMEM180), mRNA [NM_024789]
chr10 GO:0016020(membrane);GO:0016021(integral to membrane)






































































A_24_P860797 ENST00000244221 PAIP2B Homo sapiens cDNA FLJ37016 fis, clone 
BRACE2010632. [AK094335]
chr2




















A 23 P308800 AF158555 GLS AF158555 Homo sapiens glutaminase C mRNA, complete cds. 
[AF158555]




A_24_P163237 NM_020225 STOX2 NM_020225 Homo sapiens storkhead box 2 (STOX2), mRNA 
[NM_020225]
chr4

































A_23_P143374 NM_025176 RP4‐691N24.1 NM_025176 Homo sapiens KIAA0980 protein (KIAA0980), 
mRNA [NM_025176]
chr20 GO:0005874(microtubule) GO:0005509(calcium ion binding)
A_32_P108156 NR_001458 BIC NR_001458 Homo sapiens BIC transcript (BIC) on chromosome 
21 [NR_001458]
chr21









A_32_P135336 NR_002556 LOC388242 NR_002556
Homo sapiens LOC112869 pseudogene 
(LOC388242) on chromosome 16 [NR_002556] chr16
























A_23_P253012 NM_017577 GRAMD1C NM_017577 Homo sapiens GRAM domain containing 1C 
(GRAMD1C), mRNA [NM_017577]
chr3
A_24_P354651 NM_153354 TMEM161B NM_153354 Homo sapiens transmembrane protein 161B 
(TMEM161B), mRNA [NM_153354]
chr5 GO:0016021(integral to membrane)




























































































Homo sapiens transmembrane protein 111A_23_P69226 NM_018447 TMEM111 NM_018447          
(TMEM111), mRNA [NM_018447]
chr3 GO:0016020(membrane);GO:0016021(integral to membrane)
A_24_P278167 NM_006007 ZFAND5 NM_006007
Homo sapiens zinc finger, AN1‐type domain 5 




A_24_P755069 A_24_P755069 A_24_P755069 chr9
A_32_P146815 BC062473 BC062473 BC062473 Homo sapiens cDNA clone IMAGE:30374677, 
partial cds. [BC062473]
chr12
A_23_P29655 NM_020685 C3orf14 NM_020685
Homo sapiens chromosome 3 open reading frame 
14 (C3orf14), mRNA [NM_020685] chr3





































A_32_P226646 THC2661917 THC2661917 chr16

































































































A_32_P206949 NM_198276 TMEM17 NM_198276 Homo sapiens transmembrane protein 17 
(TMEM17), mRNA [NM_198276]
chr2 GO:0016020(membrane);GO:0016021(integral to membrane)






















A_23_P78053 NM_030802 FAM117A NM_030802
Homo sapiens family with sequence similarity 117, 
member A (FAM117A), mRNA [NM_030802] chr17

























































A_23_P46351 NM_006862 TDRKH NM_006862 Homo sapiens tudor and KH domain containing 
(TDRKH), mRNA [NM_006862]
chr1 GO:0016020(membrane) GO:0003723(RNA binding)















A_24_P258073 NM_021830 PEO1 NM_021830
Homo sapiens progressive external 




A_23_P200073 NM_020362 C1orf128 NM_020362
Homo sapiens chromosome 1 open reading frame 
128 (C1orf128), mRNA [NM_020362] chr1
A_23_P65983 NM_033212 CCDC102A NM_033212
Homo sapiens coiled‐coil domain containing 102A 
(CCDC102A), mRNA [NM_033212] chr16













































chr11 GO:0007154(cell communication) GO:0005622(intracellular) GO:0003674(molecular_function)
A_23_P129005 NM_025081 KIAA1305 NM_025081 Homo sapiens KIAA1305 (KIAA1305), mRNA 
[NM_025081]
chr14 GO:0015074(DNA integration) GO:0003677(DNA binding)



























A_23_P426021 NM_015187 KIAA0746 NM_015187 Homo sapiens KIAA0746 protein (KIAA0746), 
mRNA [NM_015187]
chr4 GO:0005488(binding)



























A_23_P143885 NM_019555 ARHGEF3 NM_019555
Homo sapiens Rho guanine nucleotide exchange 


















































A_23_P61987 NM_025268 TMEM121 NM_025268 Homo sapiens transmembrane protein 121 
(TMEM121), mRNA [NM_025268]
chr14 GO:0016020(membrane);GO:0016021(integral to membrane)
















A_32_P4608 A_32_P4608 A_32_P4608 chr5
































A_23_P374315 NM_153218 C13orf31 NM_153218
Homo sapiens chromosome 13 open reading 
frame 31 (C13orf31), mRNA [NM_153218] chr13
A_23_P77223 NM_018670 MESP1 NM_018670
Homo sapiens mesoderm posterior 1 homolog 
(mouse) (MESP1), mRNA [NM_018670] chr15 GO:0045449(regulation of transcription) GO:0005634(nucleus) GO:0030528(transcription regulator activity)












A_23_P122174 NM_022550 XRCC4 NM_022550
Homo sapiens X‐ray repair complementing 
defective repair in Chinese hamster cells 4 





,      ,    _












A_23_P21473 NM_024491 CEP70 NM_024491 Homo sapiens centrosomal protein 70kDa 
(CEP70), mRNA [NM_024491]
chr3
A_24_P134488 NM_052880 PIK3IP1 NM_052880 Homo sapiens HGFL gene (MGC17330), mRNA 
[NM_052880]
chr22 GO:0016020(membrane);GO:0016021(integral to membrane)
A_23_P68966 AK090725 AK090725 AK090725 Homo sapiens cDNA FLJ33406 fis, clone 
BRACE2010477. [AK090725]
chr22


















A_23_P408195 NM_152399 TMEM155 NM_152399 Homo sapiens transmembrane protein 155 
(TMEM155), mRNA [NM_152399]
chr4























A_24_P74828 AF348994 MT1JP AF348994 Homo sapiens MTB (MTB) mRNA, complete cds. 
[AF348994]
chr16 GO:0046872(metal ion binding)





A_23_P45324 NM_021637 TMEM35 NM_021637 Homo sapiens transmembrane protein 35 
(TMEM35), mRNA [NM_021637]
chrX GO:0016020(membrane);GO:0016021(integral to membrane)









A_23_P93938 ENST00000258775 NACAD Homo sapiens mRNA for KIAA0363 gene, partial 
cds. [AB002361]
chr7 GO:0015031(protein transport) GO:0005634(nucleus)
A_24_P193509 NM_144600 C16orf63 NM_144600
Homo sapiens chromosome 16 open reading 
frame 63 (C16orf63), mRNA [NM_144600] chr16
















A_23_P94434 NM_001039792 UNQ338 NM_001039792 Homo sapiens LGLL338 (LOC646962), mRNA 
[NM_001039792]
chr9
A_23_P147495 NM_021946 BCORL1 NM_021946 Homo sapiens BCL6 co‐repressor‐like 1 (BCORL1), 
mRNA [NM_021946]
chrX















A_23_P341223 NM_014851 KLHL21 NM_014851 Homo sapiens kelch‐like 21 (Drosophila) (KLHL21), 
mRNA [NM_014851]
chr1 GO:0005515(protein binding)






















































A_32_P149416 BG001037 BG001037 BG001037
BG001037 RC5‐GN0132‐131100‐012‐E05 GN0132 
Homo sapiens cDNA, mRNA sequence [BG001037] chr12
A_24_P767725 XR_017120 LOC646090 XR_017120
PREDICTED: Homo sapiens similar to rhophilin‐like 
protein (LOC646090), mRNA [XR_017120] chr15







































A_23_P332326 NM_153213 ARHGEF19 NM_153213
Homo sapiens Rho guanine nucleotide exchange 


















A_23_P358597 NM_022361 POPDC3 NM_022361
Homo sapiens popeye domain containing 3 
(POPDC3), mRNA [NM_022361] chr6 GO:0008150(biological_process) GO:0016020(membrane);GO:0016021(integral to membrane) GO:0003674(molecular_function)









D.2 Shear Stress-Responsive Microarrays
D.2.1 Conserved Shear Stress-Responsive Genes
193
Table 15: Conserved shear-responsive genes identified using two factor ANOVA and
paired t-tests of ECs and MSCs. ‘Conserved’ shear-responsive genes were defined as
those meeting three criteria: (1) significant force-dependent gene expression (two factor
ANOVA corrected p-value< 0.05), (2) significant (paired t-test p< 0.05) regulation change
of at least 1.5-fold in ECs, and (3) significant (paired t-test p< 0.05) regulation change of
at least 1.5-fold in MSCs. 574 probes met all three criteria, including 37 with no GenBank
Accession information and 91 instances of duplicate genes due to different microarray
probes. The following information is listed, as available, for each probe: identifying infor-
mation (Agilent Probe Name, common name, gene symbol, GenBank Accession number,
gene description), genomic position (chromosome number), and Gene Ontology associa-









A_23_P170719 A_23_P170719 A_23_P170719 chr19
A_32_P4882 A_32_P4882 A_32_P4882 chr4
A_32_P75141 A_32_P75141 A_32_P75141 chr1














































































































































































A_23_P352426 NM_006382 CDRT1 NM_006382
Homo sapiens CMT1A duplicated region 
transcript 1 (CDRT1), mRNA [NM_006382]
chr17 GO:0008150(biological_process) GO:0005575(cellular_component) GO:0003674(molecular_function)






































A_23_P354297 NM_022092 CHTF18 NM_022092
Homo sapiens CTF18, chromosome 
transmission fidelity factor 18 homolog (S. 
cerevisiae) (CHTF18), mRNA [NM 022092]
chr16 GO:0000166(nucleotide binding);GO:0004386(helicase 
activity);GO:0005524(ATP binding);GO:0017111(nucleoside‐
triphosphatase activity)      _  


































































































































































chr20 GO:0006260(DNA replication) GO:0005634(nucleus);GO:0005737(cytoplasm) GO:0005515(protein binding)






















r activity);GO:0045028(purinergic nucleotide receptor activity, G‐_          
protein coupled)













































































































































































A 23 P396800 NM 173808 NEGR1 NM 173808
Homo sapiens neuronal growth regulator 1 
(NEGR1), mRNA [NM 173808]
chr1 GO:0007155(cell adhesion) GO:0016020(membrane) GO:0005515(protein binding);GO:0048503(GPI anchor binding)
_ _ _ _     _










































































































































































protein signaling pathway);GO:0009968(negative regulation of
GO:0004871(signal transducer activity);GO:0005096(GTPase 
activator activity);GO:0005516(calmodulin binding)
_ _ _ _          
signal transduction)




chr22 GO:0006935(chemotaxis);GO:0007596(blood coagulation) GO:0005576(extracellular region) GO:0004867(serine‐type endopeptidase inhibitor 
activity);GO:0008201(heparin binding)















































































chr2 GO:0008631(induction of apoptosis by oxidative stress) GO:0005575(cellular_component) GO:0003674(molecular_function);GO:0008270(zinc ion 
binding);GO:0016491(oxidoreductase activity)



























































A_24_P195454 A_24_P195454 A_24_P195454 chr1
A_24_P221285 A_24_P221285 A_24_P221285 chrX
A_24_P221475 A_24_P221475 A_24_P221475 chr7
A_24_P233560 A_24_P233560 A_24_P233560
A_24_P50139 A_24_P50139 A_24_P50139 chr17
A_24_P655888 A_24_P655888 A_24_P655888 chr8
A 24 P84711 A 24 P84711 A 24 P84711 chr7
Significantly Shear‐Responsive Genes, 0.01<p<0.05 (ANOVA corrected pForce<0.05; EC paired t‐test p<0.05; MSC paired t‐test p<0.05) ‐ 474 genes
_ _ _ _ _ _
A_32_P128399 A_32_P128399 A_32_P128399 chr2
A_32_P132169 A_32_P132169 A_32_P132169 chr10
A_32_P149735 A_32_P149735 A_32_P149735 chr19
A_32_P157671 A_32_P157671 A_32_P157671 chr17
A_32_P169243 A_32_P169243 A_32_P169243 chr5
A_32_P171043 A_32_P171043 A_32_P171043 chr18
A_32_P196142 A_32_P196142 A_32_P196142 chr18


































chr11 GO:0001558(regulation of cell growth) GO:0005575(cellular_component) GO:0003674(molecular_function);GO:0005515(protein binding)












































































































Homo sapiens angiopoietin‐like 4 chr19 GO:0001525(angiogenesis);GO:0001666(response to GO:0005576(extracellular region);GO:0005615(extracellular GO:0004857(enzyme inhibitor activity);GO:0005102(receptor
A_23_P159325 NM_139314 ANGPTL4 NM_139314























































































chr15 GO:0007165(signal transduction) GO:0005622(intracellular) GO:0005096(GTPase activator activity)




chr15 GO:0007165(signal transduction) GO:0005622(intracellular) GO:0005096(GTPase activator activity)














































































chr11 GO:0006355(regulation of transcription, DNA‐dependent) GO:0005634(nucleus) GO:0003700(transcription factor activity);GO:0046983(protein 
dimerization activity)










































































































































































































chr19 GO:0007275(multicellular organismal development) GO:0005575(cellular_component) GO:0003674(molecular_function);GO:0005515(protein binding)














chr21 GO:0008150(biological_process) GO:0005575(cellular_component) GO:0003674(molecular_function)

























chr9 GO:0035023(regulation of Rho protein signal transduction) GO:0005622(intracellular) GO:0005085(guanyl‐nucleotide exchange factor 
activity);GO:0005089(Rho guanyl‐nucleotide exchange factor 
activity)






















chr15 GO:0001675(acrosome formation) GO:0001669(acrosome);GO:0005634(nucleus) GO:0005515(protein binding)





















































chr18 GO:0006817(phosphate transport) GO:0005737(cytoplasm) GO:0005509(calcium ion binding)










































































































































Homo sapiens cyclin‐dependent kinase chr1 GO:0007049(cell cycle);GO:0007050(cell cycle GO:0005634(nucleus);GO:0005737(cytoplasm) GO:0004861(cyclin‐dependent protein kinase inhibitor
A_23_P85460 NM_001262 CDKN2C NM_001262





       
activity);GO:0005515(protein binding)




























































































































































































































































































































A_23_P1552 NM_001814 CTSC NM_001814
Homo sapiens cathepsin C (CTSC), 
transcript variant 1, mRNA [NM_001814]




A_24_P115762 NM_148170 CTSC NM_148170
Homo sapiens cathepsin C (CTSC), 
transcript variant 2, mRNA [NM_148170]








































































































































































































































Homo sapiens E2F transcription factor 1 chr20 GO:0000074(regulation of progression through cell GO:0005634(nucleus);GO:0005667(transcription factor GO:0003700(transcription factor
A_23_P80032 NM_005225 E2F1 NM_005225
           
(E2F1), mRNA [NM_005225]























































chr3 GO:0006355(regulation of transcription, DNA‐dependent) GO:0005622(intracellular) GO:0003676(nucleic acid binding)









A_24_P11384 NM_018948 ERRFI1 NM_018948
Homo sapiens ERBB receptor feedback 
inhibitor 1 (ERRFI1), mRNA [NM_018948]
chr1 GO:0006950(response to stress) GO:0005737(cytoplasm) GO:0005100(Rho GTPase activator 
activity);GO:0005515(protein binding)




chr8 GO:0007049(cell cycle) GO:0005634(nucleus) GO:0008270(zinc ion binding);GO:0008415(acyltransferase 
activity);GO:0016740(transferase activity);GO:0046872(metal 
ion binding)

































chr3 GO:0001558(regulation of cell growth) GO:0005634(nucleus) GO:0003674(molecular_function);GO:0005515(protein binding)


























Homo sapiens family with sequence chr1 GO:0016020(membrane);GO:0016021(integral to
A_23_P51376 NM_024522 FAM77C NM_024522





























































































































A_23_P42969 NM_006682 FGL2 NM_006682
Homo sapiens fibrinogen‐like 2 (FGL2), 
mRNA [NM_006682]
chr7 GO:0007165(signal transduction) GO:0005577(fibrinogen complex) GO:0005102(receptor binding)





A_24_P38081 NM_004117 FKBP5 NM_004117
Homo sapiens FK506 binding protein 5 
(FKBP5), mRNA [NM_004117]
chr6 GO:0006457(protein folding) GO:0005634(nucleus) GO:0003755(peptidyl‐prolyl cis‐trans isomerase 
activity);GO:0005515(protein binding);GO:0005528(FK506 
binding);GO:0016853(isomerase activity)




















chr7 GO:0007156(homophilic cell adhesion) GO:0016020(membrane) GO:0005509(calcium ion binding)












































































































A_23_P39766 NM_014905 GLS NM_014905
Homo sapiens glutaminase (GLS), mRNA 
[NM_014905]
chr2 GO:0006543(glutamine catabolic process) GO:0005739(mitochondrion) GO:0004359(glutaminase activity);GO:0016787(hydrolase 
activity)
A_24_P294233 NM_014905 GLS NM_014905
Homo sapiens glutaminase (GLS), mRNA 
[NM_014905]
chr2 GO:0006543(glutamine catabolic process) GO:0005739(mitochondrion) GO:0004359(glutaminase activity);GO:0016787(hydrolase 
activity)


























































































































































































































































































chr2 GO:0005975(carbohydrate metabolic process) GO:0005737(cytoplasm) GO:0004454(ketohexokinase activity);GO:0005515(protein 
binding);GO:0016301(kinase activity);GO:0016740(transferase 
activity)



































































































































chr17 GO:0007018(microtubule‐based movement) GO:0005875(microtubule associated complex) GO:0003777(microtubule motor activity);GO:0005524(ATP 
binding)
Homo sapiens hypothetical protein chr4
A_23_P41476 NM_001080505 LOC152573 NM_001080505
       
BC012029 (LOC152573), mRNA 
[NM_001080505]










































































































































Homo sapiens MCM8 minichromosome chr20 GO:0006260(DNA replication);GO:0006270(DNA replication GO:0005634(nucleus) GO:0000166(nucleotide binding);GO:0003677(DNA
A_24_P305556 NM_182802 MCM8 NM_182802




























































































































































Homo sapiens NDC80 homolog, chr18 GO:0000070(mitotic sister chromatid GO:0000775(chromosome, pericentric GO:0005515(protein binding)
A_23_P50108 NM_006101 NDC80 NM_006101



































chr8 GO:0042994(cytoplasmic sequestering of transcription factor) GO:0005737(cytoplasm) GO:0003714(transcription corepressor 
activity);GO:0005488(binding);GO:0005515(protein binding)












































chr10 GO:0006457(protein folding) GO:0005634(nucleus) GO:0003676(nucleic acid binding)





































A_23_P379614 NM_007280 OIP5 NM_007280
Homo sapiens Opa interacting protein 5 
(OIP5), mRNA [NM_007280]
chr15 GO:0007154(cell communication) GO:0005575(cellular_component) GO:0005515(protein binding)

























































































































































































































































































chr14 GO:0006260(DNA replication);GO:0006281(DNA repair) GO:0005634(nucleus) GO:0003677(DNA binding);GO:0003893(epsilon DNA 
polymerase activity);GO:0016740(transferase activity)
A_23_P218827 NM_199420 POLQ NM_199420
Homo sapiens polymerase (DNA directed), 
theta (POLQ), mRNA [NM_199420]






























































chr17 GO:0008150(biological_process) GO:0005575(cellular_component) GO:0003674(molecular_function);GO:0005515(protein binding)























































Homo sapiens pentraxin‐related gene, chr3 GO:0001878(response to yeast);GO:0006954(inflammatory GO:0005576(extracellular region) GO:0001872(zymosan binding)
A_23_P121064 NM_002852 PTX3 NM_002852












chr12 GO:0015031(protein transport) GO:0005634(nucleus);GO:0005829(cytosol) GO:0005096(GTPase activator activity);GO:0005515(protein 
binding)




































































































A_23_P167812 NM_153020 RBM24 NM_153020
Homo sapiens RNA binding motif protein 
24 (RBM24), mRNA [NM_153020]
chr6 GO:0016068(type I hypersensitivity) GO:0005634(nucleus) GO:0000166(nucleotide binding);GO:0003723(RNA binding)
A_24_P252057 NM_153020 RBM24 NM_153020
Homo sapiens RNA binding motif protein 
24 (RBM24), mRNA [NM_153020]
chr6 GO:0016068(type I hypersensitivity) GO:0005634(nucleus) GO:0000166(nucleotide binding);GO:0003723(RNA binding)







































protein signaling pathway);GO:0009968(negative regulation of
GO:0004871(signal transducer activity);GO:0005096(GTPase 
activator activity);GO:0005516(calmodulin binding)
_ _ _ _          
signal transduction)






































































































































chr22 GO:0006935(chemotaxis);GO:0007596(blood coagulation) GO:0005576(extracellular region) GO:0004867(serine‐type endopeptidase inhibitor 
activity);GO:0008201(heparin binding)

































A_23_P411335 NM_152524 SGOL2 NM_152524
Homo sapiens shugoshin‐like 2 (S. pombe) 






    _  



































































chr3 GO:0006810(transport);GO:0006865(amino acid transport) GO:0016020(membrane) GO:0015171(amino acid transporter activity)






















































































regulation of insulin receptor signaling pathway)
GO:0004860(protein kinase inhibitor 
activity);GO:0005515(protein binding)
         




chr13 GO:0045449(regulation of transcription) GO:0005634(nucleus) GO:0030528(transcription regulator activity)


























A_23_P320113 NM_080725 SRXN1 NM_080725
Homo sapiens sulfiredoxin 1 homolog (S. 
cerevisiae) (SRXN1), mRNA [NM_080725]






















chr1 GO:0007155(cell adhesion) GO:0005634(nucleus);GO:0043234(protein complex) GO:0005515(protein binding)






































































A_32_P91491 THC2618570 THC2618570 chr3
A_23_P153958 THC2651501 THC2651501 chr2
A_32_P17364 THC2664263 THC2664263 chr10



























































































































chr8 GO:0006355(regulation of transcription, DNA‐dependent) GO:0000785(chromatin);GO:0005634(nucleus) GO:0003677(DNA binding)




chr8 GO:0006355(regulation of transcription, DNA‐dependent) GO:0000785(chromatin);GO:0005634(nucleus) GO:0003677(DNA binding)























chr11 GO:0006512(ubiquitin cycle);GO:0009615(response to virus) GO:0005622(intracellular) GO:0005515(protein binding);GO:0008270(zinc ion 
binding);GO:0016874(ligase activity);GO:0046872(metal ion 
binding)
A_23_P150935 NM_005480 TROAP NM_005480
Homo sapiens trophinin associated protein 
(tastin) (TROAP), mRNA [NM_005480]
chr12 GO:0007155(cell adhesion) GO:0005737(cytoplasm) GO:0005515(protein binding)



































































































chr21 GO:0008033(tRNA processing);GO:0008150(biological_process) GO:0005575(cellular_component) GO:0003674(molecular_function)




chr21 GO:0008033(tRNA processing);GO:0008150(biological_process) GO:0005575(cellular_component) GO:0003674(molecular_function)








A_24_P254705 NM_020394 ZNF695 NM_020394
Homo sapiens zinc finger protein 695 
(ZNF695), mRNA [NM_020394]
chr1 GO:0006355(regulation of transcription, DNA‐dependent) GO:0005622(intracellular);GO:0005634(nucleus) GO:0003676(nucleic acid binding)





















E.1 MSC Mechanoresponses: Cyclic Strain vs. Shear Stress
E.1.1 List of shared conserved force-responsive molecules
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Figure 45: Genes with conserved responses to strain and shear stress. Venn diagram
showing overlap between lists of conserved force-responsive genes, generated using mi-
croarray data for either cyclic strain (Chapter 4) or shear stress (Chapter 6).
226
Figure 46: List of genes with conserved force-responses to cyclic strain and shear
stress. Annotation information for genes with significant (p < 0.05) conserved expression
level changes in response to both cyclic strain and shear stress. 34 genes intersected from
the lists of conserved strain-sensitive (442 genes) and shear stress-sensitive (574 genes).
Genes are listed in order of chromosome location.
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